Shekaru nawa ne ka ke da irin wannan ciwon?
Kuma dole ne a bi da duk wani ciwon kirji a wannan hanyar, musamman ma a shekarunka.
kuma musamman idan kana da zazzabi
Kuma ya kamata a riƙa lura da yawan cholesterol da kuma hawan jini
Kuma kuna da zazzabi a yanzu?
Shin kuna jin ciwon kirji a yanzu?
Shin kuna da wahalar numfashi?
Za ku iya gaya mini idan kuna da wasu alamun cutar?
Kuma yaya zafin jikinka yake?
Kuma ni ma ina tari
Kuma ina da ɗan zazzabi kuma ina tari
Kuma yau na ji ciwon kirji sosai
Shin wannan lokaci ne da zai sa ku kamu da cutar hayaki?
Kuma ina da wannan ciwo a kirji
Kuma ina ganin ina da zazzabi kadan
Za ku iya nuna mini inda kuke jin ciwon kirji?
Kuma suna da wani zazzabi ma
da kuma tarihin ciwon sukari
Kuma kin san ina jin kamar kirjina zai fashe
Kuma kun san cewa mutane suna ta yi min kwankwasawa a koda yaushe
kuma kuna da ciwon kirji
Kuma ka ce kana jin matsi a kirjinka
Akwai wani abu da ya faru a cikin iyalinku da ya shafi zuciya, ciwon zuciya, ciwon zuciya, yawan ƙwayar cholesterol, ko kuma hawan jini?
Shin kuna lura da wasu alamun ko matsaloli banda ciwon tsoka?
Shin akwai wasu mutane da ke cikin gidanku da suke da irin wannan ciwo?
Shin kana da wasu alamun cutar?
Shin ba ka da numfashi?
har yanzu kuna da ciwon kirji?
domin wannan shine lokacin mura
Amma bai kamata mu yi watsi da yiwuwar ciwon kirji da ke da nasaba da ciwon zuciya ba
amma wannan ciwon kirji shine mafi girma matsala yanzu
Amma ina da wahalar numfashi
Amma na san mutane da yawa suna ta yi min tari
Amma dole mu bi da duk wani ciwon kirji da kulawa sosai
Amma kana numfashi yadda ya kamata a yanzu, ko ba haka ba?
saboda na manta da shi gaba daya saboda wannan ciwon a kirji
kana jin kamar ana matse kirjinka
Shin har yanzu ba ku da numfashi?
suna gunaguni cewa suna rashin lafiya ko kuma suna da irin wannan alamun?
Shin kuna da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
Shin kuna da wasu cututtuka, ko kuma ciwon sukari?
Shin kana da matsalar numfashi?
Shin kana da hawan jini?
Shin, ba ka da numfashi a kan wannan?
Ka san alamun da take da su?
Kuna ganin hoton?
sha ruwa mai yawa yau
Amma ina yin gwajin ciwon sukari
Amma kuma tana da alamun da suka yi kama da nawa.
Yaya zafin zafin jikinka?
Yaya hawan jini?
idan har yanzu kuna da zazzabi mai tsanani
idan kuna da zazzabi na ɗari biyu ko sama da haka
idan kana ganin cewa alamun cutarka ko kuma wata matsala tana bukatar a bincika ta sosai
Na yi zazzabi jiya
Ni ma na samu zazzabi kadan
Na yi zazzabi jiya
Na ji ciwo mai zafi a nan cikin kirji
Ina da wasu matsaloli numfashi ma
zan aiko muku da hoto
Ina jin ciwon kirji yau
Ina da ciwon kai da kuma wani zazzabi a yau
Ina ganin mura ce
Ina ganin wannan wani ɗan zazzabi ne
Shin kamar wani mutum mai nauyi yana zaune a kan kirjinka?
Ya fara da ciwon kai da zazzabi kusan lokaci guda
Ina jin zafi a tsakiyar kirji na
Yana da zafi sosai a kirji
Yana cikin kirjina
Yana tsakiyar kirjina
Yana tsakiyar kirji
Ina da ciwon kirji
wannan ciwon kirji yana damuna sosai
Ina son ki bayyana min wannan ciwon a kirji
kamar hawan jini ko ciwon sukari
kamar ƙura a tsakiyar ƙirjin
yanzu don zazzabi zaka iya shan paracetamol
Mary, yaya tsawon lokacin da ka kasance da bayyanar cututtuka
yanzu kin ce kina da ciwon kirji
Wani lokaci na kan ji ciwon kirji
OK kana da wasu alamun cutar ko kuma kawai wannan ciwon kirji
Ko kuwa wani yana zaune a kan kirjinka?
kamar zazzabi da tari da ciwon kai da kuma ciwon tsoka
a tsakiya na kirji
Ka nuna min a wannan hoton inda kake da ciwo
tun lokacin da kuka yi zazzabi
To, shin kuna tsammanin wasu daga cikin alamun na iya kasancewa da alaƙa da ciki?
Shin yaranku suna da wasu daga cikin waɗannan alamun?
Faɗa mini game da ciwonku a cikin kirji
zazzabi na ƙaruwa da dare
zazzabin da na samu a kwanakin nan biyu
zazzabin ya fara ƙaruwa daren jiya
Wannan shi ne Dr. Porter daga sashen kula da yanayin gaggawa.
To, za ka iya gaya mana game da ciwon kirjinka?
To, ina jin zafi a gaban jikina, a nan a kirjina
To, ina da ciwo mai tsanani a kirji
To, idan na ji wannan ciwon a kirji
wane irin ciwo kake ji a cikin kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
Ina kake jin ciwon kirji?
ina kake jin wannan ciwon kirji a kirjinka
kamar kuna jin matsi a kirjinku
kin san ina da ciwon sukari da sauran abubuwa
kin ce kina da wannan ciwon a kirjinki
Hawan gaggawa na yawan kamuwa da cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020
Ƙididdigar yawan masu kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan ci gaba a ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma a Burtaniya, wanda ya tabbatar da cewa, ko da yake a matakai daban-daban, cutar ta COVID-19 tana ci gaba cikin sauri a kowace ƙasa.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da ma'aikatun kulawa mai tsanani suna bukatar su shirya don karuwar marasa lafiya da ke da cutar COVID-19 da ke bukatar kulawa, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an samu rahoton kamuwa da cutar huhu da ba a san dalilin ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar ta kasar Sin ta bayyana cewa kwayar cutar ta coronavirus ce wacce yanzu ake kira da SARS-CoV-2.
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
A yau, kusan kashi 80 cikin ɗari na waɗanda ke da COVID-19 suna da rashin lafiya, wato, kamuwa da numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin su suna warkewa.
A cikin kashi 14 cikin ɗari na cutar, COVID-19 na haifar da mummunar cuta da ke buƙatar asibiti, yayin da sauran kashi 6 cikin ɗari na cutar ke haifar da mummunar cuta da ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 kusan kashi 4 ne.
A cikin wannan binciken, muna kimanta yadda cutar COVID-19 ta shafi ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Burtaniya (UK), kuma muna kwatanta shi da yadda cutar ta shafi lardin Hubei na ƙasar Sin.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a ƙasashen EU/EEA da kuma Birtaniya da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'ummar EU/EEA da Birtaniya sun kamu da cutar COVID-19
Bayan China, COVID-19 ya ci gaba da yaduwa, kuma halin da ake ciki na annobar COVID-19 a sauran ƙasashe na duniya yanzu haka yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri da sauransu sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai bisa ga ma'anar cutar ta WHO.
A cikin EU/EEA, an samu mutane uku na farko da aka tabbatar da cutar a Faransa a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano wasu mutane da suka kamu da cutar COVID-19 a kowace ƙasa 30 na EU/EEA da kuma a Burtaniya (UK) tare da, tsakanin 31 ga Disamba, 2019, an samu mutum 39,768 da suka kamu da cutar da kuma mutum 1,727 da suka mutu, ciki har da mutane 17,750 da suka kamu da cutar da kuma mutane 1,441 da suka mutu a Italiya kadai.
Samun adadin da kuma yawan masu kamuwa da cutar COVID-19
Cibiyar Kula da Cututtuka ta Turai (CEPCM) tana sabunta adadin mutanen da suka kamu da cutar COVID-19 a kowace ƙasa a duniya, wanda aka samo ne kawai daga tushen hukuma kamar ma'aikatar lafiya, hukumomin kiwon lafiya na ƙasa da na yanki na ƙasashe daban-daban da kuma WHO, a kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU/EEA da kuma Birtaniya, da kuma kwatanta shi da kwarewar Italiya.
Don kimanta yaduwar masu cutar COVID-19, mun lissafa adadin adadin COVID-19 na kwanaki 14 a duniya, ta haka ne muka yi la'akari da yanayin COVID-19 a cikin kowace ƙasa ta EU/EEA da kuma Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gwada adadin masu kamuwa da cutar da aka ruwaito a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe tare da bayanan Italiya na 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da kuma Birtaniya
Yanayin yawan mutane da suka kamu da cutar COVID-19 a kwanaki 14 a cikin EU/EEA da kuma Birtaniya ya yi daidai da na lardin Hubei na kasar Sin (Hoto na 1).
A cikin EU/EEA da Birtaniya, adadin cutar COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu, sai ya ƙaru sosai a kusan 28 ga Fabrairu, 2020 (ƙarin bayanai).
Wannan canji ya kasance ne musamman saboda saurin karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU/EEA da kuma Burtaniya sun nuna irin wannan karuwar yawan cutar COVID-19 (ƙarin bayanai).
Shafi na 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da kuma Birtaniya idan aka kwatanta da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
An gano cewa a ranar 15 ga Maris, da karfe 8:00 na safe, wasu ƙasashe 15 na EU/EEA da kuma Birtaniya sun riga sun ba da rahoton adadin adadin waɗanda suka kamu da cutar da ya yi daidai da na Italiya makonni 3 da suka gabata ko kuma ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka ba da rahoton cutar COVID-19 na ƙaruwa cikin sauri a cikin EU/EEA da kuma Birtaniya.
Canjin yanayin cutar COVID-19 ya nuna cewa annobar tana ci gaba da irin wannan saurin a dukkan ƙasashe.
Kuma wannan duk da cewa ƙasashe suna cikin matakai daban-daban kuma akwai bambance-bambance a cikin martanin ma'aikatun kiwon lafiyar jama'a na ƙasa, da yiwuwar bambance-bambance a cikin ma'anar maganganun da kuma bambance-bambance a cikin ka'idojin zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, gami da gwajin dawowa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun ce kusan kashi 10 cikin 100 na marasa lafiya da ke fama da COVID-19 na bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun ruwaito cewa asibitoci da sassan kulawa mai tsanani a yankunan sun riga sun kai iyakar ƙarfin su.
A halin yanzu ana samun bayanai kan shigar da mutane da cutar COVID-19 asibitoci da/ko sashen kula da masu ciwo mai tsanani a EU/EEA na kashi 6 cikin 100 da kuma kashi 1 cikin 100 na masu cutar (ba a gabatar da bayanai ba).
Duk da haka, akwai bukatar tattara bayanai a kai a kai domin a kara yawan bayanan da ake da su na sa ido a kan adadin mutanen da suka kamu da cutar da kuma mutuwar da suka faru.
Wani bincike da aka yi a shekara ta 201011 ya nuna cewa akwai babban bambanci a yawan gadaje da ake da su a cibiyoyin kulawa mai zurfi da na matsakaici a Turai, daga gadaje 29.2 a kowace mutum 100,000 a Jamus zuwa gadaje 4.2 a Portugal.
Wannan yana nufin cewa ƙasashe suna da fiye ko ƙasa da albarkatu fiye da Italiya (12.5 gado a cikin kulawa mai zurfi da matsakaici a cikin mutane 100,000 a 2010).11
An samar da yanayin yin samfurin cikewar iyawar kulawa, tare da kimantawa ga kowace ƙasa ta EU/EEA da kuma Burtaniya na yawan mutanen da ke shan magani da COVID-19 da ke da haɗarin sama da kashi 90 cikin 100 na wucewar iyawar gadajen kulawa mai tsanani a cikin sabuntawa ta shida na KARANTA KARANTA KARANTA KARANTA KARANTA COVID-19.
Tun da yake an tattara masu cutar a wasu yankuna na EU/EEA da kuma Birtaniya, kuma asibitoci da kuma ma'aikatun kulawa mai tsanani suna kula da ƙididdigar al'ummar yankin, ya kamata a fi son a samar da bayanai kan masu cutar da kuma gadajen kulawa mai tsanani a matakin 2 na Ƙididdigar Ƙungiyoyin Ƙididdigar Ƙasa (NUTS 2).
Kwarewar Italiya da kuma ci gaban da ake samu a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da kuma Birtaniya.
Saboda haka, ƙasashe, asibitoci da ma'aikatun kulawa mai tsanani suna bukatar su shirya don yanayin watsa SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya da ke da COVID-19 da ke buƙatar kulawa, musamman kulawa mai tsanani, kamar yadda aka yi a yankunan da cutar ta shafa na Italiya.
Kamar yadda aka nuna a cikin rahoton da CEPCM ta yi kwanan nan na gaggawa, gaggawa, da kuma cikakkiyar hanya na da muhimmanci wajen jinkirta yaduwar cutar SARS-COV-2, daga hanyar hanawa zuwa hanyar rage cutar, saboda karuwar yawan masu kamuwa da cutar da wuri-wuri ba zai ba masu yanke shawara da asibitoci isasshen lokaci ba don fahimtar, yarda da kuma daidaita amsarsu, idan ba a aiwatar da wani abu ba a baya.
A cikin saurin tantance hadarin, an kuma lissafa matakan kiwon lafiyar jama'a da za su iya rage tasirin annobar.
Akwai ɗan gajeren lokaci da kowace ƙasa za ta iya ƙara ƙoƙarin sarrafa cutar don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan ayyukan kiwon lafiya.
Idan ba haka ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA na iya fuskantar ƙaruwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19), wadda cutar coronavirus 2 mai saurin numfashi (SARS) (SARS-CoV-2) ta haifar, ta yi sanadiyar mutuwar mutane sama da 3,000 da kuma kamuwa da mutane sama da 80,000 a China da sauran wurare a duniya, ta haifar da bala'in jin kai.
Kamar SARS-CoV, wanda ya haifar da dubban masu cutar SARS a 2003, SARS-CoV-2 na iya yaduwa ta hanyar barewa kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsarin.
Koyaya, COVID-19 ba shi da tsanani da mutuwa kamar SARS, amma yana da yaduwar kamuwa, kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A amsa ga karuwar littattafai game da wannan cuta mai tasowa, wannan talifin ya yi ƙoƙari ya ba da cikakken bayani game da wannan bincike mai tasowa.
Za mu tattauna muhimman abubuwa na ilimin cututtuka, ilimin cututtuka, ilimin ƙwayoyin cuta, ganewar asali, magani, ganewar asali da kuma rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan bincike zai taimaka wajen fahimtar wannan mummunar cuta da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu, 2020 ya shafar jama'ar kasar Sin har abada, inda suka tilasta wa kansu su tsare kansu a cikin gidajensu har tsawon mako guda da kuma makonni masu yawa saboda yaduwar sabuwar cuta ta kwayar cuta.
Kwayar cutar tana kama da kwayar cutar korona (CoV) wadda ta haifar da barkewar cutar mai saurin numfashi (SARS) a shekara ta 2003; saboda haka ne Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma ta sanya mata sunan cutar coronavirus 19 (COVID-19).
Cutar ta fara ne a Wuhan kuma ta bazu cikin sauri zuwa duk ƙasar Sin kafin ta bazu zuwa kusan wasu ƙasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, kwayar cutar ta haifar da fiye da mutane 80,000 da aka tabbatar da cutar COVID-19, tare da sama da marasa lafiya 40,000 da aka kwantar a asibiti da kuma sama da mutane 3,000 da suka mutu.
WHO ta ce COVID-19 shine babban magabcin jama'a, wanda zai iya zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga sama da takardu 200 kan COVID-19, musamman a fannonin ilimin ƙwayoyin cuta, ilimin cututtuka, ilimin ƙwayoyin cuta, ganewar asali da magani, tun daga rahoton farko a ranar 7 ga Janairu 2020 wanda ya nuna jerin ƙwayoyin cuta, wanda aka ware daga marasa lafiya da yawa.
Wannan bincike yana ƙoƙarin taƙaita ci gaban bincike a kan wannan sabon batun da ke ci gaba.
Da wuri-wuri za mu gwada COVID-19 da SARS da kuma wani cutar coronavirus, cutar numfashi ta Gabas ta Tsakiya (MERS, annobar da ta barke a shekarar 2012).
Za mu kuma duba abin da muka koya a yanzu game da rigakafin cutar da kuma yadda za a iya gane ta, kuma za mu tattauna wasu batutuwa da ba a bayyana ba amma da ake bukata.
An yi imani cewa kwayar cutar korona ba ta kashe mutum, kuma tana sa kashi 15 cikin 100 na mura 4.
Duk da haka, a wannan ƙarni, mun ga ƙwayoyin cuta guda biyu masu saurin cutar mutane, wato SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar da ta fara a China a 2003 da Saudi Arabiya a 2012, sannan ta bazu cikin sauri zuwa ƙasashe da yawa da ke da yawan masu kamuwa da cutar da kuma masu mutuwa.
Saboda haka, cutar COVID-19 ta yanzu ita ce annoba ta uku ta cutar coronavirus a tarihin 'yan kwanakin nan.
Kamar yadda aka nuna a Fig. Fig.1, an fara samun rahoton bullar cutar huhu a Wuhan a ranar 31 ga Disamba, 2019 daga Hukumar Lafiya ta Kasa ta Sin.
Bayan kwana bakwai, an gano yadda cutar ta Corona ta kasance.
A ranar 15 ga Janairu, 2020, an samu mutum na farko da ya mutu a Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an bayar da rahoton cewa ma'aikatan kiwon lafiya sun kamu da cutar, wanda ke nuna cewa ana iya yada cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an sanya birnin Wuhan a cikin keɓewa tare da dakatar da duk hanyoyin sufuri na jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti na cutar ya nuna cewa daga cikin mutane 41 da aka tabbatar da cutar, mutane 21 ne kawai suka samu kai tsaye a kasuwar abincin teku ta Wuhan, wadda ake ganin ita ce tushen kamuwa da cutar daga dabbobi da ba a san asalinsu ba.
A ranar 30 ga Janairu, WHO ta ayyana annobar a matsayin gaggawa ta duniya.
A lokacin rubuta wannan rahoto, cutar ta riga ta bazu ko'ina cikin ƙasar Sin da kuma kusan wasu ƙasashe 50 a faɗin duniya (Fig. (Fig.2).2).
Tun da yanayin ya ci gaba da saurin ci gaba, har yanzu ba a san ko cutar za ta kai ko za ta yi tsanani ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa da aka gudanar kan marasa lafiya 8,866, ciki har da 4,021 da aka tabbatar da cutar COVID-19, ya ba da cikakken bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/Ul-Bi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a kowane zamani, amma mafi yawa a tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekara 50, kaɗan ne kawai ke da shekaru 20 ko ƙasa da haka, kuma 14 ne kawai ke da shekaru 10 ko ƙasa da haka.
SARS-CoV-2 ya fi cutar maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 na yaduwa a gidaje, musamman a lardin Hubei da kuma kewayensa.
Matsakaicin lokacin tsakanin bayyanar cututtuka da gano COVID-19 kwanaki 5 (2-9).
Matsakaicin lokacin ɗorawar ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin tsawon lokaci tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki 9.5 (4,8-13).
Matsakaicin yawan haifuwa (R0) ya kasance 3.77 ( 95% CI: 3.51-4.05) kuma daidaitaccen R0 ya kasance 2.23-4.82.
Adadin mutanen da suka kamu da cutar ya ƙaru sosai har zuwa 23 ga Janairu, 2020, wanda ya yi daidai da yawan tafiye-tafiye da aka yi kafin bikin bazara a China.
Mutuwar marasa lafiya da aka gano a matsayin tabbataccen hali ya kasance 1.44% (95% CI: 1.10-1.86%) kuma adadi na mutuwar marasa lafiya duka ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku na haɗarin COVID-19 sune jinsi (maza), shekaru (≥ 60), da kuma ciwon huhu mai tsanani.
Kwayar cutar korona wani nau'i ne na manyan ƙwayoyin cuta masu ɗauke da RNA guda ɗaya.
Ana iya rarraba su zuwa jinsi huɗu, wato alpha, beta, gamma da delta, waɗanda aka san cewa suna iya kamuwa da mutane a cikin jinsunan alpha da beta.
Glycoprotein Spike (S) na takardar ya ɗaure zuwa enzymes na canza angiotensin 2 (ACE2) da dipeptidyl peptidase-4 (DPP4) na masu karɓar ƙwayar cutar SARS-CoV da MERS-CoV, bi da bi, sannan kuma membrane fusion ya faru.
An saki kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar ta kwayar cutar, kwayar RNA ta kwayar halitta tare da glycoproteins da kuma kwayar nucleocapsid suna samar da kwayar cutar da ke dauke da virions, wanda kuma ke hade da membrane na plasma don sakin kwayar cutar.
An gabatar da jerin kwayoyin halittar SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 sabon nau'in kwayar cutar betacoronavirus ne, tare da daidaiton kwayoyin halitta sama da kashi 99.98 cikin 100 tsakanin samfuran da aka tantance guda 10 da aka ɗauka daga wurin da cutar ta bulla, kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi SARS-CoV kama da MERS-CoV.
Ta hanyar amfani da microscopy na lantarki na watsawa, an gano kwayar cutar SARS-CoV-2 a cikin ƙananan ɓangarorin epithelium na numfashi.
An gano LACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 bai da ƙarfi sosai wajen ɗaure mutum zuwa ACE2 fiye da SARS-CoV, wanda ya yi daidai da SARS-CoV-2 wanda ke haifar da ƙarancin kamuwa da cuta fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon gajeren furotin da lorf3b ke yi da kuma furotin da lorf8 ke yi.
Lorf3b na SARS-CoV-2 na iya taka rawa wajen haifar da kwayar cutar kuma ya hana bayyana lIFNβ; duk da haka, lorf8 ba shi da sanannun yankuna ko tsarin aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun gabatar da tsarin cryo-ME na cikakken mutum ACE2 a ƙuduri na 2.9 Å a cikin hadadden tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa wannan hadadden, wanda ke da bude da kuma rufe, an haɗa shi a matsayin dimer kuma hadadden ACE2-B0AT1 zai iya haɗa sunadarai biyu na S, wanda ke ba da alamun ganewa da kamuwa da cutar coronavirus.
B0AT1 na iya zama wata hanyar warkewa don tantance magunguna don kawar da cutar SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na tsakiya
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga ƙudaje kuma an watsa su ga mutane ta hanyar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar.
Bayan kwatanta SARS-CoV-2 da sauran ƙwayoyin cuta, an gabatar da beraye a matsayin asalin SARS-CoV-2, saboda sabon kwayar cutar ta yi daidai da kashi 96 cikin ɗari na nau'ikan SARS-CoVs guda biyu da aka samo daga beraye da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san wanda ya sa cutar ta shiga tsakanin jinsuna ba kuma ba a san hanyar da ta kai ga mutane ba.
Ji, da sauransu, sun yi zaton cewa cutar ta iya zuwa daga bat zuwa mutum ta hanyar macizai, wanda hakan na nufin sake haɗuwa a cikin furotin S.
Wani bincike da masu bincike a Guangzhou, China suka gudanar ya nuna cewa pangolin - wani dabba mai tsalle mai tsalle mai cin nama da ake amfani da shi a maganin gargajiya na kasar Sin - na iya zama mai watsa shiri na SARS-CoV-2 idan aka yi la'akari da kashi 99 cikin 100 na kamanceceniya tsakanin kwayar cutar coronavirus da aka gano a pangolin da kuma SARS-CoV-2.
Duk da haka, bambancin 1% tsakanin kwayoyin halitta biyu na nuna bambanci mai mahimmanci; saboda haka, dole ne a jira sakamakon da zai ba da tabbacin tabbatacce (Fig. (Fig.33).
Har yanzu ba a san yawan abubuwan da SARS-CoV-2 ke da su ba.
SARS-CoV da MERS-CoV na iya rayuwa cikin in vitro na tsawon sa'o'i 48 a cikin bushewar yanayi har zuwa kwanaki 5 a zafin jiki na 20 °C da danshi na 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan halayen.
Ana ganin SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da kuma zafin jiki na 56 °C na tsawon minti 30; ether, 75% ethanol, chlorine, peracetic acid, chloroform da sauran mai mai, amma ba chlorhexidine ba, na iya kashe kwayar cutar.
Yawan mutanen duniya gabaɗaya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken bincike game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya komawa ga binciken da aka yi a baya kan wasu ƙwayoyin cuta, musamman SARS-CoV da MERS-CoV (Hoto (Hoto.4).4).
A al'ada, idan kwayar cutar ta kamu da wani mai masauki, tsarin garkuwar jiki na mai masaukin ta farko ne ke gane ta ta hanyar masu karɓar ƙwayar cuta ta ƙwayoyin cuta (PRR), musamman masu karɓar lectin na nau'in C, masu karɓar nau'in Toll (TLR), masu karɓar nau'in NOD (NLR), da masu karɓar nau'in RIG-I (RLR).
Ta hanyoyi dabam dabam, kwayar cutar tana haifar da bayyanar cututtukan kumburi, girma kwayoyin dendritic, da kuma samar da nau'in interferon I (IFN) wanda ke hana yaduwar kwayar cutar da kuma hanzarta maganin kwayar cutar ta kwayar cutar.
Duk da haka, furotin N na SARS-CoV zai iya ba da damar cutar ta tsere wa maganin rigakafi.
Ba da daɗewa ba, tsarin rigakafin zai soma yaƙi da cutar.
Kwayoyin T, musamman CD4+ da CD8+ suna da muhimmanci a kāre jikinmu.
CD4+ T-cell suna motsa B-cell da ke samar da ƙwayoyin cuta na musamman da ke hana cutar, kuma CD8+ T-cell suna kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimako suna samar da sinadarin cytokines masu hana kumburi don tallafa wa ƙwayoyin tsaro.
Koyaya, kwayar cutar korona na iya hana ayyukan ƙwayoyin T ta hanyar haifar da apoptosis.
Ƙarin rigakafi, tare da ƙarin abubuwa kamar C3a da C5a da kuma ƙwayoyin cuta, ma suna da muhimmanci wajen yaƙi da kamuwa da ƙwayoyin cuta.
Alal misali, ƙwayoyin cuta da aka ware daga wani mai warkewa sun kawar da MERS-CoV.
A wani ɓangare kuma, idan jikin mutum ya yi tsattsauran ra'ayi, zai iya sa yawan ƙwayoyin cuta su ƙaru sosai, kuma hakan zai iya sa a yi ciwo mai tsanani a cikin huhu da kuma wasu gabobin jiki, kuma idan aka yi wani abu marar kyau, zai iya sa jikin mutum ya kasa aiki sosai ko kuma ya mutu.
Cutar SARS-CoV-2, wadda ke faruwa a gida, tana iya shafar tsofaffi da ke da cututtuka da kuma mata masu juna biyu.
An yarda cewa mutanen da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda suke da aikin rigakafi da ya raunana suna da haɗarin kamuwa da cutar fiye da sauran mutane.
An kiyasta cewa matsakaicin lokacin da cutar SARS-CoV-2 ke ci gaba da zama na kwanaki 1 zuwa 14, amma yawanci kwanaki 3 zuwa 7 bisa ga binciken da aka yi kan mutane 425 da aka fara samun su a Wuhan.
Duk da haka, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa tsawon lokacin da ake yi wa jarirai ciki ya kai kwanaki uku a matsakaici, daga kwanaki 0 zuwa 24.
Wani bincike na baya bayan nan, kamar yadda aka bayyana a sama, ya kammala cewa ana da lokacin haifuwa na kwanaki 4.8 (3.0-7.2) daga yawan mutane 8 866.
Yana da muhimmanci sosai cewa hukumomin kiwon lafiya su daidaita tsawon lokacin keɓewar kai na gaske bayan lokacin kwantar da hankali da ya fi dacewa, domin kaucewa yaduwar cutar daga mutanen da suka kamu amma ba su da alamun cutar.
A al'ada, ana ware mutanen da suka kamu da cutar, ko kuma suka kamu da ita, na tsawon kwanaki 14.
Shin za a ƙara wa mutum kwanaki 24 a cikin gida?
Zazzabi shi ne farkon alama na COVID-19, kuma yana iya kasancewa tare da wasu alamomi kamar tari mai bushe, rashin numfashi, ciwon tsoka, rashin motsi, ciwon kai, ciwon makogwaro, ciwon hanci, ciwon kirji, zawo, rashin jin daɗi da kuma amai.
Wasu marasa lafiya sun nuna rashin nutsuwa da/ ko rashin jini bayan mako guda bayan farawar cutar.
A wasu lokatai, ana iya samun ciwon numfashi mai tsanani, ciwon hauka, ciwon acid, da kuma ciwon jini.
Dole ne a gwada marasa lafiya da ke da zazzabi da/ko alamun numfashi da kuma waɗanda ke da zazzabi mai tsanani, ko da ba su da wani abu da ya faru a kan taswirar kirji, don a iya gane cutar da wuri.
Wani bincike na al'umma da aka gudanar a karshen watan Disamba na 2019 ya nuna cewa masu fama da zazzabi sun kai kashi 98 cikin dari, sun kamu da tari mai bushe kashi 76 cikin dari, sun kamu da rashin nutsuwa kashi 55 cikin dari, kuma sun kamu da zawo kashi 3 cikin dari, kuma kashi 8 cikin dari na marasa lafiya sun bukaci taimakon numfashi.
An samu irin wannan sakamakon ne a cikin bincike biyu da aka yi kwanan nan a kan iyali da kuma gida da aka samu sakamakon kamuwa da cutar daga mutum da ba shi da alamun cutar.
Hakazalika, binciken alƙaluma da aka gudanar a shekara ta 2012 ya nuna cewa alamun da ke nuna cewa marasa lafiya da ke dauke da cutar MERS-CoV suna da zazzabi (98%), tari mai bushe (47%) da kuma rashin nutsuwa (55%).
Koyaya, kashi 80 cikin ɗari sun bukaci taimakon numfashi, wanda ya fi na marasa lafiya da ke da COVID-19, wanda ya yi daidai da yawan mutuwar mutane daga cutar MERS idan aka kwatanta da COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya da ke da cutar MERS.
Game da SARS, an gano cewa alamun farko sune zazzabi (99%-100%), tari mai bushe (29%-75%) dyspnea (40%-42%), zawo (20%-25%) da ciwon makogwaro (13%-25%), kuma ana bukatar taimakon numfashi a kusan kashi 14 zuwa 20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ya kai kashi 2 cikin ɗari, inda aka tabbatar da mutane 66,576 a duniya.
A kwatankwacin haka, mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10 cikin dari na mutane 8,096 da aka tabbatar da cutar.
A cikin binciken alƙaluma da aka gudanar a watan Yunin 2012, an gano cewa cutar MERS tana kashe mutane 37% a cikin mutane 2,494 da aka tabbatar da cutar.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya kai 6.47 tare da kashi 95 cikin dari na tabbaci (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kai 2 zuwa 4.
An kwatanta bayyanar cututtuka, mutuwa, da kuma R0 na SARS-CoV-2, MERS-CoV, da SARS-CoV a cikin Table Table1.1.
Bayanai da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaɗuwa fiye da MERS-CoV da SARS-CoV, amma ba ya kashe mutane sosai.
Saboda haka, ya fi wahalar sarrafa cutar SARS-CoV-2 fiye da yadda ya kasance a lokacin cutar MERS-CoV da SARS-CoV.
Sau da yawa, ana samun gida a cikin iyali ko a cikin taro ko a cikin mota, kamar yadda yake a cikin jirgin ruwa.
Marasa lafiya sun yi tafiya ko kuma sun zauna a Wuhan ko wasu yankunan da cutar ta shafa, ko kuma sun yi hulɗa da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu kafin bayyanar cututtuka.
Duk da haka, an nuna cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba fiye da makonni biyu, kuma marasa lafiya da suka warke na iya sake ɗaukar kwayar cutar, wanda ke nuna bukatar ƙara tsawon lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini na farfajiyar jiki (musamman na lymphocytes) a farkon matakai.
Alal misali, an gano cutar lymphopenia da ƙididdigar ƙwayoyin jini 4 × 109/L da ƙididdigar ƙwayoyin lymphocyte 1 × 109/L, da kuma ƙimar aspartate aminotransferase da kuma cutar viremia a cikin marasa lafiya 1,099 da ke da cutar COVID-19.
Wasu marasa lafiya suna da ƙwayoyin hanta, ƙwayoyin tsoka, da myoglobin a cikin jini, kuma mafi yawansu suna da ƙwayoyin C-reactive da kuma ƙwayoyin erythrocyte.
A cikin waɗanda suka fi tsanani, yawan D-dimer, wanda shi ne abin da ke halaka fibrin a cikin jini, ya yi yawa, kuma ƙwayoyin lymphocytes suna raguwa a hankali.
An gano rashin daidaito a hotunan kirji a yawancin marasa lafiya da ke da COVID-19, wanda ke nuna inuwa mara daidaituwa ko kuma rashin haske a cikin gilashin da ke cikin huhu.
Marasa lafiya sukan samu ciwon huhu da ciwon huhu mai tsanani da kuma ciwon numfashi mai tsanani (ADRS).
Idan mutum yana da ARDS, zai iya yin kumburi da yawa, ya tara ruwa, kuma ya soma ciwon hauka.
Rashin aiki na ƙwayoyin cuta na jini na nau'i na I da na II yana sa a rage yawan sinadarin da ke sa a yi amfani da shi a jiki kuma a ƙara matsawa a jikin mutum, hakan yana rage ƙarancin ƙwayoyin cuta a cikin huhu kuma yana ƙara haɗarin yin kumburi.
Saboda haka, ana yin gwajin kirji mai tsanani a lokacin da ciwon ya fi tsanani.
A ranar 18 ga Fabrairu, 2020, gwajin farko na cutar COVID-19 ya nuna cewa akwai kumburin ƙwayoyin huhu, samar da membrane hyaline, shiga cikin ƙwayoyin lymphocyte, da kuma ƙwayoyin syncytial masu ƙwayoyin cuta da yawa a cikin huhu na wani mai cutar da ya mutu, wanda ya yi daidai da cutar kwayar cutar da kuma ARDS kuma ya yi kama da na marasa lafiya da ke fama da cutar SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar polymerase chain reaction bayan juyawa (RT-PCR) a matsayin babban abin da aka yi amfani da shi wajen gano cutar COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
An lura da irin wannan yanayin a lokacin da ake gane SARS.
Saboda haka, haɗuwa da tarihin lafiyar mutum, alamun rashin lafiya, gwajin asibiti, da kuma gwajin radiology suna da muhimmanci kuma suna da muhimmanci wajen kafa ganewar asali.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ya bayyana wata yarjejeniya ta amfani da fasaha ta SHERLOCK bisa fasahar CRISPR don gano SARS-CoV-2, wanda ke ba da damar gano ɓangarorin SARS-CoV-2 RNA na roba tsakanin 20 × 10-18 mol/L da 200 × 10-18 mol/L (10-100 kwafi a kowace microliter na samfurin) ta amfani da faifan mai amsawa a cikin ƙasa da awa ɗaya, ba tare da buƙatar kayan aiki masu ƙwarewa ba.
Ana fatan cewa wannan sabuwar fasaha za ta inganta ƙwarewa da amfani sosai idan aka yi amfani da ita a kan samfuran asibiti.
Saboda rashin ƙwarewa a kan sabon kwayar cutar korona, likitoci na iya bayar da tallafi ga marasa lafiya da ke da cutar COVID-19 ne kawai, yayin da suke gwada magunguna da dama da aka riga aka yi amfani da su ko kuma aka ba da shawarar su don magance wasu kwayar cutar korona, kamar SARS-CoV da MERS-CoV da kuma wasu cututtukan ƙwayoyin cuta (Table (Table2).2).
Waɗannan hanyoyin sun haɗa da maganin da ake da shi da kuma wanda ake so da maganin rigakafin ƙwayoyin cuta, maganin hana rigakafi, maganin steroids, ruwan jini daga marasa lafiya da suka warke, maganin gargajiya na kasar Sin da kuma taimakon tunani.
An kuma ba da ruwan jini daga marasa lafiya da suka warke don a yi musu magani.
Kamfanonin ƙwayoyi suna aiki tuƙuru don samar da rigakafi da kuma allurar rigakafin cutar.
SARS-CoV-2 na fara kai hari ga huhu kuma mai yiwuwa a wasu ƙananan wurare, kamar tsarin ciki da na koda.
Amma, rashin numfashi da kuma rashin numfashi ne suke jawo haɗari ga marasa lafiya kuma su ne suke kashe su.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da kuma ceton rayuka. Wannan ya haɗa da maganin oxygen na gaba ɗaya, maganin oxygen mai yawa, iska mai guba da kuma iska mai guba ta inji, dangane da tsananin cutar.
Marasa lafiya da ke fama da cututtukan numfashi masu tsanani suna bukatar a yi musu maganin oxygenation ta hanyar membrane extracorporeal (OMEC), wata hanyar gyaran zuciya da huhu da ake amfani da ita wajen magance cututtukan zuciya ko na numfashi.
Bugu da ƙari, kiyaye daidaiton lantarki, hanawa da kuma kula da cututtuka na biyu da kuma girgizar ƙasa, da kuma kare ayyukan gabobin jiki ma suna da muhimmanci ga marasa lafiya da ke dauke da SARS-CoV-2.
An gano cewa yawan halayen garkuwar jiki yana haifar da tashin cytokine a cikin marasa lafiya da ke da SARS da MERS.
Cytokine shock wani nau'i ne na amsawar kumburi ta tsarin da aka nuna ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan ƙwayoyin suna sa ƙwayoyin jiki su saki ƙwayoyin cuta masu yawa, waɗanda suke da muhimmanci wajen sa a yi ciwon ARDS da kuma rashin ƙarfi na ƙwayar cuta.
Rashin rigakafi yana da muhimmanci wajen magance cututtukan cytokine, musamman ma a mawuyacin yanayi.
An yi amfani da maganin corticosteroids da tocilizumab, wani maganin rigakafin IL6 na monoclonal don magance cututtukan cytokine.
Sauran maganin hana rigakafi na cututtukan cytokine sun hada da T-cell modulation na amsawar garkuwar jiki, toshewar IFN-γ, IL-1 da TNF cytokines, JAK inhibition, blinatumomab, cytokine siginar 4 suppressor da kuma dHDAC inhibitors.
Ana amfani da steroids a matsayin maganin hana rigakafi a maganin SARS don rage lalacewar kumburi.
Koyaya, shan magungunan steroid mai yawa bai sami sakamako mai kyau ba a kan mummunan lalacewar huhu a cikin marasa lafiya da ke da SARS da COVID-19.
Maimakon haka, za su iya haifar da munanan sakamako masu illa, musamman ma cutar osteonecrosis avascular, kuma hakan zai iya shafan ci gaban cutar.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na ƙananan zuwa matsakaitan maganin corticosteroid a hankali ga marasa lafiya da ke da mummunan nau'in COVID-19.
A lokacin rubuta wannan rahoto, babu wani maganin rigakafin cutar da aka tabbatar da inganci.
Koyaya, maganin remdesivir a cikin jijiya, kwatankwacin nucleoside, ya kasance mai tasiri a cikin wani mara lafiya na Amurka da ke da COVID-19.
Remdesivir wani sabon magani ne na rigakafin ƙwayoyin cuta wanda Gilead ta fara samarwa don maganin cututtukan da ƙwayoyin cuta na Ebola da Marburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta masu amfani da RNA guda ɗaya, ciki har da MERS da SARS.
Bisa ga wannan binciken, Gilead ta tura sinadarin zuwa China don ba da damar yin gwaji da yawa a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana sa ran sakamakon.
Bugu da ƙari, baricitinib, interferon-α, lopinavir/ritonavir, da ribavirin an gabatar da su a matsayin magunguna masu yuwuwa ga marasa lafiya da ke fama da cututtukan numfashi.
Ciwon ciki, naushi, amai, raunin hanta da sauran illa na iya faruwa bayan an hada lopinavir da ritonavir.
Ya kamata a kula da hulɗar waɗannan magunguna tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta
Tattara jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa domin a kula da wasu marasa lafiya da ke fama da wannan cuta ko kuma a kare masu lafiya daga wannan cuta ya kasance a cikin al'ada.
A gaskiya, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa da suke hana su kamuwa da cutar.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙi da ƙwayoyin cuta da sauran ƙwayoyin cuta; suna gane ƙwayoyin ƙwayoyin cuta na musamman a cikin ƙwayoyin cuta kuma suna kawar da su kai tsaye.
An cire jini daga jini daga rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da suka kamu da cutar allurar.
A cikin sa'o'i 24 suka sami sauƙi a cikin alamun su, tare da rage kumburi, rage yawan ƙwayoyin cuta, da kuma ƙaruwar iskar oxygen a cikin jini.
Duk da haka, ana bukatar a bincika kuma a bayyana shi domin a iya ba da shawarar yin amfani da wannan hanyar a kan manya-manyan wurare har sai an samu wani magani na musamman.
Bugu da ƙari, saboda tasirin maganin, ya kamata a yi la'akari da wasu rashin jin daɗi da ke tattare da plasma.
Alal misali, ƙwayoyin cuta suna iya sa jikin mutum ya yi aiki da hanzari sosai kuma hakan zai iya sa mutum ya yi rashin lafiyar ƙwayoyin cuta.
Yawan rigakafin a cikin jini yawanci ba shi da yawa, kuma ana bukatar jini mai yawa don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da takamaiman rigakafi da sauri don magance annobar duniya.
Saboda haka, ya fi muhimmanci kuma ya fi inganci a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambobin ƙwayoyin cuta da ke ƙayyadadden ƙwayoyin cuta masu dacewa ko kuma a nemi ƙwayoyin cuta masu tasiri a kan manyan sunadarai na kwayar cutar.
Wannan zai sa a yi gagarumin ƙaruwar samar da ƙwayoyin cuta.
An yi amfani da TCM a ƙasar Sin na shekaru dubbai don magance cututtuka dabam dabam.
Amma, tasirinsa ya dangana ne bisa haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta bisa ga ganewar asali, bisa ga ka'idodin TCM.
Yawancin abubuwa masu amfani ba a san su sosai ba ko kuma ba a san su ba domin yana da wuya a cire su kuma a bincika su, ko kuma a san yadda za a yi amfani da su.
A yanzu, saboda rashin ingantaccen magani na COVID-19, TCM yana ɗaya daga cikin manyan hanyoyin magani na marasa lafiya da ke da ƙananan alamun cutar ko kuma waɗanda ke samun sauƙi daga wani nau'in cutar mai tsanani.
Alal misali, Shu Feng Jie Du da Lian Hua Qing Wen sun tabbatar da inganci wajen maganin COVID-19.
An samu mafi kyawun adadin masu warkewa daga COVID-19 a lardunan China da suka yi amfani da maganin TCM a kashi 87 cikin dari na marasa lafiya, ciki har da lardin Gansu (63.7%), yankin Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da maganin TCM a kashi 30 cikin 100 na marasa lafiya da ke fama da COVID-19, ya nuna mafi ƙarancin adadin masu warkewa (13%).
Amma, wannan kwatancen na kusa ne domin akwai wasu abubuwa da yawa da za su iya shafar yanayin, kamar yawan marasa lafiya da kuma tsananin cutar, da za a yi la'akari da su a lokacin da ake tantancewar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun wallafa wani bincike da ya kwatanta maganin da ke amfani da maganin yammaci (WM) kawai da kuma maganin hadewa da ke hada WM da TCM.
Lokaci na dawowa zuwa zafin jiki na al'ada, lokacin da bayyanar cututtuka suka tafi, da tsawon lokacin asibiti sun kasance sun fi gajeren lokaci ga ƙungiyar MO + MTC fiye da ƙungiyar MO kawai.
Abin mamaki, yawan cutarwa (daga mai saukin kai zuwa mai tsanani) ya fi ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
Duk da haka, ana bukatar a ƙara tabbatar da inganci da amincin TCM ta hanyar gwajin da aka sarrafa a manyan wurare da kuma cibiyoyi.
Yana da kyau a kwatanta hanyar aikatawa kuma a bayyana abin da ke da tasiri a maganin CTM ko kuma a haɗa su, idan za ta yiwu.
Mutanen da aka gano cewa suna da cutar COVID-19 ko kuma an tabbatar da cewa suna da ita, yawanci suna da matukar damuwa game da wannan cuta mai saurin yaduwa da kuma kisa, kuma waɗanda ke keɓewa suna jin haushi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta, kamar zazzabi, rashin jin daɗi, da tari, da kuma sakamako na magani, kamar rashin bacci da ake samu ta hanyar maganin corticosteroids, na iya haifar da ƙarin damuwa da damuwa ta tunani.
A farkon barkewar cutar SARS, an ba da rahoton cututtuka da dama na rashin lafiyar kwakwalwa, ciki har da ci gaba da baƙin ciki, damuwa, tashin hankali, tashin hankali, bayyanar cututtuka, rikicewar rikicewar rikice, har ma da tunanin kashe kansa.
Binciken alaƙa da keɓaɓɓen keɓewa, a matsayin wani ɓangare na amsawar ma'aikatar kiwon lafiya na jama'a ga ɓarkewar COVID-19, na iya ƙara damuwa da kuma haifar da wasu alhakin marasa lafiya game da tasirin kamuwa da cuta, keɓewa, da kuma ƙazantar da danginsu da abokansu.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya da ke da cutar COVID-19, ga mutanen da aka gano cewa masu cutar za su iya kamuwa da cutar, ga mutanen da ke hulɗa da waɗannan mutane, da kuma duk wani mutum da ke cikin matsala.
Wannan tallafi na tunani ya kamata ya haɗa da samar da ƙungiyoyi masu fannoni daban-daban, sadarwa mai ma'ana tare da sabuntawa na yau da kullun da kuma cikakke game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da aikace-aikacen lantarki da na'urori na sana'a don kaucewa kusanci.
Alurar riga kafi mai inganci tana da muhimmanci wajen katse hanyar watsawa daga dabbobi masu cutar da mutane zuwa ga masu cutarwa, kuma sau da yawa tana da alaƙa da maganin rigakafi wajen shawo kan annobar da ƙwayoyin cuta masu tasowa ke haifarwa.
An yi ƙoƙari wajen samar da allurar rigakafin da aka yi da furotin S, don samar da ƙwayoyin cuta masu ƙarfi na dogon lokaci da kuma/ko samar da rigakafin kariya daga SARS-CoV.
An gwada rigakafin da aka rage a kan dabbobi don SARS.
Duk da haka, in vivo ingancin waɗannan alluran rigakafin a cikin tsofaffi da kuma a kan samfurori da aka yi wa kisa da kuma kariya daga kamuwa da kwayar cutar zoonotic har yanzu suna da ƙayyadaddun, saboda ba a fara gwajin asibiti ba.
Wannan wataƙila saboda SARS ta ƙare shekaru 17 da suka shige kuma babu wani sabon hali da aka ba da rahoto tun daga lokacin.
A wani bangare kuma, ana ci gaba da samun wasu cututtuka da kuma ɓarkewar cutar MERS a Gabas ta Tsakiya da kuma wasu yankuna saboda ci gaba da samun tushen dabbobi a yankunan da cutar ta ke faruwa.
An tsara dabarun allurar rigakafi daban-daban don MERS ta amfani da kwayar cutar da ba ta aiki ba, plasma na DNA, masu ɗaukar kwayar cutar, nanoparticles, kwayar cutar da ke da alaƙa da kwayar cutar, da kuma ƙwayoyin sunadarai masu haɗuwa, kuma an gwada wasu a kan dabbobi.
Samar da maganin rigakafin SARS-CoV-2 mai inganci da lafiya ga mutanen da ba su da rigakafi muhimmin abu ne na gaggawa da kuma gaggawa don shawo kan annobar da ke gudana.
Koyaya, wannan ƙalubale ne na gaske saboda dogon lokaci (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma bambance-bambancen masu saurin faruwa na coronavirus.
A matsayin cutar da ke tasowa, COVID-19 na fara ne kawai a cikin dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna samun sauƙi a hankali.
Duk da haka, kamar SARS da MERS, COVID-19 ma yana da alaƙa da yawan kamuwa da cutar da kuma mutuwar mutane a cikin mafi munin yanayin.
Saboda haka, kafa tsarin tsinkaya yana da muhimmanci domin hukumomin kiwon lafiya su iya fifita ayyukansu, musamman ma a yankunan da ke da iyakantaccen albarkatu.
Bisa ga binciken asibiti da aka yi zuwa yanzu, abubuwan da ke iya shafar ko kuma hade da yanayin cutar COVID-19 su ne:
Shekaru: Shekaru shi ne babban abin da ke sa cutar SARS ta bayyana, kuma hakan na iya faruwa da COVID-19.
COVID-19 ya fi shafar mutane masu shekaru 30 zuwa 65, tare da kashi 47.7 cikin ɗari na waɗanda suka haura shekaru 50 bisa ga binciken da aka yi kan mutane 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa mai tsanani sun fi fuskantar cututtuka da rikitarwa kuma sun fi tsufa (matsakaicin shekaru 66 zuwa 51), wanda ke nuna cewa shekaru ne ke sa a yi tsammanin cutar COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Cutar da ke tare da cutar: marasa lafiya da ke da cutar COVID-19 da ke bukatar kulawa mai tsanani suna iya samun rauni mai tsanani na zuciya da kuma rashin saurin bugun jini.
Abubuwan da ke faruwa a zuciya su ne kuma suke haddasa mutuwar marasa lafiya da ke fama da cutar SARS.
An gano cewa SARS-CoV-2 na iya ɗaure zuwa kwayar halitta mai ƙwayoyin cuta mai ƙwayoyin cuta na ACE2, wanda hakan na iya haifar da rashin aiki na hanta a cikin marasa lafiya da ke da COVID-19.
Ya kamata a lura cewa tsufa da kuma kasancewar cututtukan da ke tattare da shi suna da nasaba sosai kuma suna iya shafar juna.
Sakamakon gwaje-gwaje na rashin daidaito: matakin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar nama; an gabatar da shi a matsayin mai yiwuwar ƙaddamar da cutar, amsawa ga magani da waraka.
An kuma bayar da shawarar cewa akwai dangantaka tsakanin yawan CRP da tsananin cutar da kuma hasashen cutar COVID-19.
Bugu da ƙari, yawan lactate dehydrogenase (LDH), daspartate aminotransferase (AST), dalanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen saita hangen nesa.
Ana amfani da waɗannan ƙwayoyin a wurare da yawa, musamman a zuciya da hanta, kuma ana fitar da su sa'ad da aka yi wa nama rauni.
Saboda haka, a al'ada ana ganin cewa waɗannan sun nuna cewa zuciya ko hanta ba su da aiki.
Alamomin asibiti na farko: sakamakon radiyo na kirji da kuma ci gaban alamun asibiti a lokaci ya kamata a bincika tare da sauran abubuwa don sanin cutar COVID-19 da kuma rikitarwa.
Amfani da steroids: kamar yadda aka bayyana a sama, steroids sune magungunan hana rigakafi da aka saba amfani da su a matsayin ƙarin magani ga cututtukan cututtukan cututtuka don rage tsananin lalacewar kumburi.
Tun da an yi amfani da maganin corticosteroid mai yawa a kan manyan cututtukan SARS, mutane da yawa da suka tsira sun sami cutar osteonecrosis avascular wadda ta haifar da rashin iya aiki na dindindin da kuma rashin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a rage yawan maganin steroid ga marasa lafiya da ke da COVID-19 kuma a rage tsawon lokacin da za a yi amfani da shi.
Matsalar tunani: kamar yadda aka bayyana a baya, annobar COVID-19 ta haifar da yawan al'amuran damuwa na musamman, sau da yawa marasa lafiya suna fuskantar dogon lokaci na keɓewa, rashin tabbas mai yawa da kuma mutuwar dangi ko sauran marasa lafiya.
Yana da muhimmanci a ba da taimako na tsawon lokaci da kuma taimako na tunani domin a taimaki waɗannan mutane su shawo kan wannan matsin kuma su koma rayuwa ta al'ada.
Bisa ga binciken yawan jama'a da aka yi zuwa yanzu, COVID-19 kamar tana da halaye daban-daban na annoba da SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 yana yin kwafi sosai a cikin hanyoyin numfashi na sama kuma ba ya haifar da alamun cutar a farkon matakin kamuwa da cuta, kamar yadda coronavirus ke haifar da mura.
Saboda haka, mutane da suka kamu da cutar kwanan nan ko kuma waɗanda suke cikin lokacin da ake kamuwa da cutar, suna iya samar da ƙwayoyin cuta masu yawa a cikin ayyukansu na yau da kullum, wanda hakan ke kawo babbar matsala wajen shawo kan annobar.
Koyaya, an yi la'akari da cewa SARS-CoV yana yaduwa ta hanyar marasa lafiya masu tsanani, tare da ƙarancin yiwuwar yaduwa a matakin farko.
Saboda haka, annobar COVID-19 ta yanzu ta fi tsanani kuma da wuya a sarrafa ta fiye da SARS.
A halin yanzu ana yin gagarumin aiki a kasar Sin, ciki har da kulle Wuhan da biranen da ke kewaye da ita, da kuma ci gaba da keɓe kusan dukkan jama'a don dakatar da yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan matakan sun yi tasiri sosai a kan tattalin arziki da sauran bangarorin kasar, adadin sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
A cikin mafi yawan hasashe, cutar za ta ƙare a watan Maris kuma za ta rage tsawon watanni uku zuwa huɗu.
Amma, ba dukan masana ba ne suke da irin wannan ra'ayin.
Paul Hunter, da sauransu, sun yi imanin cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Longini, da sauransu, sun kafa wani tsari don hango sakamakon annobar kuma sun kammala cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin samfurin hanci da makogwaro na marasa lafiya da suka warke, makonni 2 bayan an sallame su daga asibiti, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama mai juyawa kamar mura.
Duk da haka, an ga alamun karfafa gwiwa a China tare da raguwar sabbin cututtuka, wanda ke nuna cewa dabarun da aka aiwatar sun yi aiki.
A farko, an yi hasashen cewa cutar Ebola za ta kai mutane miliyan ɗaya da mutuwa miliyan ɗari.
Amma, an iya shawo kan cutar ta wajen ware ta daga mutane da kuma ware ta.
Kamar SARS-CoV, SARS-CoV-2 na iya raunana a yanayin kamuwa da cuta har ya mutu ko kuma ya zama ƙarancin kwayar cuta da ke rayuwa tare da mutane.
An ba da kwatancen barkewar COVID-19 da SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana yaduwa sosai ta hanyar tari ko tari, kuma mai yiwuwa ta hanyar hulɗa kai tsaye da kayan da ke da cutar.
An kuma gano cutar a cikin kwandon mutane, wanda hakan ya nuna cewa ana iya samun cutar ta bakin jini.
Wani bincike da aka yi kwanan nan a kan marasa lafiya 138 ya nuna cewa kashi 41 cikin ɗari na cutar na iya kasancewa sanadiyyar kamuwa da cuta a asibiti, tare da marasa lafiya 17 da suka riga sun kamu da cutar da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a ɗauki matakan kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangi da abokan aiki na marasa lafiya, har ma da duk wanda zai iya samun hulɗa da marasa lafiya ko mutane masu kamuwa da cutar.
Hanya ta farko ta kariya don rage haɗarin kamuwa da cuta ita ce sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da kuma N95 (1860) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Abun rufe fuska na tiyata yana hana saukowar saukad da cutar ko kuma sauka a kan wani wuri, inda za a iya yada su ga wasu.
Duk da haka, N95 (1860) ne kawai ke ba da kariya daga numfashin kwayar cutar 10 zuwa 80 nm, tare da kashi 5 cikin 100 na kwayar cutar da ke iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma, tun da duka biyun suna da nisan kusan 85 nm.
Tun da yake ƙwayoyin suna iya ratsa abin rufe fuska biyar da aka ɗora a kan juna, ya zama wajibi ma'aikatan kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya su sa abin rufe fuska na N95 (1860s) ba abin rufe fuska ba.
Bugu da ƙari ga abin rufe fuska, dole ne ma'aikatan kiwon lafiya su sa rigunan keɓewa da suka dace domin rage hulɗa da ƙwayoyin cuta.
Ƙwayoyin cuta kuma suna iya kamuwa da mutum ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta hanyar ido saboda kumburi.
Saboda haka, ya kamata ma'aikatan kiwon lafiya su saka abin rufe fuska ko kuma tabarau na kariya sa'ad da suke hulɗa da marasa lafiya.
Ga mutanen da ke cikin yankunan da cutar ta shafa ko kuma za ta iya shafawa, an bada shawara sosai cewa su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta fiye da yadda aka saba, su kasance a cikin gida kamar yadda ya kamata, kuma su rage hulɗa da mutanen da ke da cutar.
Ana ba da shawara a kasance nesa da marasa lafiya na mita 1.
Waɗannan matakan hanyoyi ne masu inganci na rage haɗarin kamuwa da cutar da hana yaduwar cutar.
Ko da yake SARS-CoV-2 sabon kwayar cuta ne ga mutane, yawan kamaninta da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya sanya kasar Sin cikin yanayin gaggawa bayan barkewar cutar SARS a 2003.
Duk da haka, a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka da Rigakafin Cutar ta Wuhan ya tabbatar wa jama'a cewa sabon kwayar cutar ba ta da saurin yaduwa, kuma ba ta da iyakantaccen yaduwa tsakanin mutane, kuma ba zai zama da wahala a hana da kuma shawo kan cutar ba.
Wannan sakon ya haifar da wani jinkiri, musamman a lokacin da kasar ke shirin bikin bazara, kuma an rasa babbar dama ta hana cutar a Wuhan.
Ya kamata hukumomin kula da cututtuka na kasar Sin su koyi darasi daga wannan kuma su dauki matakan da suka dace.
Alal misali, waɗannan hukumomi suna bukatar (1) su kasance masu hankali a cikin sanarwarsu ga jama'a, domin kowace kalma tana da muhimmanci kuma tana iya shafar halayyar jama'a da shawarwari; (2) su kasance masu saukin kai da kuma amsawa ga bayanai na musamman daga asibitoci maimakon jiran rahotanni na yau da kullum daga likitoci ko hukumomi; (3) su kasance masu ƙuntatawa don su hana yiwuwar barkewar cutar a farkonta maimakon ƙoƙarin kwantar da hankalin jama'a; da (4) su gudanar da ƙarin ayyuka masu ma'ana da kuma dacewa don wayar da kan jama'a game da cututtukan annoba, amma kuma su gwada kuma su inganta tsarin mayar da martani na al'umma a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, a lokacin da ake rubuta wannan rahoto, ya yaɗu zuwa duk ƙasar Sin da kuma kusan ƙasashe 50 a duniya.
Tun da yake wannan kwayar cutar ta yi kama da SARS-CoV kuma alamun COVID-19 sun yi kama da na SARS, barkewar COVID-19 ta zama kamar ba a taɓa gani ba.
Duk da haka, akwai bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda ya kamata a yi la'akari da su don a iya shawo kan annobar da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa, maza fiye da mata; kuma yawan cutar da kuma yawan mutuwar mutane sun fi yawa a cikin tsofaffi.
SARS na da yawan mutuwa fiye da COVID-19 (10.91 bisa dari da 1.44 bisa dari).
Ana iya yada kwayar cutar COVID-19 ko da ba tare da bayyanar cututtuka ba, yayin da SARS ya fi yaduwa ta hanyar marasa lafiya masu tsanani, saboda haka yana da wuya a hana yaduwar COVID-19.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ya yadu da sauri kuma ya fi SARS-CoV yaduwa.
Gwajin SARS-CoV-2 na yau da kullun na RNA na iya zama mara kyau ga wasu marasa lafiya da ke da COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Wannan yana ƙara yawan haɗarin yaɗuwa.
Duk da saurin ci gaba a binciken COVID-19, akwai wasu muhimman tambayoyi da ba a amsa ba, ciki har da:
Ta yaya SARS-CoV-2 ya fito daga duniya?
Ko da yake an samu daidaiton kwayoyin halittar kashi 96 cikin dari tsakanin SARS-CoV-2 da nau'in SARS guda biyu na kwayar cutar daga beraye, wannan bai isa ba don tabbatar da cewa SARS-CoV-2 ta fito ne daga kiroptera.
Wane irin nau'i ne ya ba da damar kamuwa da cutar daga mai masaukin farko, kamar su batsa, zuwa ga mutane?
Idan ba a amsa tambayoyi 1 da 2 ba, ba zai yiwu a daina yaduwar cutar ba, kuma za a iya sake barkewar cutar a kowane lokaci.
Tsarin kwayoyin halitta da nazarin kwayoyin sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, amma ta yaya ainihin cutar take shiga cikin ƙwayoyin numfashi kuma ta yaya take haifar da canje-canje na rashin lafiya?
Shin kwayar cutar tana ɗaure kanta ga ƙwayoyin da ke nuna ACE2 a wasu gabobin jiki?
Idan ba a ba da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za a iya gano cutar da sauri ba kuma ba za a iya samun magani mai kyau ba.
Har yaushe za a ci gaba da annobar?
Ta yaya kwayar cutar take canzawa a tsarin halittar jikin mutum yayin da take yaduwa tsakanin mutane?
Zai zama annoba ta duniya, zai ɓace kamar SARS, ko kuma zai sake bayyana a kai a kai kamar mura?
Yana da muhimmanci, ko da yake zai ɗauki lokaci, a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, ko da menene farashin da hakan zai haifar, ba mu da wani zaɓi sai dai mu kawo ƙarshen wannan annobar da wuri-wuri don mu koma ga rayuwarmu ta yau da kullun.
Yawancin lokaci, lokacin ɓoyewar waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sai kuma kusan makonni biyu na rashin lafiya.
Rarraba ƙwayoyin cuta na ƙananan hanyoyin numfashi ne kawai aka yi a cikin marasa lafiya da suke da matsalar rashin garkuwar jiki.
An fara samun cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na ƙasar Sin.
Ba tare da ƙididdigar masu watsawa ba, an kimanta cewa kowane mutum zai iya haifar da ƙananan mutane biyu tare da lokacin rufi tsakanin kwanaki 4 zuwa 7, tare da ƙaruwar ƙwayar cutar a ranar 10 na cutar.
Marasa lafiya da ke dauke da cutar SARS-CoV suna fara samun ciwon zuciya, ciwon kai, zazzabi, rashin jin daɗi da kuma jin kuncin jiki, sannan kuma suna samun rashin nutsuwa, tari da kuma wahalar numfashi a matsayin alamun bayyanar cututtuka.
Lymphopenia, gwajin hanta da ba daidai ba, da kuma ƙaruwa a yawan sinadarin creatine kinase su ne abubuwan da ba su dace ba da ake gani a gwajin da ake yi a dakin gwaje-gwaje idan ana zargin SARS.
An kuma lura da lalacewar alveolar da ke yaduwa, ƙaruwar ƙwayoyin epithelial da kuma ƙaruwar macrophages a cikin marasa lafiya da ke da SARS.
Bayan haka, kashi 20 zuwa 30 cikin ɗari na marasa lafiya suna bukatar kulawa mai tsanani da kuma yin amfani da na'ura mai kwantar da iska.
Bugu da ƙari ga ƙananan hanyoyin numfashi, wasu gabobin jiki da suka haɗa da hanjin ciki, hanta da koda, za su iya kamuwa da cutar a cikin waɗannan mawuyacin yanayi, sau da yawa tare da tashin hankali na ƙwayoyin cuta, wanda zai iya zama mai mutuwa musamman a cikin marasa lafiya masu ƙarancin garkuwar jiki.
Tun daga lokacin, an yi ƙoƙari sosai wajen bincike kan cutar HCoV.
An gano HCoV-NL63 a cikin wani yaro mai wata bakwai a Netherlands a ƙarshen shekara ta 2004.
Da farko, ana samunsa a cikin yara ƙanana, tsofaffi, da kuma marasa lafiya da suke da ciwon numfashi.
Kasancewar coryza, conjunctivitis, zazzabi da kuma bronchiolitis na yau da kullun ne a cikin cutar da HCoV-NL63 ke haifarwa.
Wani bincike na 'yanci ya kwatanta warewar wannan cutar daga kwayar hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, a gaskiya yana ko'ina a duniya.
HCoV-NL63 yana da alaƙa da cutar laryngitis, wanda ake kira croup.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da ke asibiti saboda ciwon huhu da kuma ciwon huhu a Hong Kong.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 na faruwa a duniya, yana haifar da cututtukan numfashi na matsakaici.
A al'ada, idan HCoVs suka sami damar watsawa cikin nasara kuma suna ci gaba da kasancewa a cikin mutane, su ma ba sa da cutar ko kuma suna haifar da cuta.
Wani kuma annobar ta biyu ta auku a Koriya ta Kudu a shekarar 2015, inda aka tabbatar da mutane 186.
Alamar asibiti na MERS tana kama da na SARS kuma ana nuna ta ne ta ciwon huhu mai tsanani.
Ba kamar SARS ba, marasa lafiya da yawa da ke fama da cutar MERS sun kuma samu rashin aikin koda mai tsanani, wanda yake shi ne hali na MERS idan aka kwatanta da cututtukan HCoV.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna da ciwon ciki da kuma kumburi.
A ranar 14 ga Fabrairu, 2020, an samu fiye da mutane 2,500 da aka tabbatar da su a dakin gwaje-gwaje, tare da yawan mutuwar mutane 34.4%, wanda ya sanya MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi kisa da aka sani a cikin mutane.
Wasu marasa lafiya ma suna da zawo.
SARS-CoV-2 ba shi da cutar, amma yana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An samu rahotanni na mutane marasa alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida da kuma bambance-bambance sun nuna kamance da bambance-bambance masu ban sha'awa.
Na farko, lokacin da cutar HCoV ke ci da kuma tsawon lokacin da take ci suna da kama sosai.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran HCoV shida.
Na biyu, cutar COVID-19 tana da tsanani tsakanin SARS-CoV da kuma HCoVs guda huɗu na al'umma (wato HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, an kuma ga ƙaramin rukunin mutane masu cutar COVID-19 mai tsanani kamar yadda ake samu a cikin cutar SARS-CoV, ko da yake adadin ya ɗan ragu.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin fitsari.
Koyaya, halaye na SARS-CoV-2, gami da yaduwar cutar, cutar da ke haifar da cutar, da kuma ci gaba da yaduwar cutar bayan yaduwar ta zuwa ga mutane, zai yi tasiri ga makomar cutar COVID-19 ta yanzu.
An gano cewa cutar HCoVs guda huɗu da ke haifar da alamun cutar a cikin al'umma sun dace da mutane.
A wasu kalmomi, dukansu na iya zama waɗanda suka tsira daga annobar HCoV da ta gabata.
Don wannan ya faru, HCoVs dole ne su ninka a cikin mutane a cikin isasshen adadin da zai ba da damar tarawa na canjin halittar da ke daidaita abubuwan da ke hana mai masaukin.
A wannan yanayin, yayin da cutar SARS-CoV-2 ke ci gaba da yaduwa kuma yawan mutanen da ke kamuwa da cutar ya ƙaru, za a iya ganin cewa cutar za ta iya daidaita kanta ga mutane.
Idan ya daidaita da kyau, zai yi wuya a daina yaduwar cutar tsakanin maza ta hanyar killacewa ko wasu matakan sarrafa kamuwa da cuta.
Shekaru da yawa yanzu, CoVs huɗu da aka samu a cikin al'umma suna yawo a cikin jama'a, suna haifar da mura a cikin mutanen da ba su da rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar dabba.
A gefe guda, SARS-CoV da MERS-CoV, masu cutarwa sosai, ba su daidaita da kyau ga mutane ba kuma ba su da dorewar yaduwa tsakanin mutane.
Dole ne su ci gaba da yaduwa a cikin tasoshin su na dabbobi kuma su nemi damar kaiwa ga yiwuwar mutane, mai yiwuwa ta hanyar daya ko fiye da masu watsa shirye-shirye da masu karawa.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da kuma HCoVs huɗu da aka samu a cikin al'umma.
Duk da haka, ya fi cutar HCoVs da aka samu a cikin al'umma, kuma ba ya cutar SARS-CoV ko MERS-CoV.
Ya rage a gani ko zai iya daidaita kansa ga mutane kuma ya yi yawo a tsakanin mutane ba tare da wani mai masaukin dabba ko kuma wani mai shiga tsakani ba.
Kafin mu tattauna asalin HCoVs a cikin dabbobi, zai taimaka mana mu tattauna ma'anar da kuma halayen masu watsawa, masu halitta, masu riƙewa, masu matsakaici, da masu haɓaka HCoVs.
An gano cewa cutar HCoV tana iya zama mai watsawa a cikin dabba idan tana da wani dangin da ke da irin wannan hali a cikin kwayar halitta.
Kwayar cutar ta asali sau da yawa tana da sauyi kuma ba ta haifar da cuta ga mai masaukin.
Hakazalika, mai watsa labaran yana riƙe da HCoV a kai a kai kuma na dogon lokaci.
A gefe guda, HCoVs na iya daidaitawa ga mai watsa shiri na tsakiya har ma da kafa ƙwayoyin cuta na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na tanki na halitta.
Musamman, saboda kashi 80 cikin ɗari na dabbobi a kasuwar Guangzhou suna nuna ƙwayoyin cuta na SARS-CoV, ba za a iya ware yiwuwar cewa wasu ƙananan nau'in dabbobi masu shayarwa za su iya zama masu watsawa na tsakiya ba.
Waɗannan ƙwararrun sun sami kwayar cutar SARS-CoV da kuma SARSr-Rh-BatCoV HKU3 na kwayoyin halitta.
Waɗannan nazarin sun kafa tushen sabon ra'ayi cewa batsa ce mai kula da cututtukan da ke damun mutane.
An san enzyme mai sauya jini na mutum 2 (ACE2) a matsayin mai karɓar SARS-CoV.
Duk da yawan kamance tsakanin ƙwayoyin cuta biyun, ana ganin cewa WIV1 ba shine dangin SARS-CoV ba kuma cewa ƙudaje ba su ne masu riƙe SARS-CoV ba.
Saboda haka, ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar.
Bugu da ƙari, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa dabbobin da ke da kwayar cutar sun kamu da cutar HIV, kamar yadda rakuma da ke da asalin Gabas ta Tsakiya da ke a ƙasashe da dama na Afirka suke.
Bugu da ƙari, raƙuman da suka kamu da cutar suna fitar da kwayar cutar ba ta hanyar numfashi kawai ba, amma ta hanyar ƙwayoyin cuta, wanda kuma shi ne hanyar da ake fitar da ƙwayoyin cuta a cikin ƙwari.
Ba za mu iya ware yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu watsa SARS-CoV-2 ba.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 bai kai nesa tsakanin SARS-CoV-2 da SARS-CoV-2 beta-CoVs da pangolin ba.
Ana samun sauyi a cikin kwayar cutar beta-CoVs ta hanyar sake haɗuwa.
Masana kimiyya sun rarrabu kan asalin SARS-CoV-2 na dabbobi.
A cikin wannan binciken, an gano cewa an gano cewa cutar HCoV-229E tana da cutar da ke haifar da cututtuka da yawa.
Shaidar ilimin halittu ta nuna cewa HCoV-NL63 da HCoV-229E dukansu na iya fitowa daga CoV na naman-dangi, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin masu naman-dangi.
A gefe guda, an danganta HCoV-229E da wani nau'in CoV na naman-dangi, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da kuma ana zargin cewa wasu nau'in camellids ne ke daukar kwayar cutar.
Lokacin da HCoV-OC43 ya tsallaka shingen nau'in don ya kamu da mutane daga dabbobin gida a kusan 1890, an ba da rahoton annobar cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna ba shi da tabbas.
An gano alpha-CoVs na namomin kaza da ke kusa da HCoV-229E.
Na farko, ba kamar alpagas ba, mutane suna iya yin hulɗa da batsa a cikin yanayin da suke da shi.
Amma, mutane suna da dangantaka ta kud da kud da alpacas.
Na biyu, alpha-CoVs na HCoV-229E na bat suna da yawa kuma ba su haifar da cututtuka a cikin bat, yayin da alpha-CoV na alpaga ya haifar da barkewar cutar numfashi a cikin dabbobin da ke dauke da cutar.
A ƙarshe, ba a gano alpha-CoV na alpaga a cikin dabbobin daji ba.
A gaskiya, ƙwarƙwarar ƙwari ce take kai tsaye ga ƙwayoyin cuta da ke haddasa cututtuka ga mutane, kamar su cutar zazzaɓin daji, cutar Ebola, Nipah, da kuma Hendra.
Saboda haka ba abin mamaki ba ne cewa ƙwarƙwarar ƙwari za ta iya watsa HCoV-229E kai tsaye zuwa ga mutane.
Wata yiwuwar ita ce, yayin da alpha-CoVs na bat suna aiki a matsayin taskar kwayoyin HCoV-229E, alpagas da dromedaries na iya zama masu watsa kwayar cutar tsakanin mutane, kamar yadda MERS-CoV ke.
MERS-CoV misali ne mai kyau na yaduwar nau'in daga bat zuwa dromedary da kuma dromedary zuwa mutum.
An san asalin MERS-CoV da aka samu a cikin beraye ta hanyar gano shi da farko kuma an kuma tabbatar da shi ta hanyar binciken da aka yi daga baya.
A gefe guda, MERS-CoV ya kasance a cikin dabbobi masu kama da dabbobi shekaru da yawa.
Ya yi amfani da shi sosai a cikin waɗannan raƙuma da suka zama masu riƙe da ruwa.
Ba kamar rabon da ke watsa MERS-CoV ba, aikin pangolin a watsa SARS-CoV-2, idan suna da shi, ya bambanta.
A cikin wannan, an gano cewa cutar beta-CoVs na pangolin tana da illa sosai ga pangolin.
An haɗa ko kuma an cire yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane a cikin binciken nan gaba.
Na farko, ƙwayoyin fata za su iya zama masu riƙe da kwayar cutar SARS-CoV-2 da ta yi kama da SARS-CoV-2.
Mutane za su iya zama a cikin yanayi mai kyau tare da namomin kaza ta wajen yin amfani da su wajen yin haƙa da kuma hakar kwal.
Na biyu, pangolins na iya zama ɗaya daga cikin masu karfafawa na tsakiya da aka gabatar da kwayar cutar SARS-CoV-2 a kwanan nan.
Mutane suna kamuwa da cutar ta wajen cin naman dabbobin da aka kashe.
Akwai yiwuwar dabbobi masu shayarwa da dama ciki har da dabbobin gida su iya kamuwa da cutar SARS-CoV-2.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da kuma daidaita SARS-CoV-2 na iya faruwa a cikin nau'in nau'in na uku wanda ya kasance tare da bat da pangolin.
Ana ci gaba da bincike kan asalin SARS-CoV-2 daga dabbobi.
Idan aka kwatanta da sauran ƙwayoyin cuta masu RNA guda ɗaya, ƙididdigar ƙimar canjin CoVs za a iya ɗauka a matsayin  matsakaici  zuwa  mai girma  tare da matsakaicin canjin canji na ~10-4 sauye-sauye a kowace shekara a kowane wuri, dangane da matakin d daidaitawar CoV zuwa sababbin runduna.
Duk da haka, yawan kamuwa da CoV ya ninka na waɗanda suka kamu da shi sau miliyan.
Bugu da ƙari, yawan canjin kwayar cutar sau da yawa yana da girma idan CoVs ba su daidaita da mai ba da izini ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin halittar, ana ganin SARS-CoV-2 yana da ƙananan canjin halittar, wanda ke nuna cewa yana da yawan canjin halittar da ya dace da ɗan adam.
Wataƙila ya riga ya daidaita da wani da ke kusa da mu.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da dabbobi masu kama da dabbobi.
A ka'ida, ba zai yiwu ba cewa kwayar halitta za ta sa allurar rigakafin SARS-CoV-2 da maganin rigakafin cutar su zama marasa tasiri a cikin gajeren lokaci.
Na uku, CoVs suna canza salon su a kai a kai yayin yin kwafin RNA ta hanyar tsari na musamman na  zaɓi-kwafi .
An sami shaidar ilimin halittu na sake haɗuwa ta halitta ga HCoV-HKU1 da HCoV-OC43, da kuma CoVs da aka lura da su a cikin dabbobi kamar SL-CoV da batCoV-HKU9.
Haɗin kai tsakanin kwayar cutar da mai watsawa
Baya ga waɗannan abubuwa uku na ƙwayar cuta da aka ambata a sama, yin hulɗa da ƙwayar cuta da mai karɓa na mai masaukin baki wani muhimmin abu ne da ke shafar watsawar tsakanin jinsuna.
Ana amfani da sake haɗuwa da SARS-CoV a matsayin misali na yau da kullum a nan; kuma yana nuna tabbacin zaɓin mai kyau a lokacin watsawar tsakanin nau'in.
A wasu kalmomi, waɗannan sauye-sauyen amino acid guda biyu na iya zama mabuɗin sauyawar cutar zuwa ɗan adam.
Abin sha'awa, SARS-CoV-2 yana da mai karɓar kwayar halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S yana nufin cewa iyawar S na S tare da ACE2 na mutum na iya zama ya lalace.
Ainihin, binciken cryomicroscopy na lantarki ya nuna cewa wannan haɗin ya fi na ACE2 na ɗan adam sau 10 zuwa 20 fiye da na SARS-CoV S.
Hakanan zai zama da ban sha'awa a gano ko ana bukatar wani mai karɓar SARS-CoV-2 don watsawa.
Abin mamaki, HCoV-NL63 kuma yana ɗaure zuwa lACE2 amma tare da wani ɓangare na furotin S.
Akwai wasu masu karɓar HCoV da yawa, kamar su aminopeptidase N don HCoV-229E, da kuma  9-O-acetyl sialic acid don HCoV-OC43.
Rashin daidaiton furotin mai watsawa tsakanin mutane da masu watsa kwayar cutar HCoV, kamar su batsa, dromedary da rodents, na iya zama shinge ga yaduwar kwayar cutar tsakanin jinsuna.
Sabbin ƙwayoyin cuta na HCoV: komawar asali
A cikin wannan, an yi amfani da maganin cutar HCoVs a cikin nau'in HCoVs da yawa.
A wannan ma'anar, CoVs na bat ne ke da asalin HCoVs.
A cikin sunadarai na SARS-CoV, an yi la'akari da cewa ORF8 yana da muhimmanci wajen daidaitawa ga mutane, saboda ƙwayoyin cutar SARS-CoV masu kama da bat sun kasance a ware amma suna yin lambar sunadarai daban-daban na ORF8.
Wannan kawar tana raba ORF8 zuwa ORF8a da ORF8b kuma ana ganin shi a matsayin maye gurbin da ke taimakawa wajen sauya mai masaukin.
An kuma gano wuraren sake haɗuwa a cikin nsp9, a cikin yawancin nsp10 da kuma wasu nsp14.
Hakazalika, an nuna cewa annobar MERS-CoV ta sake haɗuwa tsakanin jinsuna daban-daban, wanda ya faru a cikin dabbobin da ke da ƙwayoyin halittar dabbobi a Saudi Arabiya.
Yayin da aka gano ORF4 a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaca yana nuna shigar nucleotide guda ɗaya, wanda ke haifar da sauya fasalin karatu.
A ƙarshe, an kuma ƙarfafa canjin sabon HCoVs ta hanyar zaɓin matsin lamba a cikin rukunin rundunarsu.
An gano marasa alamun cutar ko kuma alamun cutar a lokacin da namomin kaza suka kamu da CoV, wanda ke nuna cewa akwai daidaituwa tsakanin CoVs da namomin kaza.
Ya bayyana cewa batirin ya daidaita da CoVs sosai a fannin jiki da kuma jiki.
Alal misali, rashin daidaituwa a cikin kunna amsa mai hana kumburi a cikin beraye yana rage cutar da CoVs ke jawowa.
Bugu da ƙari, babban matakin magungunan oxygen (DRO) da ake samu ta hanyaraikin hawan ƙwayoyin cuta na ƙudaje na iya hana kwafin CoV da kuma shafar "rewriting" ta hanyarexoribonuclease, wanda zai haifar da matsin lamba mai zaɓaɓɓu kuma ya haifar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masauki.
Ƙarin kwayar cuta na CoV na iya canzawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawar mai masaukin baki.
Saboda haka, ba abin mamaki ba ne cewa an samu sababbin ƙwayoyin HCoV guda uku a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da wasu alamun rashin lafiya a cikin masu masaukin su kamar su bat da raƙuma.
Suna yin kwafi sosai ba tare da sa jikin mahaifinsu ya yi tsayayya da cutar ba.
A nan ne asirin gano masu dauke da cutar marasa alamun cutar yake da kuma abin da ke haddasa cututtuka masu tsanani a cikin mutane.
Ainihin dalilin bayyanar cututtuka masu tsanani shi ne yawan hawan jini da kuma tashin cytokine; idan hawan jini ya yi ƙarfi, cutar ta ƙaru.
A gefe guda, a cikin masu dauke da cutar da ba su da alamun cutar, an gano yadda rigakafin ke amsawa daga kwayar cutar CoV.
Irin wannan dabarar kawar da amsawar garkuwar jiki na iya samun sakamako mai amfani wajen maganin SARS-CoV-2.
Saboda haka, ana sa ran cewa bayar da interferon na nau'i na I aƙalla a farkon kamuwa da cutar SARS-CoV-2 zai kasance da amfani.
Bugu da ƙari, ƙwayoyin NLRP3 ba su da aiki a cikin beraye.
Bisa ga wannan tunani, hana NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Yayin da aka gano beta-CoV na bat da ke da kashi 95 cikin 100 na kwayar cutar SARS-CoV, akwai kuma CoV na bat da ke da kashi 96 cikin 100 na kwayar cutar SARS-CoV-2.
An gano beta-CoVs na pangolin da suka yi kama da SARS-CoV-2 wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu watsa shirye-shiryen tsakanin ko kuma beta-CoV na pangolin na iya ba da gudummawa ga ɓangarorin kwayoyin halittar SARS-CoV-2.
CoVs sun sake zama abin da ake magana a kai saboda barkewar cutar SARS-CoV-2 kwanan nan.
A gefe guda, MERS-CoV ya daɗe yana wanzuwa a cikin dabbobi masu kama da dabbobi.
Waɗannan raƙuma suna da muhimmanci a sufuri kuma suna kawo nama da madara da fata da kuma ulu ga mazauna yankin.
A Gabas ta Tsakiya da Afirka, mutane da yawa suna yin hakan.
Saboda haka ba zai yiwu a yanka rakuma duka don a sarrafa cutar MERS ba kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a yi amfani da cikakkiyar hanyar samar da rigakafin MERS-CoV mai inganci a cikin raƙuma, tare da sauran matakan sarrafa cutar.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za a iya samun sababbin nau'o'in da za su iya haifar da annoba.
An gano cewa akwai wasu nau'o'in kwayar cutar da ke yaduwa a cikin dabbobi.
Musamman, CoVs na bat, wanda ke da babban damar cutar dabbobi.
Ya kamata a daina cin dabbobi a wasu yankunan kasar Sin domin rage hulda da dabbobi.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin ramin da suke da shi har sai sun samu zarafin yaɗuwa.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa domin fahimtar yanayin CoVs da kuma na masu masaukin su, wanda zai taimaka wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma annobar nan gaba.
A ƙarshe, hanya mafi inganci ga mutane su hana kamuwa da cutar ta ƙwayoyin cuta ita ce su guje wa wuraren da cutar ta ƙwayoyin cuta take.
Na farko, idan dabbobin da ke da ƙwayar cutar SARS-CoV-2 sun kai su ga tsuntsaye, zai zama da ban sha'awa a bincika a wane yanayi ne dabbobin da tsuntsaye za su iya samun wuri ɗaya a cikin mahalli.
Na biyu, idan da akwai wani abu da ake yi da ke sa mutane kamuwa da cutar kai tsaye daga ƙwari, to, ya kamata a bincika yadda mutane suke hulɗa da ƙwari.
Na uku, idan dabba ta uku tana da matsayin mai masaukin baki, ba a san yadda take sha'ani da dabbobi dabam-dabam ba, har da mutane da batsa da kuma pangolin.
Ko da shi ke kunkuru ne, ko kuma wani dabba mai shayarwa, ya kamata a iya gano SARS-CoV-2 ko kuma kusan irin kwayar cutar da aka gano a cikin mahaifansu.
Alal misali, mutum zai iya kamuwa da cututtukan numfashi kamar mura ko sanyi idan bai wanke hannunsa ba kafin ya taɓa idanunsa, hanci, ko baki (watau, hancin ciki).
Babban manufar wanke hannu a fannin kiwon lafiya shi ne kawar da cututtukan cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da kuma sunadarai da ke iya cutarwa ko kuma haifar da cuta.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa; hana cututtukan da ke haddasa zawo; rage cututtukan numfashi;
Ƙarƙashin yawan yara da suke mutuwa a gida.
A ƙasashe masu tasowa, za a iya rage yawan yara da ke mutuwa daga cututtukan numfashi da kuma zawo ta wajen yin canje-canje a halayensu, kamar wanke hannu da sabulu.
Ciwon huhu, ɗaya daga cikin manyan cututtuka na RA, shi ne sanadin mutuwa mafi girma na yara 'yan ƙasa da shekara biyar, wanda ke kashe kusan mutane miliyan 1.8 a kowace shekara.
Cutar zawo da ciwon huhu suna kashe kusan yara miliyan 3.5 kowace shekara.
Wanke hannu yana kuma kāre mutum daga cutar Impetigo, wadda ake yaɗawa ta wurin taɓawa ta jiki.
Rashin wanke hannu sau da yawa yana iya lalata fata ta hanyar sa ta bushe.
Wani bincike na Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da cutar eczema ko cututtukan fata a hannu, wanda ke nuna fatar hannu da kuma itching, kuma ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin cewa yana cikin alamun cutar OCD.
A cikin wannan shirin na kasa, ana yin amfani da maganin kawar da ƙwayoyin cuta sau biyu a shekara, tare da wanke hannu da sabulu da kuma goge haƙora da maganin haƙori mai ruwan fluoride.
An yi amfani da shi sosai a ƙasar Indonesia.
Babban aikin sabulu da kayan wankewa shi ne rage shingayen da ke hana maganin kuma ƙara narkewa.
Ruwa kaɗai ba zai iya tsabtace fata ba domin ƙwayoyin jiki da kuma sunadarai, waɗanda abubuwa ne na ƙasa, suna da wuya a narke su cikin ruwa.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta daga amfani na baya.
Har zuwa yau, babu wata hujja da ta nuna cewa amfani da maganin kashe cututtukan cuta ko kuma maganin kashe cututtukan cuta zai iya kai wa ga kwayoyin da suka yi tsayayya da maganin rigakafi a cikin yanayi.
Saboda haka, ko da yake ba sauro na kashe ƙwayoyin cuta ba ne ke sa mutane su yi tsayayya da ƙwayoyin cuta, amma ba za su yi nasara ba kamar yadda ake faɗa.
Baya ga mai saurin shafawa da kuma kare fata, wasu nau'ikan kayan shafawa masu wuyar fahimta suna iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) da ke daidaita pH, benzoic acid, wanda ke da aikin rigakafin ƙwayoyin cuta, da sauran masu karewa (aloe vera, bitamin, menthol, tsire-tsire na shuka). Wani bincike mai zurfi da Jami'ar Oregon School of Public Health ta yi ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu na hannu na mutum wanda ke dauke da triclosan, wajen hana cututtuka da kawar da kwayoyin cuta.
Ruwan zafi da ake amfani da shi wajen wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna ƙaruwa da sauri a zafin jiki (37° C).
Amma ruwan dumi da sabulu ya fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke ɗauke da ƙazanta da ƙwayoyin cuta.
Amma, ba kamar yadda mutane suke tunani ba, bincike na kimiyya ya nuna cewa amfani da ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannu.
Maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta na hannu, shi ne kayan tsabtace hannu marar ruwa.
Yawancin an tsara su ne daga isopropyl alcohol ko ethanol tare da wani mai kara kauri kamar carbomer (polymer na acrylic acid) don samun gel, ko kuma wani mai laushi kamar glycerin don samun ruwa ko kumfa don mafi sauki amfani da rage tasirin busassun giya.
Ƙara hydrogen peroxide mai narkewa yana ƙara aikin rigakafin ƙwayoyin cuta. Maganin kashe ƙwayoyin cuta na hannu da ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta da kyau.
Maganin ruwan giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin kamuwa da cuta (SARM da ERV), tarin fuka, da wasu ƙwayoyin cuta (har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da hepatitis), da kuma fungi.
Maganin ruwan giya kusan ba shi da tasiri a kan ƙwayoyin cuta irin su Norovirus (ko Norwalk), wanda shi ne babban sanadin kamuwa da ciwon ciki. Ya kamata a yi amfani da isasshen maganin kashe cuta na hannu ko maganin ruwan giya don a yi wanka sosai ko kuma a rufe hannu biyu.
An ƙara amfani da waɗannan kayayyakin ne saboda sauƙin amfani da su da kuma gaggawar kawar da ƙwayoyin cuta; duk da haka, ba za su maye gurbin wanke hannu ba sai dai idan ba ku da sabulu da ruwa a hannu.
Yin amfani da maganin ruwan giya sau da yawa na iya sa fata ta bushe idan ba a ƙarfafa maganin ba tare da emollients da/ko kayan shafawa na fata.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da/ko wasu abubuwa masu narkewa a cikin maganin.
A cikin gwaji na asibiti, maganin ruwa mai narkewa da ke ɗauke da emollients ya haifar da rage yawan haushi da bushewar fata fiye da sabulu ko kayan tsabtace antimicrobial.
Cutar fata ta haɗuwa, hawan hauka ko ƙarancin ƙwarewa ga barasa ko abubuwan da ke cikin maganin ruwan-alkoho.
Ko da yake suna da amfani, kayan da ba su da ruwa ba sa kawar da abubuwa masu ƙamshi da ke hannunka, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda haka, maganin kashe cututtukan hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtuka da yawa, domin su na kan hannu.
Ingancin maganin kashe cututtukan hannu marar barasa ya dogara sosai da sinadarai da kuma tsarin da aka yi amfani da shi, kuma ya kasance ƙasa da na barasa da na maganin kashe cututtukan hannu mai tushen barasa.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da aiki na rigakafin ƙwayoyin cuta bayan an yi amfani da su, ba kamar giya ba, wanda tasirinsa ya ragu bayan an yi amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da halayen fata.
Ash ko ƙasa za su iya yin aiki fiye da ruwa kaɗai, amma ba za su iya yin aiki kamar sabulu ba.
Ƙari ga haka, idan ƙwayoyin cuta suka gurɓata ƙasa ko toka, hakan zai iya sa mutane su yi ciwo maimakon su hana su.
Kamar sabulu, toka ma tana kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da maganin alkaline.
WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu idan ba a samunsa.
Ka yi wanka da ruwan sanyi ko na dumi.
Ana ba da shawarar ruwan gudu saboda haɗarin gurɓata wuraren da ruwa ke tsayawa, yayin da zafin ruwan bai yi wani bambanci ba).
Ka zuba sabulu mai yawa a hannunka, ka shafa su a kan juna, ba tare da manta da bayan hannunka ba, tsakanin yatsanka da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna amfani da sabulu fiye da idan suna amfani da ruwa kawai.
Ka shafe akalla sakan 20 a cikin wannan takardar.
Yin shafa yana haifar da taɓawa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin taɓawa na dogon lokaci yana cire ƙwayoyin cuta da yawa.
Ka wanke da ruwa mai yawa.
Wanke hannu a cikin kwandon ruwa mai tsayawa zai iya sa hannu ya sake gurɓata.
Ka bushe da tawul mai tsabta ko kuma a waje.
Hannun da suke da danshi da kuma danshi suna da saukin sake kamuwa da cutar. Wuraren da aka fi mantawa da su su ne babban yatsan hannu, wuyan hannu, tsakanin yatsun hannu da kuma ƙusa.
Ƙwayoyin cuta suna iya zama a ƙusa da kuma ƙusa da aka yi da ƙusa.
Ana ba da shawarar yin amfani da man shafawa don hana hannuwan bushewa. Darin fata yana haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa cututtuka.
Akwai wasu hanyoyin wanke hannu masu tsada da yawa idan ba a samu ruwan famfo da sabulu ba. Misali, zubar da ruwa daga ramin da aka rataye da kuma bugawa da kuma/ko amfani da toka idan ya cancanta, a ƙasashe masu tasowa. A cikin yanayin da samar da ruwa ya iyakance (kamar a makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin da za a ceci ruwa, kamar su tippy-taps da sauran zaɓuɓɓukan tattalin arziki.
Tattalin ruwa fasaha ce mai sauƙi da ke amfani da tukunya da aka rataye ta da igiya, da kuma wani abin da ake amfani da shi don zuba ruwa a hannaye da kuma sabulu.
Yin bushewar hannu da kyau wani muhimmin bangare ne na tsaftace hannu, amma ana ta muhawara kan yadda za a bushe hannu a cikin gidan wanka na jama'a.
Bincike da yawa na nuna cewa tawul ɗin takarda sun fi na lantarki tsabtace hannu da ake samu a cikin gidajen wanka.
Bayan an wanke hannu da kuma bushe shi a bushewar hannu, an gano cewa adadin ƙwayoyin cuta sun ƙaru da kashi 194 bisa ɗari a jikin yatsunsu da kuma kashi 254 bisa ɗari a hannun hannu.
Drying hannu da iska ya haifar da karuwar adadin kwayoyin cuta a kan yatsun hannu da kashi 42 cikin dari da kuma a kan dabino da kashi 15 cikin dari.
Bayan an bushe hannu, an lura da waɗannan bambance-bambance na ƙididdigar ƙwayoyin cuta:
Akwai masana'antun bushe hannu da yawa, kuma an gwada bushe hannu da bushewa ta amfani da tawul ɗin takarda.
Wanke hannu da kayan wankewa na iya zama mafita yayin tafiya, idan babu sabulu da ruwa.
Dole ne ruwan giya ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Akwai na'urorin lantarki da suke ba da gargaɗi sa'ad da ma'aikatan asibiti suka manta da wanke hannu.
Wanke hannu na likita ya kamata ya ɗauki aƙalla dakika 15, ta yin amfani da sabulu da ruwa mai yawa ko kuma gel don kumfa da shafa kowane ɓangare na hannu.
Hannun ya kamata a shafa su a tsakanin yatsunsu.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don rufe famfo (da kuma buɗe ƙofar fita idan ya cancanta).
Manufar wanke hannu a cibiyoyin kiwon lafiya ita ce cire ƙwayoyin cuta masu cutarwa ( ƙwayoyin cuta ) da kuma hana su watsawa.
Whitby et al. sun yi bincike mai kyau.
bayan an yi amfani da jini/ruwa mai rai;
kafin yin aikin aseptic; da kuma
Dole ne a cire dukan kayan ado.
A cikin wannan tsari, ana bukatar wanke hannu da gaban hannu har zuwa gwiwoyi, yawanci na tsawon minti 2 zuwa 6.
Ya kamata a guji ruwa daga gaban hannu zuwa hannaye yayin wankewa.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko a yi amfani da maganin kashe ƙwayoyin cuta kafin a kula da mutum da kuma bayan an kula da shi.
Game da kula da kamuwa da cutar staphylococcus a asibitoci, an gano cewa an samu fa'idodi mafi girma na wanke hannu a kashi 20 na farko na wanke hannu, kuma akwai fa'idodi kaɗan na ƙara yawan wanke hannu fiye da kashi 35 cikin dari.
Ana bukatar ƙarin bincike don gano hanyoyin da suka fi tasiri a cibiyoyin kiwon lafiya dabam dabam.
Alal misali, a yawancin yankunan karkara na Afirka, ba a samun famfo don wanke hannu kusa da wuraren wanka na jama'a ko na masu zaman kansu, duk da akwai zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Duk da haka, rashin wanke hannu na iya zama saboda halaye na yau da kullum, maimakon rashin sabulu ko ruwa.
Da zarar an kai ga mafi ƙarancin ƙa'idodi, makarantu za su iya zuwa daga tauraro ɗaya zuwa uku na ƙarshe.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na inganta tsaftace hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke da'awar karfafa sauyin hali. Bayan annobar cutar korona ta 2019-2020, UNICEF ta karfafa karɓar emoji da ke nuna wanke hannu.
Amma, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftace-tsabta riba.
A lokacin, mutane da yawa sun gaskata cewa ana samun cututtuka ne daga ƙamshi mai ƙamshi da ake kira miasm.
Alal misali, a Jamus, an saka alluna da ke nuna  hanyoyin wanke hannu da suka dace  kusa da banɗaki a gidajen wanka na jama'a da kuma na ofisoshin gwamnati da kuma na filayen jirgin sama.
Furucin nan "wanke hannuwanku" yana nufin cewa mutum ya ƙi ya ɗauki alhakin wani abu ko kuma ya ƙi ya yi wani abu.
Ƙari ga haka, waɗanda aka ƙyale su su wanke hannuwansu bayan sun yi irin wannan tunanin ba sa son su yi wasu abubuwa da za su iya taimaka musu su tsarkake kansu, kamar aikin agaji.
Hakazalika, addinin Hindu, Buddha, Sikh, addinin Yahudawa, da kuma Musulunci suna bukatar a wanke hannu kafin da kuma bayan kowane abinci.
Kuma dole ne a bi da duk wani ciwon kirji a wannan hanyar, musamman ma a shekarunka.
kuma musamman idan kana da zazzabi
Kuma ya kamata a riƙa lura da yawan cholesterol da kuma hawan jini
Kuma kuna da zazzabi a yanzu?
kuma kana da wasu daga cikin wadannan alamun baya ga ciwon kirji?
Kuma hancinka yana gudana?
Kuma zafin yana motsawa daga kirjinka?
Kuma ku sha ruwa mai yawa.
Kuma yaya zafin jikinka yake?
Kuma ni ma ina tari
Kuma ina da ɗan zazzabi kuma ina tari
Kuma yau na ji ciwon kirji sosai
Kuma ina da wannan ciwo a kirji
Kuma ina ganin ina da zazzabi kadan
Kuma tana da alamun cutar iri daya
Kuma ka gaya mini, waɗanne irin alamun cutar kake da su a yanzu?
Kuma suna da wani zazzabi ma
da kuma tarihin ciwon sukari
Kuma kin san ina jin kamar kirjina zai fashe
Kuma kun san cewa mutane suna ta yi min kwankwasawa a koda yaushe
kuma kuna da ciwon kirji
kuma alamomin cutar ba sa tafiyar cikin kwana biyar
Kuma ka ce kana jin matsi a kirjinka
Shin kuna lura da wasu alamun ko matsaloli banda ciwon tsoka?
ciwon ciwon kai a gefen kirjinka na hagu?
Shin akwai wasu mutane da ke cikin gidanku da suke da irin wannan ciwo?
kuna da wahalar numfashi a yanzu?
Shin kana da wasu alamun cutar?
Shin ba ka da numfashi?
har yanzu kuna da ciwon kirji?
domin wannan shine lokacin mura
Ya kamata a kuma lura cewa yin amfani da kwayoyin halitta na iya sa a yi canje-canje a cikin kwayoyin halitta na ƙwayoyin cuta, wanda wataƙila sakamakon matsin lamba ne, musamman na tsarin garkuwar jiki na mai masaukin.
Misali na wannan shine asarar ORF4 a cikin kwayar cutar HCoV-229E, saboda ɓarkewar nucleotides biyu.
Yayin da aka gano ORF4 a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaca yana nuna shigar nucleotide guda ɗaya, wanda ke haifar da sauya fasalin karatu.
A ƙarshe, an kuma ƙarfafa canjin sabon HCoVs ta hanyar zaɓin matsin lamba a cikin rukunin rundunarsu.
An gano marasa alamun cutar ko kuma alamun cutar a lokacin da namomin kaza suka kamu da CoV, wanda ke nuna cewa akwai daidaituwa tsakanin CoVs da namomin kaza.
Ya bayyana cewa batirin ya daidaita da CoVs sosai a fannin jiki da kuma jiki.
Alal misali, rashin daidaituwa a cikin kunna amsa mai hana kumburi a cikin beraye yana rage cutar da CoVs ke jawowa.
Bugu da ƙari, ana hana aikin ƙwayoyin kisa na halitta a cikin beraye ta hanyar daidaita mai karɓar mai hana ƙwayoyin kisa na halitta NKG2/CD94 da kuma ƙarancin ƙididdigar ƙwayoyin cuta na babban tsarin haɗin tarihin Class I.
Bugu da ƙari, babban matakin magungunan oxygen (DRO) da ake samu ta hanyaraikin hawan ƙwayoyin cuta na ƙudaje na iya hana kwafin CoV da kuma shafar "rewriting" ta hanyarexoribonuclease, wanda zai haifar da matsin lamba mai zaɓaɓɓu kuma ya haifar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masauki.
Ƙarin kwayar cuta na CoV na iya canzawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawar mai masaukin baki.
Saboda haka, ba abin mamaki ba ne cewa an samu sababbin ƙwayoyin HCoV guda uku a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da wasu alamun rashin lafiya a cikin masu masaukin su kamar su bat da raƙuma.
Suna yin kwafi sosai ba tare da sa jikin mahaifinsu ya yi tsayayya da cutar ba.
A nan ne asirin gano masu dauke da cutar marasa alamun cutar yake da kuma abin da ke haddasa cututtuka masu tsanani a cikin mutane.
Ainihin dalilin bayyanar cututtuka masu tsanani shi ne yawan hawan jini da kuma tashin cytokine; idan hawan jini ya yi ƙarfi, cutar ta ƙaru.
A gefe guda, a cikin masu dauke da cutar da ba su da alamun cutar, an gano yadda rigakafin ke amsawa daga kwayar cutar CoV.
Irin wannan dabarar kawar da amsawar garkuwar jiki na iya samun sakamako mai amfani wajen maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, ana sa ran cewa bayar da interferon na nau'i na I aƙalla a farkon kamuwa da cutar SARS-CoV-2 zai kasance da amfani.
Bugu da ƙari, ƙwayoyin NLRP3 ba su da aiki a cikin beraye.
Bisa ga wannan tunani, hana NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
SARS-CoV-2 ya bayyana ne bisa ga tsarin SARS-CoV da MERS-CoV.
Yayin da aka gano beta-CoV na bat da ke da kashi 95 cikin 100 na kwayar cutar SARS-CoV, akwai kuma CoV na bat da ke da kashi 96 cikin 100 na kwayar cutar SARS-CoV-2.
Duk da yake an gano cewa civets da sauran dabbobi da ke kasuwa suna dauke da kwayar cutar SARS-CoV, ba a gano wani mai watsawa na SARS-CoV-2 ba.
An gano beta-CoVs na pangolin da suka yi kama da SARS-CoV-2 wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu watsa shirye-shiryen tsakanin ko kuma beta-CoV na pangolin na iya ba da gudummawa ga ɓangarorin kwayoyin halittar SARS-CoV-2.
Ko da yake akwai tambayoyi, babu wata hujja da ta nuna cewa SARS-CoV-2 an kirkireshi ne ta hanyar mutum, ko da gangan ko kuma ba da gangan ba.
CoVs sun sake zama abin da ake magana a kai saboda barkewar cutar SARS-CoV-2 kwanan nan.
Binciken CoVs a cikin beraye da sauran dabbobi ya canza ra'ayinmu sosai game da matsayin asalin dabbobi da wuraren ajiyar dabbobi wajen watsa HCoVs ga mutane.
Bayanai da yawa sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga namomin kaza kuma ana watsa su ga mutane ta hanyar masu watsawa.
Tun da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da ƙwarƙwarar da ke kasuwa, rufe sabbin kasuwanni da kashe ƙwarƙwarar da ke cikin su na iya kawo ƙarshen barkewar cutar SARS.
A daidai wannan hanyar, ya kamata a cire pangolins daga kasuwar kayan abinci don kaucewa yaduwar cutar zoonoses, saboda gano yawancin kwayar cutar beta-CoV na pangolins da ke da alaƙa da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa, kuma idan haka ne, ta yaya wannan yaduwar ke faruwa, zai kasance a tantancewa a cikin binciken da za a yi nan gaba.
A gefe guda, MERS-CoV ya daɗe yana wanzuwa a cikin dabbobi masu kama da dabbobi.
Waɗannan raƙuma suna da muhimmanci a sufuri kuma suna kawo nama da madara da fata da kuma ulu ga mazauna yankin.
A Gabas ta Tsakiya da Afirka, mutane da yawa suna yin hakan.
Saboda haka ba zai yiwu a yanka rakuma duka don a sarrafa cutar MERS ba kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a yi amfani da cikakkiyar hanyar samar da rigakafin MERS-CoV mai inganci a cikin raƙuma, tare da sauran matakan sarrafa cutar.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za a iya samun sababbin nau'o'in da za su iya haifar da annoba.
An gano cewa akwai wasu nau'o'in kwayar cutar da ke yaduwa a cikin dabbobi.
Musamman, CoVs na bat, wanda ke da babban damar cutar dabbobi.
Akwai dama da yawa da za su sa waɗannan CoVs na dabbobi su canza kuma su sake haɗuwa, suna haifar da sabon CoV mai saurin yaduwa da kuma/ko kisa a cikin mutane a nan gaba.
Ya kamata a daina cin dabbobi a wasu yankunan kasar Sin domin rage hulda da dabbobi.
Saboda bala'in SARS, MERS da COVID-19, ya kamata a kafa ingantaccen shiri da shirin magance cutar.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin ramin da suke da shi har sai sun samu zarafin yaɗuwa.
Ko da yake akwai abubuwa da yawa da suke sa ƙudaje su yaɗu, za a iya rage haɗarin da mutane za su iya samu da ƙudaje da sauran namun daji idan aka sanar da mutane game da bukatar nisantar su.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa domin fahimtar yanayin CoVs da kuma na masu masaukin su, wanda zai taimaka wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma annobar nan gaba.
A ƙarshe, hanya mafi inganci ga mutane su hana kamuwa da cutar ta ƙwayoyin cuta ita ce su guje wa wuraren da cutar ta ƙwayoyin cuta take.
Ba a san duk asirin asalin SARS-CoV-2 ba.
Na farko, idan dabbobin da ke da ƙwayar cutar SARS-CoV-2 sun kai su ga tsuntsaye, zai zama da ban sha'awa a bincika a wane yanayi ne dabbobin da tsuntsaye za su iya samun wuri ɗaya a cikin mahalli.
Na biyu, idan da akwai wani abu da ake yi da ke sa mutane kamuwa da cutar kai tsaye daga ƙwari, to, ya kamata a bincika yadda mutane suke hulɗa da ƙwari.
Na uku, idan dabba ta uku tana da matsayin mai masaukin baki, ba a san yadda take sha'ani da dabbobi dabam-dabam ba, har da mutane da batsa da kuma pangolin.
A ƙarshe, saboda dabbobi masu shayarwa da yawa, musamman dabbobi masu gida, suna iya kamuwa da cutar SARS-CoV-2, ya kamata a yi sa ido da kuma gwajin kamuwa da cutar.
Ko da shi ke kunkuru ne, ko kuma wani dabba mai shayarwa, ya kamata a iya gano SARS-CoV-2 ko kuma kusan irin kwayar cutar da aka gano a cikin mahaifansu.
Bincike na gaba a wannan fannin zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi kuma zai yi tasiri sosai a kan rigakafi da kuma kula da COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin ganewar asali na  masu zargi  da  waɗanda aka tabbatar  na COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da Shawarwarin Gyara na Ganowa da Kula da Cutar Coronavirus 2019 (2019-nCoV) kuma wannan Shawarwarin ya bayyana kwarewarmu da kuma samar da ƙa'idodi don magance wannan annoba a duniya.
Duk da haka, cutar coronavirus 2019 (COVID-19) ba ta daɗe ba, iliminmu da iliminmu suna ci gaba a hankali bisa sakamakon binciken da ake yi da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta dabarun ganewar asali da magani.
A cikin wannan wasikar mun amsa ga wani bayani game da jagororinmu kuma mun samar da sabbin hanyoyin gano cutar don  wanda ake zargi  da  wanda aka tabbatar da shi  bisa ga sabon jagorar gano cutar COVID-19 da kuma maganin ta (na bakwai) da Hukumar Lafiya ta Jamhuriyar Jama'ar Sin ta fitar.
A watan Disamba na shekarar 2019, sabon kwayar cutar coronavirus 2019 (2019-nCoV) ta haifar da barkewar cutar da yanzu ake kira da sunan cutar coronavirus 2019 (COVID-19), kuma an sanya wa kwayar cutar sunan coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta samar da shawarwari na gaggawa da aka buga a kan layi a kan bincike na likitanci na soja a ranar 6 ga Fabrairu, 2020.
An yi ta magana sosai tun da aka buga ta.
Amma, a lura cewa COVID-19 sabuwar cuta ce, kuma iliminmu da kuma iliminmu suna ci gaba a hankali bisa sakamakon binciken da ake yi da kuma kwarewar da ake samu a asibiti; saboda haka ana ci gaba da sabunta hanyoyin ganewa da maganin.
Alal misali, jagororin gano cutar COVID-19 da kuma maganin da Hukumar Lafiya ta Jamhuriyar Jama'ar Sin ta fitar (http://www.nhc.gov.cn/) sun sami sau bakwai a tsakanin 16 ga Janairu, 2020 da 3 ga Maris, 2020, tare da wasu abubuwan da aka gyara sosai.
Bayan da aka ba da bayani game da wannan umurni daga Zhou da sauransu, sun gabatar da wani tsari mai sauƙi na kimantawa bisa ga kwarewarsu.
Aikin su ya kawo ƙarin tabbaci ga umarninmu kuma ya zama muhimmin abin da za a yi amfani da shi a wannan annobar ta duniya.
Muna godiya da kuma amincewa da muhimmin aikin da suke yi.
Koyaya, aikin su kuma yana buƙatar sabuntawa bisa ga sabon Jagora don Ganowa da Kulawa da COVID-19 (Gwaji na bakwai) da kuma binciken da aka yi kwanan nan.
Bisa ga fitowar ta bakwai (3 Maris 2020), tabbatar da mutuwar da ake zargi dole ne ya haɗa da ɗaya daga cikin abubuwan da ke cikin tarihin annobar tare da abubuwa biyu na bayyanar asibiti don yin cikakken bincike, ko kuma ya dace da abubuwa uku na bayyanar asibiti ba tare da bayyanar tarihin annobar ba:
Tarihin cutar: (1) Tarihin tafiya ko zama a birnin Wuhan da ke kewaye da shi ko kuma wasu al'ummomi inda aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya masu zazzabi ko alamun numfashi a birnin Wuhan ko kuma kewaye da shi ko kuma wasu al'ummomi inda aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da wasu mutane da aka tabbatar da cutar (≥ 2 da zazzabi da alamun cutar/ numfashi a cikin makonni 2 a cikin gida, a cikin ofishin makaranta, a cikin aji, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin
Alamomin asibiti: (1) zazzabi da/ko alamun numfashi; (2) hotunan da ke nuna alamun kamuwa da COVID-19; (3) jimillar adadin ƙwayoyin jini masu farin jini da ke nuna ƙarancin ƙwayoyin lymphocyte na al'ada, ko kuma ƙarancin ƙwayoyin jini tun lokacin da alamun cutar suka fara.
Binciken da aka tabbatar da shi dole ne ya dogara da wanda ake zargi tare da duk wani abu na asibiti ko na asibiti: (1) gwajin PCR na lokaci-lokaci mai kyau don SARS-CoV-2; (2) jerin kwayoyin cuta na gaba ɗaya wanda ke da daidaituwa mai ƙarfi tare da sabbin ƙwayoyin cuta na coronavirus; (3) gwajin kwayar cuta mai kyau don SARS-CoV-2 IgM da IgG; ko canza takamaiman SARS-CoV-2 IgG daga mara kyau zuwa mai kyau ko ƙaruwa ≥ sau 4 a cikin lokacin dawowa idan aka kwatanta da lokacin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na lokaci na atomatik a cikin hanyoyin numfashi ko kuma a cikin jinin a cikin fitowar ta biyu (Janairu 18, 2020) da kuma fitowar ta uku (Janairu 22, 2020).
An ƙara bincike kan kwayar cuta a cikin jini a fitowar ta huɗu (27 ga Janairu 2020) da kuma fitowar ta biyar (8 ga Fabrairu 2020); daga baya an ƙara tabbacin ƙwayar cuta a fitowar ta bakwai.
Waɗannan gyare-gyare sun gina kan ci gaba da aikin masu bincike na samun mafi kyawun kayan bincike na nucleic acid don saurin ganewar asali, da kuma samfurori na hanyar numfashi da suka haɗa da ɗaukar jini, tare da ƙarin samfurori daban-daban, kuma sun taimaka wajen ƙara tabbataccen sakamakon takamaiman antibody a cikin ka'idojin da aka tabbatar.
Bugu da ƙari, ƙarin tabbaci yana ƙarfafa mu mu mai da hankali game da marasa lafiya da ba su da alamun cutar da marasa lafiya da ba su da alamun cutar.
Saboda haka, ya kamata a sabunta hoton Zhou et al. domin sun ware mutanen da ba su da alamun asibiti a matsayin masu ƙarancin haɗari.
Dole ne a kuma gwada tsarin tantancewar a cikin aikin asibiti da kuma a cikin nazarin nan gaba.
A ƙarshe, muna fatan ƙarin tabbaci kai tsaye ya bayyana kuma muna roƙon masu karatu su kawo mana ra'ayoyinsu.
Game da ganewar  masu zargi  da  masu tabbatar da cutar , muna ba da shawara su bi kuma su bi sababbin ka'idoji a ƙasashensu.
Ƙungiyarmu za ta kuma riƙa sabunta umurninmu a kan lokaci don ta taimaka.
Bangladesh ta sanar da karin mutane biyar da suka mutu sakamakon COVID-19, wanda ya kai ranar da aka fi kowacce rana mutuwa
Jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu sakamakon COVID-19 a rana ɗaya.
Wannan ya sa kasar ta samu adadin mutane da suka mutu a rana guda saboda cutar.
Jiya, Cibiyar Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ce adadin mutanen da suka kamu da cutar sun hada da masu cutar 114 da suka kamu da cutar, kuma mutane 33 sun warke, kuma suna tsare a gida.
An samu mutuwar mutane 17.
An fara rufe hanyoyin sufuri na jama'a a ranar 26 ga watan Maris kuma an shirya za a gama a ranar Asabar, 4 ga watan Afrilu.
An ci gaba da ƙyale a kai kayayyakin da ake bukata (magani, mai, da abinci).
A ranar 19 ga Maris, mutanen uku sun warke.
A ranar Alhamis, jimillar adadin masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duniya, a cewar bayanan Jami'ar Johns Hopkins.
A dukan duniya, ƙasashe sun ba da sanarwar tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Majalisar Portugal ta amince da tsawaita dokar ta-baci na tsawon kwanaki 15; an amince da ita da kuri'u 215 da suka amince, 10 suka yi kauracewa, kuma 1 ya ki.
Tushen kwayar cutar korona ta mutum daga dabbobi
Cutar cutar ta numfashi mai tsanani (SARS) da cutar numfashi ta Gabas ta Tsakiya (MERS) sun juya yanayin don bayyana yadda kamuwa da cutar HCoV ke iya zama mai hallaka da kuma kisa.
Yawancin kwayar cutar HCoVs daga ƙwararrun ƙwayoyin cuta ne.
An kuma san masu watsa kwayar cutar HCoVs.
Gano mai watsa labaran dabbobi yana da tasiri kai tsaye a kan rigakafin cututtuka a cikin mutane.
Binciken hulɗar CoV-mai masaukin baki a cikin dabbobi na iya ba da damar fahimtar CoV a cikin mutane.
Bisa ga bambancin jerin sunayen sunadarai, an rarraba CoVs zuwa jinsi huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV). Tsarin Beta-CoV ya ƙunshi yawancin HCoVs kuma an rarraba shi zuwa jinsi huɗu (A, B, C, da D).
Shaida ta ilimin halittu ta nuna cewa namomin kaza da masu ci suna da matsayin tushen kwayoyin halittar alpha-CoVs da beta-CoVs, yayin da tsuntsaye su ne manyan wuraren samun gamma-CoVs da delta-CoVs.
An san mutane bakwai da ke dauke da kwayar cutar HCoVs.
A cikin su, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar rashin numfashi mai tsanani (SARS-CoV), cutar rashin numfashi ta Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
Binciken asalin kwayar cutar HCoV na dabbobi yana ba da tsari don fahimtar tarihin halitta, abubuwan motsawa, da abubuwan da ke hana ƙetare shingen nau'in.
Hakanan zai iya jagorantar ko sauƙaƙa bincike na mai watsa shiri, matsakaici da mai haɓaka SARS-CoV-2, tare da muhimman abubuwan da zai iya haifar da rigakafin kamuwa da cuta a nan gaba.
An san cewa akwai kwayar cutar dabbobi tun daga ƙarshen shekarun 1930.
An gano kwayar cutar HCoV guda bakwai a cikin shekarun baya bayan nan.
An fara gano kwayar HCoV-229E a cikin hanyoyin numfashi na marasa lafiya da ke da kamuwa da cutar numfashi a shekarar 1966, sannan kuma ta daidaita don girma a cikin layin ƙwayar WI-38 na huhu.
Marasa lafiya da ke dauke da cutar HCoV-229E suna da alamun sanyi na yau da kullun, gami da ciwon kai, tari, rashin jin daɗi da ciwon makogwaro, tare da zazzabi da tari a kashi 10 zuwa 20 cikin dari na masu cutar.
HCoV-229E da HCoV-OC43 duk suna ko'ina a duniya kuma suna iya yaduwa a lokutan sanyi a ƙasashen da ke da yanayin zafi.
Shaguna a Ostareliya sun rage adadin takardar bayan gida da za su iya saya
A ranar Lahadi da Asabar, manyan kantunan Woolworths da Coles na Australia sun rage takunkumin sayen takardar bayan gida zuwa biyu da kuma kunshin daya a kowane kantin sayar da kayayyaki a duk fadin kasar.
A ranar Litinin, ALDI ta kuma kafa iyaka na fakiti guda.
An wallafa waɗannan iyakokin a cikin saƙonni da aka aika wa tashoshin tallace-tallace da kuma a shafukan Facebook na tashoshin.
A bayyane yake cewa masu sayen suna tara kayayyaki saboda tsoron COVID-19 da kuma bukatar killace kansu.
A ranar Laraba, Woolworths ta kuma rage sayen takarda ta gida don isar da kaya zuwa gida zuwa fakiti ɗaya a kowane oda.
Waɗannan matakan sun biyo bayan ƙuntatawa ta farko ta fakiti huɗu da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
Coles, a cikin sanarwar manema labarai ta ranar 8 ga watan Maris, ta ce, tare da takunkumin kunshin guda hudu da ke aiki, kantuna da dama na ci gaba da ƙarancin kaya a cikin sa'a guda bayan isar da su, kuma ta kira bukatar da ba a taɓa ganin irinta ba, yayin da ALDI, a cikin wani sakon Facebook na ranar Talata, ta kira shi "ba zato ba tsammani".
An samu karuwar tallace-tallace a makon da ya gabata, in ji mai magana da yawun Woolworths.
Har ila yau, kantin sayar da kayayyaki na Costco a Canberra ya ƙuntata adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ta yi odar manyan kaya daga masu samar da kayayyaki kuma ta ƙara yawan isar da su, Woolworths ta yi odar ƙarin kaya, yayin da ALDI ta yi odar kayayyaki a farkon lokacin da za a yi tallar a ranar Laraba.
Russell Zimmerman, darektan zartarwa na Ƙungiyar 'yan kasuwa na Australiya, ya ce 'yan kasuwa suna ƙoƙarin ƙara kaya, amma ƙuntatawa da majalisar ke yi game da lokutan isar da kaya ta hanyar mota na sa aikin ya yi wuya.
Ya ce farashin kayayyakin zai ƙaru yayin da masu samar da kayayyaki suke ƙoƙarin biyan bukatar da ake yi, kuma ba za a riƙa ba da tallace-tallace ba.
A ranar Talata, ALDI ta sanar da cewa bayan an bude kayayyaki da wuri, wasu shagunan ba za su iya biyan kuɗin da aka yi a ranar Laraba ba.
A wani talifi da aka wallafa a shafin News.com.au, Dr. Gary Mortimer, masanin harkar sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya bayyana cewa, shaguna suna cika kayayyaki a kowane dare.
Ya lura cewa takarda ta wc abu ne mai girma, wanda ke haifar da karancin kaya wanda idan aka gama, zai bar manyan sarari a cikin shinge, yana kara nuna rashin wadata.
 Coles da Woolworths sun yi la'akari da cewa idan shelves sun cika, idan kayayyaki kamar takardar bayan gida da magungunan kashe ƙwayoyin cuta za a iya [saya] kuma ana samun su a manyan adadi, hakan na iya rage fargaba , Russell Zimmerman ya bayyana wa ABC News.
Kamfanin da ke yin takardar bayan gida da aka sake amfani da ita mai suna Who Gives a Crap ya ce a ranar Laraba da ta gabata cewa sun kasa.
Kimberly-Clark, wanda ke kera takardar wanka ta Kleenex, da Solaris Paper wanda ke kera takarda mai amfani da ruwa, sun ce suna aiki a ko'ina don ci gaba da samar da kayayyaki, kamar yadda wani labarin News.com.au ya nuna.
Wani shafin yanar gizo na tallace-tallace na Domain.com ya ruwaito cewa wasu masu sayar da kayayyakin gida suna ba da takardar wanka kyauta ga mai sayarwa na farko a lokacin gwanjo a Melbourne, yayin da aka rage sayar da kayayyaki saboda masu sayarwa suna hutu a lokacin hutun ranar ma'aikata.
Jaridar NT News da ke Darwin a ranar Alhamis ta ƙunshi takarda mai shafuffuka takwas da za a yanke a yi amfani da ita a matsayin takardar wanka.
Shaguna sun yi jinkirin sanya takunkumi a farko, a cewar wani rahoto na ABC Australia na ranar 3 ga watan Maris inda suka sanar da cewa ba su da shirin sanya takunkumin sayen.
Russell Zimmerman ya kara da cewa akwai sauran kayayyaki da ake bukatarsu sosai, kamar su abin rufe fuska, maganin kashe ƙwayoyin cuta, kayan bushewa, kayayyakin tsabtace hannu da kuma gari.
Hakazalika, a waje da Australia, an lura da cewa a daren Lahadi, kantin sayar da kayayyaki na Ocado na Birtaniya ya ƙuntata sayen takardar bayan gida na Andres zuwa fakiti biyu na 12 na takarda.
Kungiyar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana annobar COVID-19 (cutar da cutar korona SARS-CoV-2 ke haifarwa) a matsayin annoba.
Ko da yake kalmar  annobar  tana nufin yadda cutar ta yadu ne kawai, ba yadda wasu cututtuka suke da haɗari ba, WHO ta nuna bukatar tura gwamnatoci su dauki mataki:
 Duk ƙasashe na iya canja yanayin wannan annobar.
"Ya kamata a yi bincike, a gwada, a yi magani, a ware, a gano inda mutane suke, a kuma sa su shiga cikin wannan aikin", in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
 Muna da matukar damuwa, ba wai kawai game da munanan matakan yaduwar cutar ba da kuma tsananin cutar ba, har ma game da munanan matakan rashin aiki. 
A cewar Dokta Tom Frieden, tsohon daraktan Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka, annobar ta  ba ta da misali .
Ya ce a cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, banda mura, babu wani kwayar cutar numfashi da aka gano tun lokacin da ta fara har sai da ta ci gaba da yaduwa a duniya.
Ghebreyesus ya bayyana irin wannan ra'ayi, yana mai cewa  ba mu taɓa ganin wata annobar da coronavirus ta haifar ba. 
Ya kuma kara da cewa:  kuma ba mu taɓa ganin wata annobar da za a iya shawo kanta a lokaci guda ba 
Sabon matsayin annobar ya biyo bayan shawarar WHO a watan Janairu na ayyana annobar a matsayin gaggawa ta lafiyar jama'a ta duniya.
Daraktan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya sanar da cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4,600.
Cutar cutar coronavirus ta 2019-20 annoba ce ta cutar coronavirus da ke gudana tun daga shekarar 2019 (COVID-19), wadda cutar coronavirus 2 (SARS-CoV-2) ta haifar.
An gano annobar a Wuhan, China a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu rahoton kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya yi sanadiyyar mutuwar mutane 97,000.
Kusan mutane 364,000 ne suka warke.
An kiyasta cewa adadin mutuwar mutane a ƙasar Sin ya kai kashi 4 cikin ɗari, yayin da a sauran ƙasashe na duniya, ya kai kashi 13.04 cikin ɗari a ƙasar Aljeriya da kuma kashi 0.08 cikin ɗari a ƙasar New Zealand.
Alamun da ake yawan samu sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Ƙari ga haka, ana iya samun ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci tsakanin bayyanar da bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma yana iya zama tsakanin kwana biyu zuwa goma sha huɗu.
Babu wani allurar rigakafi ko magani na musamman na rigakafin cutar.
Magani na farko shi ne maganin cututtuka da kuma tallafi. Matakan rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe baki idan ka yi tari, nisantar mutane, da kuma lura da kuma ware mutanen da ake zargin suna da cutar.
Hukumomi a dukan duniya sun amsa da kafa takunkumin tafiye tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki, da kuma rufe wuraren aiki.
Cutar ta haifar da mummunar tashe-tashen hankula a fannin tattalin arziki da zamantakewa a duniya, da jinkirta ko soke wasannin motsa jiki, addini, siyasa da al'adu, da kuma karancin abinci da aka yi ta hanyar sayen kayan jin tsoro.
Makarantu da jami'o'i sun rufe a kasa ko a yankuna a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin 100 na ɗaliban duniya.
An yada labaran karya game da cutar a Intanet, kuma an samu wasu abubuwa na nuna kyamar baki da nuna wariya ga Sinawa, wasu mutanen da suke da asali da kuma kamannin Asiya ta Gabas da Kudu maso Gabas, da kuma wasu mutane daga yankunan da ke da yawan masu cutar.
Saboda rage tafiye tafiye da kuma rufe masana'antu masu nauyi, an samu raguwar gurbataccen iska da fitowar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton ciwon huhu na sanadin da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon watan Janairu, 2020.
Yawancin cututtukan sun shafi kasuwar cin abincin teku a Huanan, saboda haka ana ganin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haddasa annobar ana kiranta SARS-CoV-2, kwayar cutar da aka gano kwanan nan kuma tana da alaƙa da kwayar cutar bat, kwayar cutar pangolin, da SARS-CoV. Daga baya an gano cewa mutum na farko da aka sani da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da cutar da ta faru a kasuwar kayan lambu.
A cikin adadin mutanen da suka kamu da cutar a watan Disamba na 2019, kashi biyu bisa uku sun yi hulɗa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tantance ba daga South China Morning Post ya nuna cewa cutar ta fara bayyana a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 a lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabbin cututtuka ke raguwa a China amma ba zato ba tsammani suna ƙaruwa a Italiya, Iran, da Koriya ta Kudu, adadin sabbin cututtuka a wajen China ya wuce adadin sabbin cututtuka a China a karon farko.
Ana iya rage yawan waɗanda ba su da ciwo sosai, musamman waɗanda ba su da ciwo sosai.
A ranar 26 ga watan Fabrairu, an samu rahotanni na ƙarancin adadin waɗanda suka kamu da cutar a tsakanin matasa, waɗanda shekarunsu suka kai 19 da ƙasa da haka, wanda ya kai kashi 2.4 cikin ɗari na waɗanda suka kamu da cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya yi kiyasin cewa kashi 60 cikin ɗari na mutanen Burtaniya suna bukatar kamuwa da cutar kafin a samu gagarumar rigakafin cutar.
Al'amuran sun nuna adadin mutanen da aka gwada wa COVID-19, kuma an tabbatar da cewa sun kamu da cutar bisa ga ka'idojin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa suna da manufofin hukuma na rashin gwada waɗanda ke da alamun rashin lafiya, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa a China, har zuwa ranar 23 ga watan Janairu, an kiyasta cewa kashi 86 cikin 100 na kamuwa da cutar COVID-19 ba a gano ba, kuma cewa wadannan kamuwa da cutar da ba a rubuta ba ne suka haifar da kamuwa da kashi 79 cikin 100 na waɗanda aka samu.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kimanta cewa yawan masu kamuwa da cutar a Italiya ya fi adadin waɗanda aka ba da rahoto.
Kwanan baya, an kiyasta cewa yawan haifuwa na COVID-19 (R0) ya kai 1.4 zuwa 2.4.
Wani bincike da aka wallafa daga Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke da cutar COVID-19 suna samun sauƙi.
Ga waɗanda ba su warke ba, tsawon lokacin da ya rage tsakanin bayyanar cututtuka da mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, mafi yawan kwanaki 14 ne.
A ranar 10 ga Afrilu, 2020, an samu mutuwar mutane kusan 97,000 da cutar COVID-19 ta haddasa.
A China, a ranar 5 ga Fabrairu, kusan kashi 80 cikin 100 na mutuwar sun kasance waɗanda suka haura shekaru 60, kuma kashi 75 cikin 100 suna fama da matsalolin kiwon lafiya da suka riga sun kasance kamar cututtukan zuciya da ciwon sukari. Bayanan hukuma na mutuwar da ke da nasaba da annobar COVID-19 yawanci suna nufin mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID bisa ga ka'idojin hukuma.
Adadin mutanen da suka mutu da gaske daga COVID-19 na iya zama mafi girma, saboda ba zai haɗa da mutanen da suka mutu ba tare da an gwada su ba - misali a gida, a gidajen tsofaffi, da sauransu.
Bayanai na musamman daga Italiya sun nuna cewa yawan mutuwar mutane a lokacin annobar ya ninka na COVID sau 4-5 fiye da yadda aka sani.
Mai magana da yawun Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) ta amince  Mun san cewa [adadin mutuwar da aka sanar] ba a kimanta su ba , wata sanarwa da aka tabbatar da rahotannin da aka yi a Amurka. Irin wannan rashin kimantawa yakan faru a lokacin annobar cutar kamar annobar mura ta alade H1N1 na shekarar 2009. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020.
Mutuwa ta farko a waje da China ta faru a ranar 1 ga Fabrairu a Philippines, kuma mutuwar farko a waje da Asiya ta faru a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a waje da kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a kowace kasa a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga watan Maris, sama da kasashe da yankuna 40 sun ba da rahoton mutuwar mutane a duk nahiyoyi sai dai Antarctica. An yi amfani da alamomi da dama wajen kimanta yawan mutuwar.
Waɗannan adadi sun bambanta a yankuna da kuma lokaci, kuma suna da nasaba da yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma al'amuran alƙaluma kamar su shekaru, jinsi, kuma musamman lafiyar jiki.
A cewar ƙididdigar Jami'ar Johns-Hopkins, adadin mutuwar mutane a duniya ya kai kashi 6.0 cikin ɗari (97 039/1 617 204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta a wurare dabam dabam.
A China, kimantawar yawan mutuwar mutum ya ragu daga kashi 17.3 cikin dari (ga waɗanda ke da alamun cutar tsakanin 1 zuwa 10 ga Janairu 2020) zuwa kashi 0.7 cikin dari (ga waɗanda ke da alamun cutar bayan 1 ga Fabrairu 2020). Sauran alamomin su ne yawan mutuwar mutum (talakawa), wanda ke wakiltar yawan mutanen da aka gano cewa suna mutuwa daga cutar, da kuma yawan kamuwa da cuta (talakawa), wanda ke wakiltar yawan masu kamuwa da cuta (wanda aka gano da wanda ba a gano ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a lokaci kuma suna bin takamaiman yawan mutane da suka kamu da cutar a ƙarshen cutar.
Masana kimiyya da yawa sun yi ƙoƙari su ƙididdige waɗannan adadi don ƙididdigar mutanen da suke da irin wannan ciwon.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar a matsayin dukan annobar ya kai tsakanin kashi 0.1% da 0.39%.
Matsakaicin wannan adadin ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus, da kuma nazarin ƙididdiga da ke nazarin tasirin gwajin a kan kimantawar yawan mutuwa.
Hukumar lafiya ta duniya ta ce za a iya shawo kan annobar.
Ba a san lokacin da cutar za ta kai ƙarshenta ba kuma za ta iya bambanta a yankuna dabam dabam.
Maciej Boni na Jami'ar Jihar Pennsylvania ya ce: "Idan ba a iya sarrafawa ba, yawanci annoba na kamuwa da cuta tana daidaita sannan kuma ta fara komawa baya idan cutar ta kasa samun masu garkuwa da ita".
Amma a yanzu kusan ba zai yiwu a yi hasashen lokacin da hakan zai faru ba.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya ce za a iya kammala wannan aikin nan da watan Yuni idan dukkan kasashe suka yi aiki tare don bin shawarar WHO kan matakan da za a dauka don hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magunguna ta London ya ce SARS-CoV-2  zai ci gaba da yaduwa, mai yiwuwa har shekara ɗaya ko biyu .
Wani bincike na Kwalejin Imperial wanda Neil Ferguson ya gudanar, ya nuna cewa za a bukaci nisantar mutane da sauran matakan har sai an samu rigakafin (mai yiwuwa cikin watanni 18 ko fiye) .
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar korona, saboda tana da saukin yaduwa, za ta ɓace gaba ɗaya, kuma za ta iya zama wata cuta ta yanayi, wadda za ta sake bayyana a kowace shekara".
Ainihin cutar da wannan komawar take nunawa ya dogara ne akan yawan garkuwar jiki da kuma yawan kwayar cutar.
A wasu lokatai, alamun cutar COVID-19 ba su da takamaiman bayani, kuma waɗanda ke da cutar ba sa nuna alamun cutar.
Alamun da suka fi yawa su ne zazzaɓi (kashi 88) da kuma tari mai bushewa (kashi 68).
Alamun da suka fi yawa sun haɗa da gajiya, samar da ɓarkewar numfashi (mucosity), rashin ƙamshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, jin zafin jiki, amai, haemoptosis, zawo, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) sun gano alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsin lamba, rikicewar kwatsam, wahalar farkawa, da fuska ko lebe masu shuɗi; ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun suna nan. Ci gaban cutar na iya haifar da mummunar cutar huhu, mummunar cutar numfashi, cutar jini, cutar jini, da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa alamun cutar, ba tare da wata alama ba amma suna da sakamakon gwajin da ke tabbatar da kamuwa da cutar, saboda haka masu bincike sun bada shawarar cewa mutanen da suka yi hulɗa da mutanen da aka tabbatar suna da cutar su a kula da su sosai kuma a gwada su don kawar da hadarin kamuwa da cutar.
Ƙididdigar da Sin ta yi game da yawan marasa cutar sun bambanta daga kaɗan zuwa kashi 44 cikin ɗari.
Lokacin kwantar da cutar (lokacin da ake samun cutar da bayyanar cututtuka) ya kasance tsakanin kwana 1 zuwa 14; yawanci kwanaki biyar.A wani misali na rashin tabbas, kimantawa na yawan mutanen da ke dauke da COVID-19 da suka rasa ƙanshin ƙanshi ya kasance daga kashi 30 cikin dari kafin ya ragu zuwa kashi 15.
Har yanzu ba a san yadda cutar take yaɗuwa ba.
An yi imanin cewa ana yaduwar cutar ne ta hanyar kusanci da kuma saukowar ruwa mai laushi daga tari, tari, ko magana; wannan kusanci ya yi daidai da radius na mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya nuna cewa idan mutum ya yi tari ba tare da ya kāre kansa ba, zai iya zubar da ɗigon ruwa daga nisan mita 15 zuwa mita 27.
Wasu sun ba da shawarar cewa za a iya yada kwayar ta hanyar ƙananan ɗigon ruwa da ke cikin iska na tsawon lokaci, wanda za a iya fitarwa ta hanyar magana. Za a iya fitar da ɗigon numfashi ta hanyar numfashi, musamman ta hanyar magana, ko da yake ba a yawanci ana ɗaukar kwayar ta iska.
Za a iya sauko da su a bakin ko kuma hanci na wasu da ke kusa da su ko kuma a sha su a cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intubation da kuma CPR na iya haifar da ɓarkewar numfashi wanda ke yin iska kuma saboda haka yana haifar da yaduwar iska.
Hakanan za a iya yada cutar ta wurin taɓa wani abu da ke da cutar, musamman fata, kafin a taɓa idanu, hanci, ko baki.
Idan akwai wasu da suke tsoron cewa za a iya yada shi ta hanyar kwance, ana ganin wannan hadarin bai da yawa.
Gwamnatin China ta yi watsi da yiwuwar yaduwar SARS-CoV-2 ta hanyar magana ta baki. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, duk da haka, yaduwar na iya yiwuwa kafin bayyanar cututtuka da kuma a matakan ciwon da suka wuce.
An gwada mutane suna da cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya samun yaduwar cutar kafin bayyanar cututtuka masu muhimmanci.
Rahotanni kaɗan ne kawai na lab da suka tabbatar da cewa akwai marasa cutar, amma wasu ƙasashe sun gano cewa akwai cutar da ba ta da alamun cutar a lokacin binciken da aka yi.
Cibiyar Kula da Cututtuka da Tsaro ta Turai (ECDC) ta ce idan ba a san yadda cutar take yaɗuwa ba, mutum ɗaya yakan yaɗa cutar zuwa mutane biyu ko uku, kuma ƙwayoyin cuta suna iya rayuwa a kan mutane na tsawon sa'o'i ko kwanaki.
An gano cutar bayan kwana uku a kan filastik (polypropylene) da bakin karfe 304, bayan kwana ɗaya a kan kwali, kuma bayan awa huɗu a kan jan ƙarfe.
An gwada dabbobi da sauran dabbobi da suka tabbatar da cewa suna da cutar COVID-19.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, duk da haka hukumomin Birtaniya sun bada shawarar wanke hannu bayan sun taba dabbobi, da kuma bayan sun taba wasu wuraren da mutane masu cutar suka taba.
Cutar numfashi mai tsanani 2 (SARS-CoV-2) sabuwar kwayar cuta ce, da farko an gano ta a cikin mutane uku da ke da ciwon huhu da ke da nasaba da ciwon numfashi mai tsanani na Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna wanzu a cikin kwayar cutar coronavirus da ke da alaƙa da yanayi. A waje da jikin mutum, ana lalata kwayar cutar ta hanyar sabulu na gida, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
An yi imani cewa ya samo asali ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar korona ta fito ne daga nau'in Betacoronavirus, wanda ke cikin nau'in Sarbecovirus (B lineage) wanda ke da alaƙa da nau'i biyu na ƙudaje.
Ya yi daidai da kashi 96 cikin ɗari na dukan kwayoyin halitta na wani kwayar cutar bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a wasu sassan jerin kwayoyin halittar dan adam tsakanin kwayar cutar da ke kama da kwayar cutar da ke kama da kwayar cutar da ke kama da kwayar cutar dan adam.
Kwatantawar dukkanin kwayoyin halitta ya nuna cewa har zuwa yanzu akwai kashi 92 cikin dari na kwayoyin halittar da ke tsakanin kwayar cutar korona ta pangolin da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolin ne mai watsawa ba.
Ana iya gane kamuwa da kwayar cutar a ɗan lokaci bisa ga bayyanar cututtuka, amma ana tabbatar da shi ta hanyar juyawa da kwayar cutar ta hanyar polymerase chain reaction (rRT-PCR) ko kuma ta hanyar yin amfani da na'urar daukar hoto.
Wani bincike da ya kwatanta PCR da na'urar daukar hotuna a Wuhan ya nuna cewa na'urar daukar hotuna ta fi PCR saukin ganewa, ko da yake ba ta da cikakken bayani, domin yawancin ayyukanta na daukar hotuna sun yi daidai da na wasu cututtukan huhu da kuma hanyoyin cutar.
A watan Maris na shekarar 2020, Kwalejin Kula da Hasken Wuta ta Amurka ta ba da shawarar cewa kada a yi amfani da na'urar daukar hotan takarda don gano ko kuma a yi amfani da ita a matsayin gwajin farko na gano cutar COVID-19.
WHO ta wallafa wasu ka'idojin gwajin RNA na SARS-CoV-2, tare da fitowar farko a ranar 17 ga Janairu.
Ana amfani da gwajin ta hanyar yin amfani da tsarin juyin halittar polymerase chain reaction (rRT-PCR) a lokaci na ainihi.
Ana iya yin gwajin ne ta hanyar yin numfashi ko kuma jini.
Sakamakon yana zuwa cikin sa'o'i ko kwanaki.
Ana yin wannan gwajin ne a kan ƙwayar hanci da hanci, amma ana iya yin amfani da ƙwayar hanci.
A ranar 6 ga Afrilu, 2020, babu wani daga cikinsu da ya tabbatar da cewa ya isa a amince da shi don amfani a ko'ina.
A Amirka, an amince da gwajin ƙwayar cuta da Cellex ya samar don amfani da shi a gaggawa a cibiyoyin bincike da aka amince da su.
Abubuwan da ake gani a hoton radiyo da kuma na'urar daukar hoto (scanner) na mutanen da suke da alamun sun haɗa da asymmetrical peripheral glass opacities da rashin zubar da pleural.
A halin yanzu, Hukumar Radiology ta Italiya tana gina wani babban rumbun adana bayanai na kan layi na duniya na sakamakon hoton da aka tabbatar da shi.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, yin hoto ba tare da tabbacin PCR ba yana da iyakantaccen daidaito wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon gwajin kirji da PCR kuma ya nuna cewa yayin da hoton ba shi da cikakken bayani game da kamuwa da cuta, ya fi sauri kuma ya fi jin dadi, yana ba da shawarar yin amfani da shi a matsayin kayan aikin bincike a wuraren da ake da annobar.
An kuma samar da hanyoyin sadarwa na ƙwayoyin cuta masu amfani da fasaha na wucin gadi domin gano halayen cutar a cikin hotuna da kuma a cikin na'urar daukar hoto.
Hanyoyin hana yaduwar cutar sun hada da tsaftace kai, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannayen da ba a wanke ba, da kuma yin tari ko sneezing a cikin tawul sannan a jefa tawul din kai tsaye cikin jakar shara.
An shawarci waɗanda aka yi zaton cewa sun riga sun kamu da cutar su sanya abin rufe fuska a fili.
An kuma bada shawarar nisantar jiki don hana yaduwar cutar. Gwamnatoci da dama sun hana ko kuma sun hana duk tafiye-tafiye marasa muhimmanci zuwa ko daga ƙasashe da yankunan da cutar ta shafa.
Duk da haka, cutar ta kai matakin yaduwa a yankuna da yawa a duniya.
Wannan yana nufin cewa cutar tana yaɗuwa a cikin al'umma, kuma wasu membobin waɗannan al'ummomin ba su san inda ko yadda suka kamu ba. Ana ba da shawara ga ma'aikatan kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullum da kuma na tuntuɓar mutane, da kuma sanya tabarau na kariya. Binciken tuntuɓar mutane hanya ce mai muhimmanci da hukumomin kiwon lafiya za su iya gano tushen kamuwa da cuta da kuma hana yaduwar cutar a nan gaba.
Amfani da gwamnatoci ke yi da bayanan wurin da wayar salula take a wannan batun ya jawo damuwa game da tsare sirri, inda Amnesty International da wasu kungiyoyi sama da 100 suka fitar da wata sanarwa da ke kira da a kawo wa irin wannan sa ido kan abubuwa.
An kaddamar da aikace-aikacen wayar hannu daban-daban ko kuma an gabatar da su bisa aikin sa kai, kuma a ranar 7 ga Afrilu, 2020, sama da gungun masana goma sha biyu suna aiki kan hanyoyin da za su kare sirrin mutane, kamar amfani da Bluetooth don yin rikodin kasancewar mai amfani a kusa da wasu wayoyin hannu.
Masu amfani suna samun saƙo idan sun yi hulɗa da wani wanda ya sami cutar COVID-19. Akwai ra'ayoyi na karya a halin yanzu game da yadda za a hana kamuwa da cutar; misali, wanke hanci da gargadi da ruwan wanka na baki ba su da tasiri.
Babu maganin rigakafin COVID-19, amma ƙungiyoyi da yawa suna ƙoƙarin samar da ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu suna da datti sosai; kafin cin abinci; da kuma bayan sun yi amai, tari, ko kuma tari.
Wannan saboda a waje jikin mutum, sabulu na gida yana kashe kwayar cutar, kuma ta karya garkuwar kariya.
CDC ta kuma ba da shawarar yin amfani da maganin kashe cutar hannu mai barasa wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane kada su taɓa idanunsu, hanci, ko bakinsu da hannu marasa wanke.
Za a iya tsabtace farfajiyar ta hanyoyi da dama (a cikin minti daya na bayyanar da maganin kashe cuta don farfajiyar bakin karfe), ciki har da 62% ethanol, 50% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2% iodized povidone.
Sauran hanyoyin, kamar su benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da cutar COVID a cikin wani wuri kamar ginin ofis ko wurin kula da yara, a tsabtace dukkan ɗakuna kamar ofisoshi, bayan gida, ɗakunan da ake raba, da kuma kayan aikin lantarki na kowa kamar su allunan hannu, allon taɓawa, maɓallan rubutu, na'urorin sarrafawa na nesa, da na'urorin sayar da kayan aiki da masu cutar ke amfani da su.
Ƙungiyoyin kiwon lafiya sun shawarci mutane su rufe bakinsu da hanci da wuyan wuyansu ko kuma tawul lokacin da suke tari ko kuma hancin su, kuma su jefar da duk wani tawul nan da nan.
Ana ba da shawarar sanya abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, domin saka abin rufe fuska na iya rage girman da nisan da ƙwayoyin da aka jefa suke bi ta wurin magana, sneezing, da kuma tari.
Hukumar lafiya ta duniya ta bayar da umarni game da inda kuma lokacin da za a yi amfani da abin rufe fuska.
Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, ya ce sanya abin rufe fuska na iya rage sha'awar mutane su taba fuskokinsu, wanda shine babban tushen kamuwa da cuta idan ba a yi tsabtace hannu ba. An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda ke da cutar.
WHO ta ba da shawarar sanya abin rufe fuska ga mutanen da ke da lafiya kawai idan suna fuskantar babban haɗari, kamar su kula da wanda ke da COVID-19, duk da cewa ta yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuska.
Kasashe da dama sun fara karfafa wa jama'arsu gwiwa su sanya abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na masana'anta wanda ba na likita ba. China ta ba da shawarar musamman yin amfani da abin rufe fuska na likita ga mutanen da ke da lafiya, musamman idan sun kusanci (1 mita (3 feet) ko ƙasa da haka) da wasu mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata a cikin sufuri na jama'a ko kuma wuraren da mutane suke da yawa.
A Thailand, hukumomin kiwon lafiya sun ƙarfafa mutane su yi abin rufe fuska a gida kuma su tsabtace shi kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da rufe hanci da baki ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska a wuraren jama'a, domin kowa ya kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umurni cewa duk wanda ya shiga babban kanti ya sa abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna kasar su sanya abin rufe fuska a fili.
Taiwan, wadda ta samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta tilasta wa fasinjojin jiragen kasa da bas masu tafiya tsakanin birane su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta tilasta saka abin rufe fuska a duk lokacin da ta fita waje, yayin da ta ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya saya ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda ake kira nesa na jiki) ya ƙunshi matakan sarrafa kamuwa da cuta da ake nufi da rage yaduwar cutar ta hanyar rage hulɗa tsakanin mutane.
Hanyoyin sun haɗa da keɓewa, hana tafiye-tafiye, da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Za a iya yin amfani da hanyoyin nisantar mutane ta wajen zama a gida, rage tafiye-tafiye, guje wa taron jama'a, gaishe-gaishe ba tare da tuntuɓar juna ba, da kuma nisantar mutane.
Gwamnatoci da yawa yanzu suna ba da umarni ko kuma ba da shawarar nisantar jama'a a yankunan da cutar ta shafa.
An rage yawan taron da hukumomin gwamnati da na kiwon lafiya na Amurka suka ba da shawarar daga mutane 250 (idan ba a san akwai COVID-19 a yankin) zuwa mutane 50, daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a na sama da mutane biyu. Manya tsofaffi da waɗanda ke da matsalar rashin lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini ko kuma rashin karfin garkuwar jiki suna fuskantar haɗarin kamuwa da cuta mai tsanani da rikitarwa. CDC ta shawarce su da su zauna a gida gwargwadon iko a yankunan da cutar ta bulla. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin kalmar  nisantar zamantakewa  da  nisantar jiki , don bayyana manufar rage hulɗa ta jiki ta hanyar kiyaye alaƙar zamantakewa, ko dai ta zahiri ko ta nesa.
Amfani da kalmar  nisantar zamantakewa  ya nuna cewa ya kamata a yi amfani da keɓewar jama'a gaba ɗaya, maimakon ƙarfafa mutane su ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun fitar da jagororin da suka shafi lafiyar jima'i da za a bi yayin annobar.
Sun haɗa da shawarar yin jima'i da wanda kuke zama tare da shi, wanda ba shi da cutar ko kuma ba shi da alamun cutar.
An ba da shawarar a ware mutane a gida domin waɗanda aka gano suna da cutar COVID-19 da waɗanda ake tsammanin suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓewa da kyau. Gwamnatoci da yawa sun ba da umurni ko kuma sun ba da shawarar keɓewa ga dukan mutanen da ke zaune a yankunan da cutar ta shafa.
An ba da umarni mafi tsauri na keɓewa ga mutane a cikin rukunin da ke da haɗari.
An shawarci mutanen da suka yi hulɗa da wanda ke da cutar COVID-19 da waɗanda suka yi tafiya zuwa wata ƙasa ko yanki da ke da yawan yaduwar cutar su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka fara hulɗa da cutar.
Dabaru na sarrafa annobar su ne hana ko kawar da ita, da kuma rage ta.
An kafa rigakafi a farkon ɓarkewar cutar kuma an yi shi ne don bibiya da ware mutanen da suka kamu da cutar, da kuma gabatar da wasu matakan sarrafa kamuwa da cuta da kuma allurar rigakafi don hana yaduwar cutar ga sauran al'umma.
Lokacin da ba za a iya hana yaduwar cutar ba, ana mai da hankali ga matakin rage cutar: ana daukar matakai don rage yaduwar cutar da kuma rage tasirinta a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan hanawa da ragewa a lokaci guda.
Cire cutar na bukatar tsauraran matakai domin a rage cutar ta hanyar rage yawan haifuwa zuwa kasa da 1. Wani bangare na gudanar da cutar mai yaduwa shi ne a yi kokarin rage yawan cutar: wannan shi ne abin da ake kira daidaita yanayin cutar.
Wannan zai rage haɗarin ɗora wa ma'aikatan kiwon lafiya nauyi kuma zai ba da lokaci don samar da allurar rigakafi da magunguna.
Matakan da ba na magani ba da za su iya magance annobar sun hada da matakan rigakafin mutum, kamar tsaftace hannu, sanya abin rufe fuska da keɓewa; matakan nisantar jama'a kamar rufe makarantu da wuraren ibada; kokarin jama'a don karfafa yarda da halartar irin waɗannan matakan; da kuma ayyukan muhalli kamar tsabtace wurare. An dauki matakai masu tsauri don sarrafa annobar a China lokacin da ta zama bayyane, kamar keɓe birane baki ɗaya da kuma takurawa kan tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki matakai da dama don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da gwajin taro da keɓewa a wurare dabam dabam, kuma ta ba da gargaɗi game da tafiye-tafiyen waɗanda ke da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da suka keɓe kansu, kuma ta ci tarar waɗanda ba su yi hakan ba.
Taiwan ta kara samar da abin rufe fuska kuma ta hukunta kwace kayayyakin kiwon lafiya.Girman gwaji ga Burtaniya da Amurka sun nuna cewa rage (rage amma ba kawar da yaduwar cutar) da kawar (juya ci gaban cutar) suna fuskantar manyan kalubale.
Manufofin rage yawan cutar za su iya rage bukatar kiwon lafiya da kashi biyu cikin uku da mutuwar mutane da rabi, amma ba za su iya hana dubban dubban mutuwar ba, kuma tsarin kiwon lafiya zai cika.
Ana iya ba da fifiko ga kawar da cutar, amma dole ne a ci gaba da hakan muddin cutar tana yawo a cikin al'ummar mutane (ko kuma har sai an samu rigakafin, idan hakan ta fara faruwa), in ba haka ba, watsawar za ta dawo da sauri idan aka saki matakan.
Samun dogon lokaci don kawar da annobar yana da farashi na zamantakewa da tattalin arziki.
Babu wani maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da kokarin samar da shi, gami da gwajin maganin da ake da shi.
Shan magungunan sanyi da ba a rubuta wa likita ba da kuma shan giya da kuma hutawa na iya taimaka wajen rage alamun.
Dangane da tsananin cutar, ana iya bukatar maganin oxygen, maganin intravenous, da kuma taimakon numfashi.
Yin amfani da steroids zai iya sa sakamakon ya yi muni.
An riga an amince da wasu magunguna da dama don maganin wasu cututtukan ƙwayoyin cuta a yanzu ana yin nazarin su don maganin COVID-19.
WHO ta ce wasu magunguna na gargajiya da na gida na iya rage alamun cutar SARS-CoV-19.
Ƙarfafa iya aiki da daidaita kulawar lafiya ga bukatun marasa lafiya da ke fama da COVID-19 WHO ta bayyana shi a matsayin babban matakin amsa cutar.
ECDC da Ofishin Yankin WHO na Turai sun fitar da jagororin ga asibitoci da ma'aikatun kiwon lafiya na farko don sake tura albarkatu a matakai daban-daban, gami da sadaukar da ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke ayyukan da ba na gaggawa ba a inda ya yiwu, warewa da ware marasa lafiya da suka gwada tabbatacce ga COVID-19, da kuma karfafa ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da kuma ƙara yawan masu yin iska da gadaje.
Akwai ra'ayoyi da dama game da inda aka fara samun wannan cutar (wanda ake kira "marasa lafiya".
An yi hasashen cewa an samu mutum na farko da ya kamu da cutar coronavirus a ranar 1 ga Disamba, 2019, a Wuhan, lardin Hubei na kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An yi bincike a kan cutar da ke da nasaba da kasuwar cin abincin teku ta Huanan, wadda kuma ke sayar da dabbobi masu rai. Wani ra'ayi shi ne cewa cutar ta fito ne daga daya daga cikin waɗannan dabbobi; a wasu kalmomi, ta samo asali ne daga dabbobi. An gano wani ciwon huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba kuma Dr. Zhang Jixian ne ya yi maganin cutar a asibitin lardin Hubei, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan sun gargadi abokan aikinsu game da cutar korona mai kama da SARS.
'Yan sanda sun tsawata wa takwas daga cikin likitocin, ciki har da Li Wenliang, don ya yaɗa jita-jita, kuma wani, Ai Fen, ya sha tsawata wa shugabanninsa don ya ba da gargaɗi.
Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An samu isassun mutane da suka kamu da cutar huhu da ba a san su ba, da aka kai rahoton su ga hukumomin kiwon lafiya na Wuhan don fara bincike a farkon watan Janairu. A farkon lokacin annobar, adadin masu kamuwa da cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, wanda hakan ya taimaka wajen ƙaurawar mutanen kasar a lokacin bikin Sabuwar Shekarar kasar Sin da kuma kasancewar Wuhan cibiyar sufuri da kuma babbar hanyar jirgin kasa.
A ranar 20 ga Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, an bayar da rahoton sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kusan ƙasashe 200 suna da mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata tafiye-tafiye kuma sun kafa hanyoyin dubawa a kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan hanawa kamar su keɓewa (wanda ake kira da zama a gida, buɗewa a wurin ko kuma umarnin keɓewa) da dokar hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'i na keɓewa a Amurka, sama da mutane miliyan 50 suna cikin Filifin, kusan miliyan 59 a Afirka ta Kudu da biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna da wasu nau'o'in tsare-tsare, wanda ya kai biliyan 2.6 bayan kwana biyu  kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An fara gano farkon wanda ya kamu da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an fara gano farkon wanda ya kamu da cutar a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ta lura da ciwon huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba, kuma ta sanar da CDC na Wuhan Jianghan a ranar 27 ga watan Disamba.
Gwajin kwayoyin halitta na farko na samfurori na marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar SARS.
Hukumar kula da lafiya ta birnin Wuhan ta fitar da sanarwar a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
An gargadi likitoci a Wuhan saboda yada jita-jita game da cutar.
Hukumar Lafiya ta kasa ta kasar Sin ta fara da cewa babu wata hujja ta kai tsaye na yaduwar cutar tsakanin mutane.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen yaduwar cutar, wanda daga baya babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana shi a matsayin yakin jama'a.
A cikin abin da aka kwatanta da  mafi girma a cikin tarihin ɗan adam , an sanar da dokar hana fita daga Wuhan a ranar 23 ga Janairu, kuma an faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane kusan miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekara ta kasar Sin (ranar 25 ga watan Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Huoshenshan, wanda aka kammala cikin kwanaki 10.
Daga baya aka gina wani asibiti, wato asibitin Leishenshan don a kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci, kasar Sin ta maida wasu gine-gine 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa sabbin matakai don dakile barkewar COVID-19, ciki har da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a kasar.
Yankin Hong Kong da Macau sun kafa wasu matakai, musamman game da makarantu da jami'o'i.
An kafa matakan aiki daga nesa a yankuna da yawa na kasar Sin.
An kafa takunkumin hana tafiye-tafiye a Hubei da kuma bayan ta.
An sauya hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na kasar Sin na ɗan lokaci.
An yi amfani da takunkumin tafiye-tafiyen jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin jama'a) sun fuskanci wasu nau'o'in takunkumin tafiye-tafiye. Bayan annobar ta shiga duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar ta shigo daga wasu ƙasashe.
Alal misali, Beijing ta sanya wa duk matafiya na duniya da ke shiga birnin keɓewa na kwanaki 14. A ranar 23 ga watan Maris, a babban yankin kasar Sin, an samu mutum daya ne kawai da ya kamu da cutar a cikin gida a cikin kwanaki biyar da suka gabata, wanda ya kamu ne ta hanyar matafiyi da ya koma Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Minista Li Keqiang ya ce an dakatar da yaduwar masu kamuwa da cutar a cikin gida, kuma an sarrafa cutar a China.
A wannan rana, an sassauta takunkumin tafiye-tafiye a Hubei, sai dai Wuhan, watanni biyu bayan farawar dokar kulle. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar masu da takardar izinin shiga ko izinin zama daga ranar 28 ga Maris, ba tare da bayyana lokacin da wannan manufofin za su ƙare ba.
Saboda haka, waɗanda suke son shiga ƙasar Sin dole ne su nemi biza a ofishin jakadancin ƙasar Sin ko kuma ofishin jakadancin ƙasar.
Gwamnatin kasar Sin ta karfafa wa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, kuma ta ba da tsare-tsaren karfafa kudi ga kamfanoni. Majalisar Harkokin Jiha ta sanar da ranar makoki da za a fara da yin shiru na mintuna uku a ranar 4 ga watan Afrilu da karfe 10:00 na safe, wanda ya yi daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta bukaci iyalai su yi tabawa ta hanyar intanet don kiyaye nisantar jiki da kuma guje wa sake barkewar cutar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar kiwon lafiya ta kasar ta bayar da rahoton karuwar masu kamuwa da cutar a ranar 20 ga watan Fabrairu, wanda aka danganta da taron da aka yi a Daegu na wani sabon addini mai suna Shincheonji Church of Jesus.
An yi zargin cewa masu bin addinin Shincheonji da suka ziyarci Daegu daga Wuhan ne suka haddasa annobar.
A ranar 22 ga watan Fabrairu, daga cikin masu bin coci 9,336, 1,261 ko kuma kusan kashi 13 cikin 100 sun ba da rahoton alamun cutar.
A ranar 28 ga Fabrairu, an samu fiye da mutane 2,000 da suka kamu da cutar a Koriya, sannan a ranar 29 ga Fabrairu, an samu mutane 3,150.
An killace dukkan sansanonin soji na Koriya ta Kudu bayan da sojoji uku suka kamu da cutar.
An kuma daidaita jadawalin jiragen sama, saboda haka Koriya ta Kudu ta gabatar da abin da aka yi la'akari da shi a matsayin mafi girma da kuma mafi kyawun tsari a duniya don gwada jama'a don cutar, da ware duk waɗanda ke da cutar da kuma bin diddigin waɗanda suka yi hulɗa da su da kuma ware su.
Hanyoyin gwajin sun hada da bayar da rahoton alamun cutar a kai a kai ta hanyar aikace-aikacen wayar salula, da kuma gwajin cutar da ke bayar da sakamakon a rana ta gaba, da kuma kara karfin gwajin don a iya gwada kusan mutane 20,000 a kowace rana.
An dauki shirin Koriya ta Kudu a matsayin nasara wajen shawo kan annobar, duk da cewa ba ta killace dukkan birane ba. Da farko al'ummar Koriya ta Kudu sun rabu kan yadda shugaba Moon Jae-in ya magance matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhumi Moon kan yadda gwamnatin kasar ta gudanar da annobar ko kuma a yaba masa saboda yadda ya amsa.
A ranar 23 ga watan Maris, Koriya ta Kudu ta samu mafi ƙarancin adadin masu kamuwa da cutar a kowace rana cikin makonni huɗu.
A ranar 29 ga Maris aka sanar da cewa daga ranar 1 ga Afrilu, duk wanda ya zo daga kasashen waje za a killace shi na tsawon makonni biyu.
A cewar kafofin watsa labarai, a ranar 1 ga Afrilu, Koriya ta Kudu ta samu buƙatun taimako don gano cutar daga ƙasashe daban-daban 121.
Iran ta bayar da rahoton kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda a cewar ma'aikatar lafiya da ilimin kiwon lafiya, mutane biyu suka mutu a ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'amuran al'adu, wasanni da addu'o'in Juma'a, da rufe jami'o'i, makarantun gaba da sakandare.
Iran ta ba da tiriliyan biyar na riyal don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa ba a shirya ware wuraren da cutar ta bulla ba, kuma za a ware mutane ne kawai.
An sanar da tsare-tsaren hana tafiye-tafiye tsakanin birane a watan Maris, duk da cewa ana ci gaba da samun cunkoson zirga-zirga tsakanin birane a lokacin bikin Sabuwar Shekarar Farisa.
An bude wuraren ibada na Shi'a a Qom ga mahajjata har zuwa 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Bisa ga zargin cewa ana iya ɓoye yaduwar cutar a Iran, sama da kasashe goma sun gano asalin cutar a Iran a ranar 28 ga Fabrairu, suna nuna cewa cutar ta iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, yayin da 23 daga cikin mambobinta 290 suka bayar da rahoton cewa sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yari da su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewarsu da zaman lafiya ba tare da wani sharadi ba, da kuma sakin duk fursunoni da suka cika wasu sharudda na wucin gadi.
Kungiyar ta ce akwai babbar barazanar yaduwar cutar a wuraren da aka rufe kamar cibiyoyin tsare mutane, wadanda kuma ba su da kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana guda, wanda shi ne mafi girma a kasar tun lokacin da cutar ta fara bulla.
Aƙalla 'yan siyasa 12 na Iran da suka mutu ko kuma mambobin gwamnati sun mutu daga cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran tana samun sabbin mutane 50 a kowace awa kuma tana samun sabon mutum daya da ke mutuwa a kowane minti goma saboda cutar coronavirus.
Wani jami'in WHO ya ce akwai yiwuwar akwai masu cutar sau biyar a Iran fiye da yadda aka ruwaito.
An kuma nuna cewa takunkumin Amurka na iya shafar ikon kasar wajen magance cutar.
Ofishin Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da yaduwar cutar a Italiya a ranar 31 ga Janairu, lokacin da aka gwada masu yawon bude ido biyu na China da cutar SARS-CoV-2 a Rome.
Cutar ta fara ƙaruwa cikin sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma zuwa China kuma ta ayyana dokar ta baci.
An gano cibiyar cutar COVID-19 da ba ta da alaƙa da juna, tare da tabbatar da mutane 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da sabon doka don shawo kan annobar, gami da keɓe mutane sama da 50,000 a garuruwa 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce:  Ba za a yarda da kowa ya shiga ko ya fita daga yankunan da cutar ta bulla ba.
An riga an ba da umarnin dakatar da ayyukan sana'a da wasannin motsa jiki a waɗannan yankuna. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a ƙasar yayin da Italiya ke da mutuwar mutum 100.
An shirya cewa za a gudanar da duk manyan wasannin wasanni, ciki har da wasannin Serie A na ƙwallon ƙafa, a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin wasa na akalla wata ɗaya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya umarci a dakatar da kusan dukkan ayyukan kasuwanci, sai dai manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Cibiyar Nazarin Magunguna, Magunguna, Tashin hankali da Kulawa mai tsanani ta Italiya (SIAARTI) ta fitar da shawarwari kan dabi'un likitanci game da hanyoyin da za a iya bi.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasa da ta fi yawan mutanen da suka mutu sakamakon cutar coronavirus a duniya bayan da ta bayar da rahoton mutane 3,405 da suka mutu sakamakon annobar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama tara na soja dauke da kayan aikin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, Italiya ta samu mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke. Mafi yawan mutanen da suka kamu da cutar sun fito ne daga yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi a Italiya da kuma rashin iya gwada duk waɗanda ke da cutar zuwa yanzu na iya taimakawa ga yawan mutuwar.
Amsar da Birtaniya ta bayar ga cutar da farko ta bayyana a matsayin daya daga cikin mafi sauƙin a cikin ƙasashe da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani nau'i na nisantar jama'a ko kuma keɓewar jama'a ga 'yan ƙasa ba.
Saboda haka, an soki gwamnati saboda rashin amsawa da kuma saurin amsawa ga damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwa, yana ba da shawarar duk tafiye-tafiye da tuntuɓar zamantakewar da ba su da mahimmanci, yana ba da shawarar mutane su yi aiki daga gida idan ya yiwu kuma su guji wurare kamar mashaya, gidajen cin abinci da wuraren wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren motsa jiki dole ne su rufe da wuri-wuri, kuma ta yi alkawarin biyan har zuwa kashi 80 cikin 100 na albashin ma'aikata, a cikin iyakar £2,500 a wata, don kaucewa rashin aikin yi da ke tattare da rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewa, yana hana taron mutane sama da biyu da kuma iyakance tafiye-tafiye da ayyukan waje ga waɗanda suka zama dole.
Ba kamar yadda aka yi a dā ba, ana bin dokar 'yan sanda, musamman ma a kan tarar mutane da kuma a kan tarar da su.
An umarci yawancin kamfanoni su rufe, sai dai waɗanda aka yi la'akari da su da muhimmanci, kamar su kantunan kantin sayar da kayayyaki, kantin magani, bankuna, kantunan DIY, tashoshin mai da kuma gidajen ajiye motoci.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da ya kamu da cutar COVID-19 a yankin Pacific Northwest, a jihar Washington, a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa rukunin aiki na fadar White House kan cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana gaggawa ta kiwon lafiya ta jama'a kuma ta sanya takunkumi kan shiga balaguro daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta samar da kayan gwajin kanta.
Duk da haka, Amurka ta jinkirta fara gwajin, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwaje-gwajen sun lalace saboda ƙarancin kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen watan Fabrairu, da kuma takunkumin cancantar gwajin har zuwa farkon watan Maris (ka'idar likita ta zama tilas daga baya).
A ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ruwaito cewa an yi gwaje-gwaje kasa da 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Mutane da yawa da ke da alamun cutar da kuma umarnin likita sun jira na tsawon sa'o'i ko ma kwanaki don yin gwaji. Da zarar an samu mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma wasu jihohi sun bi wannan matakin.
Makarantu a yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, wani rukuni na masana ilmin cututtuka daga Kwalejin Imperial ta London sun sanar da Amurka game da hasashen tasirin sabon coronavirus a kasar.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Coronavirus da Amsa da Ƙarin Kuɗaɗe, wanda ya ba da kuɗin gaggawa na dala biliyan 8.3 don taimakawa hukumomin tarayya wajen magance annobar.
Kamfanoni sun hana ma'aikatansu yin tafiye-tafiye, sun soke taro, kuma sun ƙarfafa ma'aikatansu su yi aiki daga gida.
An soke wasannin motsa jiki da kuma lokutan wasanni. A ranar 11 ga watan Maris, Trump ya sanar da takunkumin tafiye-tafiye ga yawancin kasashen Turai, sai dai Birtaniya, na tsawon kwanaki 30 daga ranar 13 ga watan Maris.
Washegari, ya faɗaɗa takunkumin zuwa Ƙasar Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana gaggawa ta kasa, wanda ya ba da damar samar da kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage ayyukansu a duk faɗin Amurka don su yi kokarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da bullar cutar a kowace jiha 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an samu mutane 10,700 da suka kamu da cutar a birnin New York, wanda ya fi adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ya yi kama da cewa nisantar mutane yana aiki ne saboda an kara kimantawa na ninka yawan masu kamuwa da cutar daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da kamuwa da cutar a New York 32,308 kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, Amurka ta bayar da rahoton ƙarin masu kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da kamuwa da cutar a Amurka 400,335, kuma mutane 12,841 sun mutu.
A ranar 30 ga watan Maris, ta hanyar kafofin watsa labarai, shugaban Amurka Trump ya yanke shawarar tsawaita dokokin nisantar juna har zuwa ranar 30 ga watan Afrilu.
A wannan ranar, jirgin asibiti mai ɗauke da gado kusan 1,000, wato, USS Comfort, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 da cutar coronavirus ta yi a cikin sa'o'i 24.
A jihar New York, adadin masu kamuwa da cutar ya zarce mutane 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda ta rage barazanar kuma ta sarrafa sadarwa ta hanyar umurtar jami'an kiwon lafiya da masana kimiyya su daidaita maganganun jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
An samu rabuwa a tsakanin jam'iyyun da ke goyon bayan yadda Trump ya magance matsalar.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi, ciki har da kayan aikin kiwon lafiya, daga China.
An yi amfani da bincike kan yanayin tafiye-tafiye ta jirgin sama don tsarawa da kuma hango yadda za a iya yaduwar cutar, kuma an buga shi a cikin Journal of Travel Medicine a tsakiyar watan Janairu na shekarar 2020.
Bisa ga bayanan 2018 na Ƙungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun fi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne kuma sun shahara wajen zuwa Wuhan.
An yi la'akari da Bali a matsayin birni mafi ƙarancin ƙwarewa a cikin birane 20 da suka fi shahara a cikin shirye-shirye, yayin da biranen Ostiraliya aka yi la'akari da su a matsayin mafi dacewa. Ostiraliya ta fitar da shirin ta na gaggawa na amsawa ga sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya ce har yanzu akwai sauran abubuwa da za a gano game da COVID-19 kuma Australia za ta kara kula da iyakokinta da sadarwa a cikin maganin cutar.
A ranar 21 ga Maris, an sanar da gaggawa ta lafiyar ɗan adam a Ostareliya.
Saboda keɓewar hanyoyin sufuri na jama'a a Wuhan da Hubei, ƙasashe da dama sun shirya su kwashe 'yan ƙasarsu da ma'aikatan diflomasiyya daga yankin, musamman ta jiragen da ƙasarsu ta haya, tare da izinin hukumomin China.
Kasashen Kanada, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand na cikin na farko da suka fara shirya kwashe 'yan kasashensu.
Pakistan ta ce ba za ta kwashe 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, ban da 'yan Poland huɗu, da 'yan China guda ɗaya da kuma 'yan Indiya guda ɗaya.
'Yan ƙasar Poland, Sin da Indiya sun sauka a ƙasar Poland, inda jirgin Brazil ya tsaya kafin ya ci gaba zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a wani sansanin soji kusa da Brasília.
A wannan rana, an kwashe 'yan Kanada 215 (masu jirgin sama 176 da 39 a jirgin sama na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa BFC Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga birnin Wuhan ya sauka a BFC Trenton.
Hukumomin Australiya sun kwashe mutane 277 a ranar 3 da 4 ga watan Fabrairu zuwa gidan yarin da ke tsibirin Kirsimeti, wanda aka mai da shi wuri na keɓewa, inda suka zauna na kwanaki 14.
Jirgin saukar jiragen ruwa na New Zealand ya isa Auckland a ranar 5 ga Fabrairu. An killace fasinjojinsa (musamman daga Australia da Pacific) a sansanin jiragen ruwa na Whangaparaoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin sama mai dauke da fasinjoji 129 na Kanada da aka kwashe daga jirgin Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin South African Airways da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan kasar Afrika ta Kudu 112.
An yi gwajin lafiya kafin tashi kuma 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus sun kasance a wurin don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin rashin lafiya ne kawai aka mayar da su gida.
Sakamakon gwajin ya cire duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin, matukan jirgin, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, waɗanda, a matsayin kariya, duk sun kasance a karkashin lura da keɓewa na tsawon kwanaki 14 a Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraqi saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (musamman Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin da suka yi rajista a jami'o'in Amurka sun taru don taimakawa wajen tura kayan agaji zuwa yankunan da cutar ta shafa na kasar Sin, tare da wani rukuni na hadin gwiwa daga yankin Greater Chicago da aka ruwaito cewa sun aika da takunkumin N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwa da FedEx, ta aika da takunkumin kariya 200,000 da sauran kayan kariya na mutum, ciki har da safofin hannu da riguna, ta hanyar jirgin sama zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken rigakafi da kuma kokarin magani da kuma kare mutanen da ke cikin hadari a Afirka da Kudancin Asiya.
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga watan Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu ne kungiyar agajin agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 na taimakon agaji ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan 1 zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da kayan Hazmat 10,000, kuma Amurka ta ba da gudummawar kayan aikin likita tan 17.8 ga China kuma ta yi alkawarin ƙarin dala miliyan 100 na tallafin kuɗi ga ƙasashen da cutar ta shafa. Da zarar al'amuran da ke China sun daidaita, kasar ta aika da taimako ga ƙasashe da yawa da cutar ta shafa.
A watan Maris, Sin, Cuba da Rasha sun aika da kayan aikin likita da masana don taimakawa Italiya wajen magance annobar cutar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika da kayan gwajin cutar miliyan 1.1, da abin rufe fuska miliyan 6, da kuma riguna na kariya dubu 60 zuwa birnin Addis Ababa na Habasha domin rarraba su ta hanyar kungiyar tarayyar Afirka.
Daga baya, ya aika da kayan gwaji 5,000, abin rufe fuska 100,000, da kuma na'urorin numfashi guda biyar zuwa Panama.
Ma ya kuma ba da gudummawar kayan aikin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a China.
Alal misali, Spain ta janye kayan gwajin cutar korona 58,000 da aka yi a China da daidaito na kashi 30 cikin dari, yayin da Netherlands ta janye kayan rufe fuska na kare lafiyar China 600,000 da suka lalace.
Belgium ta dawo da abin rufe fuska 100,000 da ba su da amfani; an yi zaton cewa sun fito ne daga China, amma a gaskiya daga Colombia ne.
A wani bangare kuma, an samu karbuwa a taimakon da kasar Sin ta bayar a yankunan Latin Amurka da Afirka.A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafa wa kasashe masu tasowa.
WHO ta yaba wa kokarin da hukumomin China suka yi wajen sarrafa da kuma shawo kan annobar.
WHO ta lura da bambanci tsakanin annobar SARS ta 2002-2004, inda aka zargi hukumomin China da ɓoyewa da ta hana hana rigakafin cutar da kuma magance ta, da kuma matsalar yanzu, inda gwamnatin tsakiya ta ba da rahotanni na yau da kullum don kauce wa fargaba a ranar Sabuwar Shekara ta Lunar.
A ranar 23 ga watan Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na sanya dokar hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya lura cewa ko da yake ba shawarar WHO ba ce, amma muhimmiyar alama ce ta jajircewar da ake da ita na dakile annobar a inda ta fi yawa, kuma ya yi magana game da abin da ba a taɓa gani ba a tarihin kiwon lafiyar jama'a. A ranar 30 ga watan Janairu, bayan tabbatar da yaduwar cutar tsakanin mutane a China da kuma karuwar adadin masu kamuwa da cutar a wasu ƙasashe, WHO ta bayyana cewa annobar ta zama gaggawa ta lafiyar jama'a ta duniya (IPH), wanda ya zama mataki na biyu da aka ɗauka tun lokacin annobar cutar APPI a shekarar 2009.
Darakta Janar na WHO Tedros Adhanom ya ce cutar ta USPPI ta samo asali ne daga hadarin yaduwar cutar a duniya, musamman a ƙasashe masu karancin kuɗi da matsakaitan kuɗi da ba su da tsarin kiwon lafiya mai ƙarfi.
A cikin martani ga takunkumin tafiye-tafiye, Tedros ya ce: "Babu wani dalili da zai sa matakan su tsoma baki ba tare da bukatar tafiya da kasuwanci ba kuma WHO ba ta ba da shawarar hana kasuwanci da tafiye-tafiye ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga kasashen duniya da su ba da gudummawar dala miliyan 675 domin tallafawa shirye-shiryen dabarun a ƙasashe masu karancin kuɗi, inda ta yi kira ga gaggawa don tallafa wa ƙasashen da ba su da tsarin da ya dace don gano mutanen da suka kamu da cutar, ko da yake ta kusan bayyana.
Tedros ya ci gaba da cewa muna da ƙarfi kamar yadda muke da rauni, kuma ya bukaci kasashen duniya su zuba jari a yau ko su biya ƙarin gobe. A ranar 11 ga watan Fabrairu, WHO ta kafa a taron manema labarai cewa cutar ta kasance COVID-19.
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya hada da karfin dukkan tsarin Majalisar Dinkin Duniya a cikin martani.
Saboda haka, an kafa ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya, wanda zai ba da damar daidaita duk abin da Majalisar Dinkin Duniya ta amsa, wanda WHO ta ce zai ba su damar mayar da hankali kan maganin kiwon lafiya yayin da sauran hukumomin za su iya ba da kwarewarsu don magance tasirin zamantakewar jama'a, tattalin arziki da ci gaba na annobar.
A ranar 14 ga watan Fabrairu, an kaddamar da wata tawagar hadin gwiwa ta WHO a kasar Sin domin tura masana na kasa da kasa da na WHO zuwa kasar Sin don tallafawa gudanar da cutar a kasar da kuma tantance yadda ta ke da tsanani da kuma yaduwar cutar ta hanyar gudanar da bita da tarurruka tare da manyan hukumomin kasa da kuma kai ziyara a filin domin tantance tasirin ayyukan da ake yi a larduna da kananan hukumomi, ciki har da birane da karkara. A ranar 25 ga watan Fabrairu, WHO ta ce duniya ta kamata ta yi karin shiri don yiwuwar barkewar cutar coronavirus, inda ta nuna cewa ko da yake lokaci ya yi da wuri a ce za a yi magana game da cutar, duk da haka kowace kasa ta kamata ta shiga wani mataki na shiri.
Dangane da ci gaban annobar a Iran, WHO ta aika da tawagar hadin gwiwa zuwa wurin don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce an inganta tantancewar barazanar coronavirus a duniya daga  high  zuwa  very high , matakin sa na mafi girma na faɗakarwa da tantance haɗarin.
Mike Ryan, darektan gudanarwa na shirin kula da gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa: "Wannan shine komawar gaskiya ga kowace gwamnati a duniya: tashi.
Wannan kwayar cuta na iya kasancewa a kan hanyar ta, kuma ya kamata ku kasance a shirye, ya kara da cewa, matakan da suka dace na amsawa na iya taimakawa duniya wajen kaucewa mafi muni.
Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba su ba jami'an kiwon lafiya damar sanar da annobar duniya ba, ya ce irin wannan sanarwar na nufin cewa mun yarda da cewa kowane mutum a duniya yana da cutar.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ce za a iya kiransa annobar korona.
Darakta Janar ya bayyana cewa WHO tana da matukar damuwa game da matakan yaduwar cutar da kuma tsananin cutar da kuma rashin aiki. WHO ta fuskanci zargi mai yawa game da yadda ta gudanar da annobar, wanda aka yi la'akari da rashin dacewa, musamman saboda jinkirin sanar da gaggawa na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annoba.
An tallafa wa wannan rashin amincewa da takarda neman shugaban WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masana 'yancin ɗan adam na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun taimakon agaji kuma gwamnati ce ke da wannan hakkin.
Ƙungiyar ta nace cewa rashin wadata ko inshorar lafiya ba za su taɓa zama hujja ba ga kowane irin nuna bambanci ga takamaiman rukuni.
Masana sun jaddada cewa kowane mutum na da hakkin samun lafiya, ciki har da nakasassu, 'yan tsiraru, tsofaffi, mutanen da suka rasa gidajensu, marasa gidajensu, waɗanda ke cikin matsanancin talauci, fursunoni, da 'yan gudun hijira da sauran kungiyoyi da ba a bayyana su ba da suke bukatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna kula da tasirin tattalin arziki da zamantakewa na rikicin COVID-19.
Ƙungiyar Tattalin Arziki da Ƙaddamarwa ta ƙaddamar da dandamali da ke ba da cikakken bayani game da martani na siyasa a ƙasashe daban-daban na duniya, da kuma ra'ayoyi da shawarwari.
Tsakanin manufofi na ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya da kuma amsawa ga tasirin kulle-kulle da ƙuntatawa na tafiye-tafiye, dandalin dijital ya haɗa da kayan aikin Country Policy Tracker da aka tsara don taimakawa ƙasashe su koya daga juna da kuma sauƙaƙe haɗin kai na duniya game da ƙalubalen da coronavirus ke kawowa.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan ofishin hukuma na Burtaniya Michael Gove da kuma dan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda suka gudanar da annobar, wadda ta fara a lardin Hubei na kasar Sin.
An cire wasu jami'an jam'iyyar kwaminis ta kasar Sin (CCP) daga mukaman su sakamakon gudanar da keɓewar kai a tsakiyar kasar Sin, alamar rashin jin daɗin yadda jami'an siyasa ke magance annobar a waɗannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu manyan jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da ra'ayin farko cewa cutar coronavirus ta fara ne a Wuhan, suna goyon bayan ra'ayoyin da ke nuna cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira cutar coronavirus da  cutar Sin  ko  cutar Wuhan , inda ta ce a China  tace-tallace ta yi amfani da cutar da ta zama annoba ta duniya , wanda daga baya wasu masu adawa suka yi zargin wariyar launin fata da kuma nufin  karkatar da hankali daga rashin iyawar gwamnatinsa na shawo kan cutar .
Jaridar Daily Beast ta samu sakon waya daga gwamnatin Amurka da ke bayyana wani makircin sadarwa da ake ganin ya fito ne daga kwamitin tsaron kasa, wanda aka ce dabarar shi ne:  Duk abin daga kasar Sin ne.
An bukaci mu yi kokarin isar da wannan sako ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. Jaridu kamar Politico, Foreign Policy da Bloomberg sun ce kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin farfagandar da take yi domin samun rinjaye a duniya.
Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai wani bangare na siyasa wanda ya kunshi gwagwarmaya don samun rinjaye ta hanyar maganganu da kuma "siyasa ta karimci".
Borrell ya kuma ce  China ta nace da karfi cewa, ba kamar Amurka ba, ita ce abokiyar hulda mai alhakin gaskiya .
China ta kuma bukaci Amurka ta dage takunkumin da ta kafa kan Syria da Venezuela da kuma Iran, tare da aika da taimakon farko ga kasashen biyu na karshe.
An dakatar da takunkumin Amurka a ranar 3 ga watan Afrilu, a kan kayan rufe fuska 100,000 da Jack Ma ya bayar ga Cuba.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka yi niyya ga wasu ƙasashe zuwa ƙasarsu.
Kuma an kuma samu wasu rikice-rikicen da suka shafi abin rufe fuska a wasu ƙasashe, kamar Jamus, Austria da Switzerland, da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta kama ɗarurruwan na'urorin numfashi da ake nufi zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kan Tarayyar Turai ga Italiya da cutar korona ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce China ce kawai ta amsa ta fuska biyu.
Wannan ba alama ce mai kyau ba ga haɗin kan Turai.
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe cututtuka na musamman da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto wani babban jami'in siyasa wanda bai bayyana sunansa ba, wanda ya ce kashi 80 cikin 100 na taimakon Rasha ba shi da amfani ga Italiya.
Majiyar ta zargi Rasha da shiga wani harin da ake yi na nuna cewa kasar tana da siyasa da kuma siyasa.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Waje na Italiya Luigi Di Maio sun musanta rahoton kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin ruwa mai jigilar kayayyaki da ke dauke da kayan kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce, "ta hanyar bayar da taimakonsa ga takwarorinsa na Amurka, [Putin] ya yi tunanin cewa idan masana'antun kayan aikin likita na Amurka sun samu saurin, za su iya mayar musu da abin da suka samu idan an bukaci hakan".
Za a rage girman atisayen sojan NATO na Defender 2020 da aka shirya a Jamus, Poland da kuma ƙasashen Baltic, wanda shi ne mafi girma a cikin atisayen NATO tun ƙarshen Yakin Cacar Baki.
Babban sakataren Kamfen na kawar da makaman nukiliya Kate Hudson ta soki aikin Defender 2020:  A cikin matsalar lafiyar jama'a ta yanzu, ba wai kawai yana barazana ga rayukan sojojin Amurka da na kasashen Turai da yawa da ke cikin aikin ba, har ma da rayukan mutanen kasashen da suke aiki . Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa ashirin da suka kamu da cutar, da kuma wasu manyan 'yan siyasa 15 na baya da na yanzu.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, inda ya bayyana cewa kasarsa na fama da cutar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin Amurka kan Iran. Cutar ta haifar da kira ga Amurka da ta bi manufofin zamantakewa na sauran kasashe masu arziki, ciki har da tsarin kiwon lafiya na duniya, shirin kula da yara na duniya, izinin iyaye da ake biya da kuma karin kudaden tallafin kiwon lafiyar jama'a.
Masu sharhi a fannin siyasa na tsammanin hakan zai shafi damar da Donald Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta yi muni saboda annobar.
Koriya ta Kudu ta soki ƙoƙarin Japan na keɓewa da ke da wuyar fahimta bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi na makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai, al'ummar Koriya ta Kudu sun rabu biyu game da yadda za a bi da matsalar da Shugaba Moon Jae-in ya yi.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a zargi Moon da rashin kula da cutar daga gwamnati ko kuma a yaba masa saboda yadda ya amsa. Cutar ta ba da damar kasashe su kafa dokokin gaggawa a matsayin martani.
Wasu masu sharhi sun nuna damuwa cewa wannan zai ba gwamnatoci damar ƙarfafa ikonsu.
A Hungary, majalisar dokokin kasar ta kada kuri'a ta ba Firayim Minista Viktor Orbán damar yin mulki ta hanyar zartar da doka har sai an ba da umarni, ta dakatar da majalisar da kuma zaben, da kuma hukunta duk wanda aka zarga da yada labaran karya game da cutar da kuma yadda gwamnati ke tafiyar da rikicin.
An zargi annobar coronavirus da yawan matsalar rashin samar da kayayyaki, sakamakon karuwar amfani da kayan aiki a duniya don magance annobar, sayayya ta firgita, da katsewar masana'antu da ayyukan da ake yi.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin karancin magunguna da kayan aikin kiwon lafiya saboda karuwar bukatar masu sayen kayayyaki da kuma katsewar masu samar da kayayyaki.
Ƙauyuka da yawa kuma sun fuskanci sayayya ta firgita wanda ya sa kayayyakin da ake bukata kamar abinci, takardar wanka da kwalaben ruwa suka ɓace, kuma hakan ya jawo ƙarancin kayayyaki.
Masana'antar fasaha, musamman, ta yi gargadi game da jinkirin jigilar kayayyakin lantarki.
A cewar babban daraktan WHO Tedros Adhanom, bukatar kayayyakin kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashi har sau ashirin fiye da na al'ada kuma ta haifar da jinkiri a samar da na'urorin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan kuma ya haifar da karancin kayan kariya na mutum a duniya, kuma WHO ta yi gargadin cewa hakan zai sa ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayar da kayayyakin da suka fito daga Australia zuwa China.
Aikin ya haifar da karancin madara na jarirai a wasu manyan kantuna kuma daga bisani gwamnatin Australia ta hana shi. Duk da yawan cutar COVID-19 a arewacin Italiya da yankin Wuhan, da kuma bukatar abinci mai yawa da ta biyo baya, waɗannan yankuna biyu ba su fuskanci tsananin karancin abinci ba.
Matakan da China da Italiya suka ɗauka a kan ɓoyewa da cinikin kayayyakin rayuwa da ba bisa ka'ida ba sun yi nasara sosai, ta haka ne suka kauce wa munanan karancin abinci da aka yi hasashen za su auku a Turai da kuma Arewacin Amirka.
Saboda yawan amfanin gona da ake samarwa, arewacin Italiya ba ta ga raguwa mai yawa ba, amma farashin zai iya ƙaruwa bisa ga wakilan masana'antu.
An kwashe abinci na ɗan lokaci ne kawai, har ma a birnin Wuhan, yayin da ma'aikatan gwamnatin China suka buɗe abincin alade don tabbatar da wadataccen abinci ga jama'a.
A Italiya ma, akwai irin waɗannan dokoki don masu shuka abinci su ajiye kayan da za su iya amfani da su a lokacin gaggawa.
An ji mummunan tasiri a kan tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai na ranar 16 ga watan Maris, tattalin arzikin China ya sha wahala sosai a cikin watanni biyu na farko na shekarar 2020 saboda matakan da gwamnati ta dauka na rage yaduwar cutar, kuma tallace-tallace na sayar da kayayyaki ya ragu da kashi 20.5.
Tun da babban cibiyar tattalin arziki da masana'antu ne, an ga cewa annobar ta zama babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwanni za su ci gaba da zama marasa ƙarfi har sai an sami cikakken bayani game da yiwuwar fita.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin tattalin arziƙin cutar kan ci gaban duniya na iya wuce na cutar SARS ta 2002-2004.
Wani masani a jami'ar Washington da ke St. Louis ya ce zai iya jawo hasara fiye da dala biliyan 300 a kan kayayyakin da ake sayarwa a duniya, kuma hakan zai iya kaiwa shekaru biyu.
An ce kungiyar OPEC ta rushe ne bayan faduwar farashin mai saboda karuwar bukatar da ake samu a kasar Sin.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga watan Fabrairu sakamakon karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda karuwar fargabar annobar korona, wasu alamomin hannayen jari na Amurka da suka hada da NASDAQ-100, S&ampP 500 da Dow Jones Industrial Average sun yi raguwa sosai tun shekarar 2008, inda Dow Jones ya fadi da maki 1,191, mafi girma a rana guda tun bayan rikicin tattalin arzikin 2007-08.
Ƙididdigar da aka yi a cikin waɗannan sigogi uku sun ƙare mako da raguwa da ta wuce kashi goma cikin ɗari.
A ranar 28 ga Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da darajar bashin da kasar Sin ke da shi, amma ya ci gaba da nuna rashin amincewa.
Hannun jari sun sake faduwa saboda fargabar cutar coronavirus, inda aka fi samun raguwa a ranar 16 ga watan Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai koma baya.
Wani masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa da aka kafa a kan lokaci ta bangarorin banki da jihohi.
Bankunan tsakiya sun fi saurin amsawa fiye da yadda suka yi a lokacin matsalar tattalin arziki ta 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da aka fi shafa saboda takunkumin hana tafiye-tafiye, rufe sararin jama'a, musamman wuraren yawon buɗe ido, da shawarwarin gwamnatoci game da tafiye-tafiye a duk duniya.
Saboda haka, kamfanonin jiragen sama da yawa sun soke jirage saboda raguwar bukatar, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin Birtaniya Flybe ya yi fatara.
Tasirin da ya shafi masana'antar jirgin ruwa ya kai matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa.
Cutar ta faru ne a lokacin da ake bikin Chunyun, babban lokacin yawon bude ido da ake yi a lokacin bikin Sabuwar Shekarar kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka shafi taron jama'a, ciki har da bikin Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren shakatawa, kamar su Hong Kong Disneyland da Shanghai Disneyland.
An soke bukukuwa da dama na bikin Sabuwar Shekara, kuma an rufe wuraren da ake sha'awar yawon bude ido don kauce wa taron jama'a, ciki har da birnin Beijing da kuma wuraren bikin haikalin gargajiya.
A larduna 24 cikin 31 na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga watan Fabrairu, suna ba da umarnin cewa yawancin wuraren aiki kada su sake buɗewa har sai wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin ɗari na GDP na ƙasar da kuma kashi 90 cikin ɗari na fitar da kayayyaki.
Hong Kong ta kai matakin da ta fi dacewa na amsa cututtukan cututtuka kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bukukuwan Sabuwar Shekara. An shafi sashen sayar da kayayyaki a duniya, tare da rage lokutan buɗe shaguna ko rufewa na ɗan lokaci.
Ziyarar 'yan kasuwa a Turai da Latin Amurka ta ragu da kashi 40 cikin ɗari.
A Amirka ta Arewa da Gabas ta Tsakiya, masu sayar da kayayyaki sun rage kashi 50 zuwa 60 bisa ɗari.
Wannan kuma ya sa zirga-zirgar mutane a manyan kantuna ta ragu da kashi 33 zuwa 43 cikin ɗari a watan Maris idan aka kwatanta da na Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duniya sun sanya ƙarin matakan, kamar ƙara yawan tsabtace gidaje, shigar da na'urorin duba zafin jiki don lura da yanayin zafin jiki na abokan ciniki, da kuma soke abubuwan da suka faru. A cewar wani kimantawa na Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da cutar ta haifar na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka idan aka kwatanta da yanayin da babu cutar.
A watan Janairu da Fabrairu na shekarar 2020, lokacin da cutar ta yi zafi a birnin Wuhan, mutane kusan miliyan 5 a kasar Sin sun rasa ayyukansu.
A China, yawancin ma'aikatan da ke ƙaura daga karkara kusan miliyan 300 sun makale a gidajensu a lardunan cikin gida ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32 bisa dari, a cewar kimantawar Bankin Tarayya na St. Louis. Kullewa a Indiya ya bar dubun miliyoyin ma'aikatan bakin haure na Indiya (masu karbar albashi na rana) a cikin rashin aikin yi. Binciken Cibiyar Angus Reid ya gano cewa kashi 44 cikin 100 na iyalai na Kanada sun sami wani nau'in rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka kafa dokar kulle a tsakiyar watan Maris na 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi a ba su tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi a ba su lamuni na duniya.Kusan kamfanoni miliyan daya da rabi a Jamus sun sauya ma'aikatansu zuwa tsarin aikin lokaci na gwamnati da ake kira Kurzarbeit.
An amince da tsarin biyan albashi na aikin lokaci na Jamus a Faransa da kuma Birtaniya.
Yankin fasaha da al'adun gargajiya sun sha wahala sosai sakamakon annobar, wanda ya shafi yadda kungiyoyi da mutane, ma'aikata da masu zaman kansu, ke aiki a duniya.
Ƙungiyoyin al'adu da fasaha sun yi ƙoƙari su ci gaba da aikinsu (wanda galibi gwamnati ke tallafawa) na ba da damar al'adun al'umma, tabbatar da lafiyar ma'aikatansu da jama'a, da kuma tallafa wa masu fasaha a duk inda zai yiwu.
A watan Maris na shekarar 2020, a ko'ina a duniya, da kuma a matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu an rufe su har sai an sake ba da umarni kuma an soke ko kuma jinkirta nune-nunen su, abubuwan da suka faru da kuma nuna su.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ya hanzarta cutar, soke ayyukan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide, taron fasaha da nunin tufafi.
Har ila yau, masana'antar fim ta yi kasala, kuma Vatican ta sanar da cewa an soke bikin Makon Mai Tsarki a Roma, wanda ake yi a makon ƙarshe na lokacin azumin azumin Kirista na Lent.
Da yawa daga cikin majami'u sun ba da shawarar cewa tsofaffi su zauna a gida maimakon su halarci ibadar ranar Lahadi. Wasu majami'u suna watsa ayyukan su ta hanyar rediyo, intanet, da kuma talabijin, wasu kuma suna ba da sabis a cikin mota.
Kamar dai yadda cocin Roman Katolika na Roma ya rufe majami'unsa da kuma St. Peter's Square, inda aka kawar da dukan masu zuwa bauta, wasu majami'u ma sun soke ayyuka kuma sun hana mutane yin taro a majami'u, masallatai, majami'u, haikali, da gurdwaras.
Ministan Lafiya na Iran ya sanar da soke sallar Juma'a a yankunan da cutar ta addabi, kuma an rufe wuraren ibada, yayin da Saudiyya ta haramta shiga wuraren ibada na Makka da Madina ga mahajjata da kuma 'yan kasar.
Cutar ta haifar da babbar katsewa a kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
An soke ko kuma dage manyan wasannin wasanni, ciki har da gasar zakarun Turai ta 2019-20, gasar cin kofin kwallon kafa ta Ingila ta 2019-20, UEFA Euro 2020, kakar NBA ta 2019-20, da kuma kakar NHL ta 2019-20.
Cutar ta lalata gasar wasannin Olympics na bazara na 2020, wanda aka shirya fara a karshen watan Yuli. Kwamitin wasannin Olympics na duniya ya sanar a ranar 24 ga watan Maris cewa za a sake shirya taron bayan shekarar 2020, amma ba a baya ba har zuwa lokacin bazara na 2021. Gidajen caca da sauran wuraren caca a duniya sun rufe, kuma an jinkirta ko kuma soke wasannin karta na rayuwa.
Wannan ya sa 'yan wasa da yawa suka shiga shiga yanar gizo, kuma shafukan caca na kan layi da yawa sun ga karuwar sabbin rajista. Har ila yau, harkar nishaɗi ta sami matsala, tare da wasu kungiyoyin kiɗa da suka dakatar ko soke rangadin wasan kwaikwayo.
Manyan gidajen wasan kwaikwayo, kamar su Broadway, sun daina yin wasan kwaikwayon.
Wasu masu fasaha sun nemi hanyoyin da za su ci gaba da kirkira da kuma raba ayyukansu ta hanyar intanet a matsayin maye gurbin wasan kwaikwayon gargajiya na rayuwa, kamar wasan kwaikwayo na kan layi da raye-raye ko kuma  bukukuwa  na kan layi da aka kirkira don masu fasaha su yi, yadawa da inganta ayyukansu.
A kan layi, an yi amfani da labaran yanar gizo masu yawa game da cutar korona domin mutane da yawa suna son yin dariya da kuma shagala a kan rashin tabbas.
Tun da annobar COVID-19, an ga ƙaruwa na nuna bambanci, ƙiyayya da wariyar launin fata ga mutanen da suka fito daga ƙasar Sin da Asiya ta Gabas, da kuma mutanen da suka fito daga yankunan da ke da ƙarancin damuwa a Turai, Amurka da wasu ƙasashe.
An lura da abubuwan da suka shafi tsoro, rashin yarda da kuma ƙiyayya a ƙasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amirka da yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin masu kamuwa da cutar har yanzu suna China) sun bayyana ra'ayoyin wariyar launin fata da aka bayyana a cikin kungiyoyi daban-daban a duniya cewa Sinawa sun cancanci cutar ko kuma suna samun hukunci mai kyau.
Wasu ƙasashen Afirka ma sun ga ƙaruwar rashin amincewa da ƙasar Sin.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna wariya bisa asalin yankin da suke.
An ba da tallafi ga mutanen China, a kan layi da wajen layi, da kuma ga mazauna yankunan da cutar ta shafa.
A sakamakon yaduwar cutar zuwa wasu ƙasashe masu saurin kamuwa da cutar, Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunan barkewar cutar COVID-19, na iya fuskantar shakku da ƙiyayya da baƙi. 'Yan ƙasa daga ƙasashe kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun neman hana Sinawa shiga ƙasarsu don dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya yi ta tawaye a shafin Twitter.
Sinanci da sauran mutanen Asiya da ke zaune a Birtaniya da kuma Amurka sun ba da rahoton karuwar yawan lalatattun kalmomi da kuma cin zarafi.
Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran cutar korona  cutar Sin , kalmar da masu sukar sa ke ganin wariyar launin fata ce da kuma adawa da kasar Sin.
A Ukraine, masu zanga-zanga sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da kuma 'yan gudun hijira daga kasashen waje tsakanin Wuhan da Novi Sanzhary.
An yi zargin cewa dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya sun fuskanci tsangwama dangane da annobar cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na West Bengal Dilip Ghosh ya ce, Sinawa sun lalata yanayi kuma saboda haka Allah ya rama musu.
Bayan haka, ofishin jakadancin China da ke Kolkata ya la'anci wannan furucin da cewa ba gaskiya ba ne. A kasar Sin, cutar ta kara tayar da hankalin 'yan kasashen waje da nuna wariyar launin fata ga mutanen da ba 'yan kasar Sin ba, inda aka bayyana 'yan kasashen waje a matsayin 'yan ƙazamar ƙasa da ya kamata a kawar da su.
Jaridu da yawa da ke biyan kuɗi sun cire su saboda wasu ko duka labaran da suka yi game da cutar korona.
Masu wallafa littattafan kimiyya da yawa sun ba da takardunsu na kimiyya da suka shafi annobar a cikin hanyar da ba a rufe ba.
Wasu masana kimiyya sun zaɓi su raba sakamakon binciken da sauri a kan sabobin da za a fara buga su kafin a fara buga su kamar bioRxiv.
Cutar cuta mai tasowa Cutar cuta mai tasowa ta fito daga wata cuta mai tasowa, sau da yawa sabon abu ne a fannin yaduwar cutar ko hanyar watsawa
Duniya da cuta  Bayani game da duniya da kuma yaduwar cuta
Jerin annoba da annobar  Jerin adadin mutuwar cututtukan da ke haddasa kamuwa da cuta
Cinikin dabbobi da cututtukan dabbobi Hadarin kiwon lafiya da ke tattare da cinikin dabbobi masu ban mamaki
Binciken dakin gwaje-gwaje na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke hade da shi ya hada da hanyoyin gano kwayar cutar da kuma gano kwayoyin cutar da aka samar a sakamakon kamuwa da cutar.
An tabbatar da kasancewar kwayar cutar a cikin samfurori ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
An tsara wannan bincike musamman don gano SARS-CoV-2 RNA kawai.
Ana amfani da shi wajen tabbatar da cewa akwai kamuwa da cuta da aka yi kwanan nan ko kuma a yanzu.
Ana iya amfani da gwajin rigakafi (serology) don ganewar asali da kuma lura da al'umma.
Gwajin rigakafin yana nuna yawan mutanen da suka kamu da cutar, har da mutanen da alamun cutar ba su da tsanani da za a iya bayyana su ko kuma mutanen da ba su da alamun cutar.
Za a iya ƙayyade ainihin yawan mutuwar cutar da kuma matakin garkuwar garkuwar jama'a daga sakamakon wannan gwajin.
Saboda ƙarancin gwaji, babu wata ƙasa da ke da tabbataccen bayanai game da yaduwar kwayar cutar a cikin al'ummarta a watan Maris na shekarar 2020.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambance-bambance masu yawa a yawan gwajin da aka yi a kowace ƙasa.
Wannan canji na iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama da yawa a wasu ƙasashe.
Ta yin amfani da juyin juya hali da kuma amsawar polymerization na sarkar lokaci (rRT-PCR), ana iya yin gwajin a kan samfurorin numfashi da aka samu ta hanyoyi dabam dabam, kamar su nasopharyngeal swab ko kuma samfurin ƙyallen.
Sakamakon zai kasance cikin sa'o'i kadan zuwa kwana biyu.
Gwajin RT-PCR da aka yi daga faringed swabs ne kawai abin dogara a cikin makon farko na cutar.
Bayan haka, ƙwayoyin cuta na iya ɓacewa daga cikin makogwaro yayin da suke ci gaba da yawaita a cikin huhu.
A cikin mutane masu kamuwa da cutar da aka gwada a mako na biyu, ana iya ɗaukar samfurin daga cikin hanyoyin numfashi ta hanyar yin amfani da catheter na numfashi, ko kuma a yi amfani da tsotsa (expectoration).
Ɗaya daga cikin gwaje-gwajen PCR na farko an samar da shi ne ta hanyar Charité a Berlin a watan Janairun 2020 ta hanyar yin amfani da fassarar baya da kuma amsawar polymerization na sarkar lokaci (rRT-PCR), kuma ya kasance tushen kayan aikin 250 000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Ƙasar Ingila ta kuma samar da gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan bincike na SARS-CoV-2 na asibiti bisa PCR (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
Yana gano kwayar  E  da ke cikin beta-coronavirus, da kuma kwayar RdRp ta SARS-CoV-2. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Magunguna ta China don kayan aikin gano SARS-CoV-2 bisa PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) suna rarraba na'urar ganowa ta RT-PCR na sabuwar coronavirus 2019 (2019-nCoV) a lokaci na ainihi ga dakunan gwaje-gwaje na kiwon lafiyar jama'a ta hanyar International Reagent Resource.
A cikin tsofaffin kayan gwajin, gwajin kwayoyin halitta guda ɗaya cikin uku yana da sakamako mara kyau saboda ƙarancin maganin, da kuma ƙuntatawa a gwajin a CDC a Atlanta. Saboda haka, an yi nasarar sarrafa samfurori kasa da 100 a kowace rana a cikin watan Fabrairu na 2020.
Ba a yi la'akari da gwajin da ke amfani da bangarori biyu a matsayin abin dogaro ba har zuwa 28 ga Fabrairu, 2020, kuma a lokacin ne aka ba wa dakunan gwaje-gwaje na tarayya da na karkara izinin fara gwajin.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samuwar gwajin COVID-19 bisa RT-PCR a duk fadin kasar.
Quest Diagnostics ta kuma rarraba gwaje-gwajen COVID-19 a duk faɗin ƙasar a ranar 9 ga Maris, 2020.
Ba a sanar da iyakancewar adadi ba. Dole ne a tattara da kuma sarrafa samfurori bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike ta Kasa a kan Kwayoyin cuta da Fasahar Halitta ta VECTOR ce ta kirkiro da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an sanar da cewa Mayo Clinic ta kirkiro gwajin da zai iya gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izini daga FDA don gwajin da za a iya yi a cikin manyan adadi a cikin awanni 3.5, wanda ke ba da damar na'urar yin kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (US) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott. FDA ta ba da izini iri ɗaya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami EUA daga FDA don gwajin da zai ɗauki kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar isothermal amplification na nucleic acid maimakon PCR.
Tun da ba a buƙatar jerin juzu'i na zafin jiki, wannan hanyar na iya samar da sakamako mai kyau a cikin minti biyar kawai da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka, kuma Abbott na shirin kara samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana ci gaba da gwajin da ke amfani da kwayar cutar daya-daya da ke ɗaure da furotin nucleocapsid (N) na sabon kwayar cutar korona a Taiwan, da fatan zai iya samar da sakamako cikin mintuna 15 zuwa 20, kamar yadda gwajin mura mai sauri yake.
Wani bincike na Maris 2020 ya kammala da cewa  hotunan radiyo na huhu ba su da ƙimar ganewar asali a farkon matakan, yayin da sakamakon CT zai iya zama tabbatacce tun kafin bayyanar cututtuka .
A cikin alamun da ake gani a kan DMT akwai nau'in gilashin da ke da nau'i biyu da kuma yawa da ke da rarraba a gefen, a baya da kuma a waje.
Ƙarin ƙwayar cuta da kuma ƙullawa suna faruwa yayin da cutar take ci gaba.
Wani bincike da ya kwatanta PCR da DMT a Wuhan, inda cutar ta fara, ya nuna cewa DMT ta fi PCR sauƙin ganewa, ko da yake ba ta da cikakkiyar bayani, saboda yawancin sakamakon da aka samu daga hoton da aka yi ta daidai da wasu cututtukan huhu da cututtuka.
A watan Maris na shekarar 2020, Kwalejin Kula da Magunguna ta Amurka ta ba da shawarar cewa kada a yi amfani da  MDT don yin gwaji ko kuma a matsayin gwajin farko don gano COVID-19 . A watan Maris na shekarar 2020, CDC ta ba da shawarar PCR don yin gwaji na farko.
Samar da ƙwayoyin cuta, ciki har da IgM da IgG, wani bangare ne na amsawar garkuwar jiki ga kamuwa da cuta.
Ana iya amfani da su wajen gano kamuwa da cuta a cikin mutane daga kwanaki 7 bayan bayyanar cututtuka, domin sanin rigakafi da kuma a matsayin wani ɓangare na kulawar jama'a. Ana iya yin gwajin a cibiyar bincike ta tsakiya (CLC) ko kuma a wurin kwance (point-of-care testing, PoCT).
Tsarin sarrafa kansa mai saurin gudu a dakunan gwaje-gwaje da yawa na asibiti na iya yin irin wannan bincike, amma samuwarsu zai dangana ne a kan yadda tsarin yake samarwa.
Don CLC, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurori masu yawa don lura da amsawar garkuwar jiki.
Ana yin amfani da maganin PoCT wajen cire jini sau ɗaya ta hanyar sutura.
Ba kamar hanyoyin PCR ba, ba a buƙatar wani matakin cirewa kafin bincike. A ranar 26 ga Maris, 2020, FDA ta nada ƙungiyoyi 29 waɗanda suka sanar da hukumar yadda ya kamata kuma waɗanda yanzu za su iya rarraba gwajin su na gano ƙwayoyin cuta.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya ne kawai bisa izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su, waɗanda ke iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfuran jini.
Ana iya yin gwajin ɗaruruwan samfurori a cikin sa'o'i kaɗan, wanda ya fi gwajin PCR na RNA na kwayar cutar sauri.
Antibodies yawanci ana iya gano su kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin antibody da ta saya da ya isa a yi amfani da shi.
Hong Kong ta kafa wani shiri wanda masu kamuwa da cutar za su iya zama a gida,  sashen gaggawa zai ba marasa lafiya bututun samfurin , marasa lafiya za su tofa a ciki, su mayar da shi, kuma daga baya su sami sakamakon gwajin. NHS ta Burtaniya ta sanar da cewa tana gudanar da aikin gwaji na gwada masu kamuwa da cutar a gida, wanda ke kawar da haɗarin mai cutar ya kamu da wasu ta hanyar zuwa asibiti ko kuma bukatar kashe cutar a motar asibiti idan aka yi amfani da ita. A cikin gwajin motsa jiki na COVID-19 ga masu kamuwa da cutar, ma'aikacin kiwon lafiya zai ɗauki samfurin tare da ɗaukar matakan kariya.
Cibiyoyin  drive  sun ba Koriya ta Kudu damar yin wasu daga cikin gaggawa da kuma cikakken gwajin a duniya. A Jamus, Ƙungiyar Likitocin Jiyya ta Ƙasa ta ce a ranar 2 ga Maris tana da damar yin gwaji 12,000 a rana a waje, kuma an gwada marasa lafiya 10,700 a makon da ya gabata.
In likita ya rubuta gwajin, inshorar lafiya ce take biyan kuɗin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaji 160,000 a mako.
A ranar 19 ga Maris, ana iya yin gwajin mota a manyan birane da yawa.
Har zuwa 26 ga Maris, 2020, ba a san jimillar gwajin da aka yi a Jamus ba, saboda sakamakon da aka bayar na tabbatacce ne kawai.
Binciken farko na dakin gwaje-gwaje ya gano cewa a makon kalanda na 12/2020, an gwada jimillar samfurori 483,295 har zuwa makon 12/2020, kuma samfurori 33,491 (kashi 6.9) sun nuna cewa sun kamu da cutar SARS-CoV-2. A Isra'ila, masu bincike a Technion da Rambam Hospital sun kirkiro kuma sun gwada hanyar yin nazarin samfurori daga marasa lafiya 64 a lokaci guda, suna tara samfurori tare kuma suna yin gwaji ne kawai idan an samu samfurin hade. A Wuhan, wani dakin gwaje-gwaje na gaggawa mai tsawon mita 2,000 da ake kira Huo-Yan (a harshen Sinanci,  火眼:  Eye of Fire) an bude shi a ranar 5 ga Fabrairu, 2020, kuma zai iya sarrafa sama da samfurori 10,000 a kowace rana.
Ginin da aka yi cikin kwanaki 5 wanda Wang Jian, wanda ya kafa BGI, ya kula da shi, samfurin ya nuna cewa a lardin Hubei, yawan masu kamuwa da cutar zai karu da kashi 47 cikin dari, kuma farashin keɓewa zai ninka idan ba tare da wannan damar ba.
Labarin Wuhan ya yi saurin biye da labaran Huo-Yan a Shenzhen, Tianjin, Beijing da Shanghai, a birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, jimillar damar gwajin yau da kullun ya kai 50,000 a kowace rana. An fitar da samfuran kyauta masu yawa waɗanda Origami Assays ya haɓaka don gwada har zuwa samfuran marasa lafiya 1,122 don COVID-19 ta amfani da gwaje-gwaje 93 kawai. Ana iya yin waɗannan daidaitaccen samfuran a ƙananan dakunan gwaje-gwaje ba tare da mai sarrafa ruwa ba.
A watan Maris, karancin iskar gas da isassun iskar gas sun zama matsala ga gwajin taro a EU, United Kingdom da kuma United States.
Wannan ya sa wasu marubuta suka yi la'akari da hanyoyin shirya samfurori da suka haɗa da dumama samfurori zuwa 98 °C (208 °F) na tsawon minti 5 don sakin kwayoyin RNA don ci gaba da bincike. A ranar 31 ga Maris, an sanar da cewa UAE yanzu ita ce kasa da ke gwada mafi yawan al'ummarta a kowace mutum don Coronavirus, kuma tana kan hanyar kara gwadawa don kaiwa ga mafi yawan al'umma.
An samu waɗannan sakamakon ta hanyar haɗuwa da iyawar gudanar da gwaje-gwaje na tuki da kuma sayen dakin gwaje-gwaje mai saurin gudu a kan sikelin jama'a daga Group 42 da BGI (bisa ga dakunan gwaje-gwajen gano gaggawa na Huo-Yan a China).
An gina dakin gwaje-gwaje cikin kwanaki 14, yana iya yin dubun dubatan gwaje-gwaje na RT-PCR a kowace rana kuma shi ne na farko da ke da wannan damar da za a fara aiki a wajen kasar Sin.
An kirkiro hanyoyin gwaji daban-daban da ke nuna bangarori daban-daban na tsarin kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta yi amfani da tsarin Jamus wajen yin kayayyakin da ake aikawa ƙasashe masu ƙarancin kuɗi waɗanda ba su da isassun albarkatu don samar da nasu kayayyakin.
An fitar da maganin Jamus a ranar 17 ga Janairu, 2020. An fitar da tsarin da Cibiyoyin Kula da Cututtuka na Amurka suka tsara a ranar 28 ga Janairu, wanda ya jinkirta samun gwajin a Amurka. China da Amurka sun sami matsala game da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe, da Australia, ba su iya samar da isassun kayan aikin ba don biyan buƙatun da shawarwarin gwajin daga masana kiwon lafiya.
A gefe guda, masana sun nuna cewa samun gwajin da ya fi haka a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar korona.
Gwamnatin Koriya ta Kudu ta ƙara ƙarfin bincike, musamman a cikin dakunan gwaje-gwaje na masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta ba da shawarar a kara inganta shirye-shiryen gwaji a matsayin hanya mafi kyau ta rage yaduwar cutar COVID-19. Bukatar gwaji saboda yaduwar cutar ta sa an jinkirta yin dubban dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu a Amurka, kuma an gama samar da takardun shaida da kuma kayan aikin sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton matsalolin da suka shafi amincin kayan gwajin ta.
A Amirka, kayan gwajin da CDC ta samar suna da  aibi . Gwamnati ta kawar da shingen da ke hana gwajin da ba na gwamnati ba. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta ga cewa sakamakon ba shi da tabbaci.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya kasancewa saboda rashin iyawar tattara samfur ko amfani da kayan aikin yadda ya kamata.
Ma'aikatar Spain ta ce za ta cire kayan gwajin da suka ba da sakamako mara kyau, kuma za ta maye gurbin su da wani kayan gwajin da kamfanin Shenzhen Bioeasy ya bayar. Kashi 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan gwajin miliyan 1.2 daga China waɗanda suka gaza.
Firayim Minista Matovič ya ba da shawarar a jefa su cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da  yawan kurakurai  kuma ba ta  amfani da su . Birtaniya ta sayi kayan gwajin miliyan 3.5 daga China, amma ta sanar a farkon watan Afrilu 2020 cewa ba za su iya amfani ba.
Gwajin, da kuma keɓe waɗanda suka sami sakamako mai kyau da kuma bin diddigin mutanen da suka sadu da masu dauke da SARS-CoV-2, sun ba da sakamako mai kyau.
Masu bincike da ke aiki a birnin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan yawan mutane kusan 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da wata alama, kuma an ware duk waɗanda aka gano.
Da aka hana mutane yin tafiya a cikin gari, wannan matakin ya kawar da sababbin kamuwa da cuta.
Ta hanyar bin diddigin abokan hulɗa, ƙuntatawa kan tafiye-tafiye masu shigowa, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta ci gaba da jinkiri fiye da sauran ƙasashe masu tasowa, amma ba tare da takunkumi masu tsanani ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki.
An soke ayyuka da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris, lokacin da aka shirya.
Wasu ƙasashe da dama sun kuma gudanar da annobar ta hanyar bin diddigin mutanen da suka kamu da ita, ƙuntata tafiye-tafiye masu shigowa, gwaji da keɓewa, amma tare da ƙuntatawa, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa ƙasashen da suka yi gwaje-gwaje mafi yawa, dangane da yawan mutuwar, suna da ƙananan ƙimar mutuwa, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano mutanen da ke da ƙananan alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ikon bincike kuma waɗanda dakunan gwaje-gwajen ƙasa ba su da ƙarancin ƙwarewar COVID-19 su aika da samfuran COVID-19 na farko guda biyar da na farko guda goma zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 na WHO don tabbatar da gwajin.
A cikin waɗannan dakunan gwaje-gwaje guda 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Amirka ta Arewa, ɗaya kuma a Ostareliya.
A cikin tebur na gaba, shafi  Tabbatacce a % na gwaje-gwaje  ya dogara da manufar gwajin ƙasa.
Kasar da take gwadawa kawai waɗanda aka kwantar a asibiti za ta sami kashi mafi girma na tabbatacce na gwaji fiye da ƙasar da take gwada dukan 'yan ƙasa, ko suna da alamun cutar ko babu, duk da sauran abubuwan.
Wanke hannu, wanda ake kira da tsaftace hannu, yana nufin wanke hannu don cire datti, kitse, ƙwayoyin cuta, ko wasu abubuwa da ba a so.
Wanke hannu da sabulu a "lokaci masu muhimmanci" na rana yana hana yaduwar cututtuka da yawa, kamar su zawo da kuma cutar kwalara, waɗanda ake ɗauka ta hanyar hanci da jini.
Alal misali, mutum zai iya kamuwa da cututtukan numfashi kamar mura ko sanyi idan bai wanke hannunsa ba kafin ya taɓa idanunsa, hanci, ko baki (watau, hancin ciki).
Wanke hannu da sabulu a muhimman lokatai biyar na rana: kafin da bayan yin najasa, bayan wanke jariri ko canja mata mayafinsa, kafin ciyar da yaro, kafin cin abinci, da kafin da bayan shirya abinci ko sarrafa naman kaza, kifi, da naman kaza.
Idan ba ka da sabulu ko ruwa a hannunka, kana iya wanke hannunka da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannuwa:
kafin, lokacin da kuma bayan shirya abinci;
kafin da kuma bayan kula da mutum mara lafiya;
bayan ka canja wa jariri mayafinsa ko kuma bayan ka wanke yaron da ya je gidan wanka
bayan shan hanci ko yin tari/yanƙwasa;
bayan ta taɓa dabba, abincin dabbobi ko kuma sharar dabbobi.
Tsabtace hannu a fannin kiwon lafiya na nufin hanyoyin tsabtace hannu da ke da nasaba da hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kuma a yi jinya zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu a fannin kiwon lafiya shi ne kawar da cututtukan cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da kuma sunadarai da ke iya cutarwa ko kuma haifar da cuta.
Wannan yana da muhimmanci musamman ga waɗanda suke sarrafa abinci ko kuma waɗanda suke aikin kiwon lafiya, amma ga jama'a ma.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa; hana cututtukan da ke haddasa zawo; rage cututtukan numfashi;
Ƙarƙashin yawan yara da suke mutuwa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa, idan aka kyautata tsabtace hannu, hakan zai iya sa yara 'yan shekara biyar ko ƙasa da hakan su yi girma sosai.
A ƙasashe masu tasowa, za a iya rage yawan yara da ke mutuwa daga cututtukan numfashi da kuma zawo ta wajen yin canje-canje a halayensu, kamar wanke hannu da sabulu.
Wannan hanya mai sauƙi na rage yawan mutuwar mutane daga waɗannan cututtuka da kusan kashi hamsin.
Shirya ayyuka na inganta wanke hannu zai iya rage yawan ciwon zawo da kashi ɗaya bisa uku, wanda ya yi daidai da samun ruwa mai tsabta a yankunan da ke da karancin kuɗi.
Wanke hannu da sabulu yana rage yawan ciwon zawo da kashi 48 cikin dari kuma hanya ce mafi inganci da kuma mafi arha wajen hana ciwon zawo da cututtukan numfashi na gaggawa (Acute Respiratory Infections, IRA) kuma dole ne a yi hakan a gidaje, makarantu da kuma al'ummomi a duk duniya.
Ciwon huhu, ɗaya daga cikin manyan cututtuka na RA, shi ne sanadin mutuwa mafi girma na yara 'yan ƙasa da shekara biyar, wanda ke kashe kusan mutane miliyan 1.8 a kowace shekara.
Cutar zawo da ciwon huhu suna kashe kusan yara miliyan 3.5 kowace shekara.
UNICEF ta ce wanke hannu da sabulu kafin cin abinci da kuma bayan wanka zai iya ceton rayuka fiye da duk wani allurar rigakafi ko magani, kuma zai iya rage mutuwar masu ciwon zawo da kusan rabi da kuma mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana amfani da wanke hannu tare da wasu matakan kiwon lafiya a cikin shirin ruwa, tsaftacewa da kuma tsabta (WASH).
Wanke hannu yana kuma kāre mutum daga cutar Impetigo, wadda ake yaɗawa ta wurin taɓawa ta jiki.
Rashin wanke hannu sau da yawa yana iya lalata fata ta hanyar sa ta bushe.
Wani bincike na Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da cutar eczema ko cututtukan fata a hannu, wanda ke nuna fatar hannu da kuma itching, kuma ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin cewa yana cikin alamun cutar OCD.
Wanke hannu da sabulu a muhimman lokatai biyar na rana don rage yaduwar cututtuka ta hanyar hanci da jini: kafin da kuma bayan amfani da banɗaki (naurin jini, zubar da jini), bayan wanke bayan jariri (ko canza mata mayafinsa), kafin ciyar da yaro, kafin cin abinci da kafin da kuma bayan shirya abinci ko sarrafa naman alade, kifi, ko kaji.
Ya kamata a wanke hannu sosai don hana yaduwar cuta, musamman kafin da kuma bayan an yi wa mutum rauni ko an yi masa rauni, bayan an yi tari, tari ko tsotse, bayan an taɓa ƙurar dabbobi ko kuma dabbobi, da kuma bayan an taɓa shara.
A ƙasashe da yawa, ba a wanke hannaye da sabulu sosai ba.
Wani bincike na shekara ta 2015 a ƙasashe 54 da ya shafi tsabtace hannu ya nuna cewa, kashi 38.7 na yawan gidaje suna wanke hannu da sabulu. Wani bincike na shekara ta 2014 ya nuna cewa, Saudi Arabiya ce ke da yawan wanke hannu da sabulu (97%), Amurka ce ke da yawan wanke hannu (77%), kuma China ce ke da mafi ƙarancin adadin wanke hannu (23%) . Akwai hanyoyi da dama da ake amfani da su a yau don sauya halayya da kuma inganta amfani da sabulu wajen wanke hannu a lokuta masu muhimmanci na rana.
Alal misali, Ma'aikatar Ilimi ta Philippines ta kafa  Shirin Kula da Kiwon Lafiya na Farko  don inganta lafiyar yara da iliminsu.
A cikin wannan shirin na kasa, ana yin amfani da maganin kawar da ƙwayoyin cuta sau biyu a shekara, tare da wanke hannu da sabulu da kuma goge haƙora da maganin haƙori mai ruwan fluoride.
An yi amfani da shi sosai a ƙasar Indonesia.
Don kawar da ƙwayoyin cuta da ke cikin fata, ya kamata a ƙara sabulu ko kayan wanki a cikin ruwa.
Babban aikin sabulu da kayan wankewa shi ne rage shingayen da ke hana maganin kuma ƙara narkewa.
Ruwa kaɗai ba zai iya tsabtace fata ba domin ƙwayoyin jiki da kuma sunadarai, waɗanda abubuwa ne na ƙasa, suna da wuya a narke su cikin ruwa.
Amma, samun isashen ruwa zai sa tsabtace wurin ya yi sauƙi.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta daga amfani na baya.
Wasu ƙananan bincike da suka yi game da canja wurin ƙwayoyin cuta daga sabulu mai ƙarfi da ke da ƙazanta sun kammala cewa ba zai yiwu ba saboda ana wanke ƙwayoyin cuta da kumfa.
Duk da haka, Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta ce  na'urar sayar da sabulu mai ruwa ta fi kyau .
An ba da shawarar sosai ga waɗanda suke damuwa da lafiyarsu su yi amfani da sabulu mai hana ƙwayoyin cuta.
Har zuwa yau, babu wata hujja da ta nuna cewa amfani da maganin kashe cututtukan cuta ko kuma maganin kashe cututtukan cuta zai iya kai wa ga kwayoyin da suka yi tsayayya da maganin rigakafi a cikin yanayi.
Amma sabulu na hana ƙwayoyin cuta yana ɗauke da maganin ƙwayoyin cuta da aka saba amfani da su, kamar triclosan, wanda yawancin ƙwayoyin cuta ba sa iya sha.
Saboda haka, ko da yake ba sauro na kashe ƙwayoyin cuta ba ne ke sa mutane su yi tsayayya da ƙwayoyin cuta, amma ba za su yi nasara ba kamar yadda ake faɗa.
Baya ga mai saurin shafawa da kuma kare fata, wasu nau'ikan kayan shafawa masu wuyar fahimta suna iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) da ke daidaita pH, benzoic acid, wanda ke da aikin rigakafin ƙwayoyin cuta, da sauran masu karewa (aloe vera, bitamin, menthol, tsire-tsire na shuka). Wani bincike mai zurfi da Jami'ar Oregon School of Public Health ta yi ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu na hannu na mutum wanda ke dauke da triclosan, wajen hana cututtuka da kawar da kwayoyin cuta.
Ruwan zafi da ake amfani da shi wajen wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna ƙaruwa da sauri a zafin jiki (37° C).
Amma ruwan dumi da sabulu ya fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke ɗauke da ƙazanta da ƙwayoyin cuta.
Amma, ba kamar yadda mutane suke tunani ba, bincike na kimiyya ya nuna cewa amfani da ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannu.
Maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta na hannu, shi ne kayan tsabtace hannu marar ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayayyakin tsabtace hannu marasa ruwa da ke da tushen barasa (wanda ake kira maganin ruwa, maganin kashe ƙwayoyin cuta na hannu ko kuma maganin kashe ƙwayoyin cuta na hannu) sun fara samun karbuwa.
Yawancin an tsara su ne daga isopropyl alcohol ko ethanol tare da wani mai kara kauri kamar carbomer (polymer na acrylic acid) don samun gel, ko kuma wani mai laushi kamar glycerin don samun ruwa ko kumfa don mafi sauki amfani da rage tasirin busassun giya.
Ƙara hydrogen peroxide mai narkewa yana ƙara aikin rigakafin ƙwayoyin cuta. Maganin kashe ƙwayoyin cuta na hannu da ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta da kyau.
Maganin ruwan giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin kamuwa da cuta (SARM da ERV), tarin fuka, da wasu ƙwayoyin cuta (har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da hepatitis), da kuma fungi.
Maganin ruwan giya mai kashi 70 cikin dari na barasa yana kawar da kashi 99.97 cikin dari (rage 3.5, log daidai da rage 35 decibels) na kwayoyin cuta a hannuwanka da dakika 30 bayan an yi amfani da shi, kuma kashi 99.99 cikin dari zuwa kashi 99.999 cikin dari (rage daga log 4 zuwa 5) na kwayoyin cuta a hannuwanka da minti 1 bayan an yi amfani da shi.
Maganin ruwan giya kusan ba shi da tasiri a kan ƙwayoyin cuta irin su Norovirus (ko Norwalk), wanda shi ne babban sanadin kamuwa da ciwon ciki. Ya kamata a yi amfani da isasshen maganin kashe cuta na hannu ko maganin ruwan giya don a yi wanka sosai ko kuma a rufe hannu biyu.
Ka yi amfani da hannunka da bayan hannunka da kuma tsakanin yatsanka da ƙusa na kimanin dakika 30, har sai ruwan ya bushe.
Ƙungiyar Kula da Cututtuka da Rigakafin Cutar Amurka ta ba da shawarar wanke hannu maimakon amfani da magungunan ruwa da giya, musamman idan hannayen suna da datti.
An ƙara amfani da waɗannan kayayyakin ne saboda sauƙin amfani da su da kuma gaggawar kawar da ƙwayoyin cuta; duk da haka, ba za su maye gurbin wanke hannu ba sai dai idan ba ku da sabulu da ruwa a hannu.
Yin amfani da maganin ruwan giya sau da yawa na iya sa fata ta bushe idan ba a ƙarfafa maganin ba tare da emollients da/ko kayan shafawa na fata.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da/ko wasu abubuwa masu narkewa a cikin maganin.
A cikin gwaji na asibiti, maganin ruwa mai narkewa da ke ɗauke da emollients ya haifar da rage yawan haushi da bushewar fata fiye da sabulu ko kayan tsabtace antimicrobial.
Cutar fata ta haɗuwa, hawan hauka ko ƙarancin ƙwarewa ga barasa ko abubuwan da ke cikin maganin ruwan-alkoho.
Da yake ruwan giya ba ya saurin sa mutum ya yi ciwon fata, hakan ya sa ya fi wanke hannu da sabulu da ruwa kyau.
Ko da yake suna da amfani, kayan da ba su da ruwa ba sa kawar da abubuwa masu ƙamshi da ke hannunka, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda haka, maganin kashe cututtukan hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtuka da yawa, domin su na kan hannu.
Ingancin maganin kashe cututtukan hannu marar barasa ya dogara sosai da sinadarai da kuma tsarin da aka yi amfani da shi, kuma ya kasance ƙasa da na barasa da na maganin kashe cututtukan hannu mai tushen barasa.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da aiki na rigakafin ƙwayoyin cuta bayan an yi amfani da su, ba kamar giya ba, wanda tasirinsa ya ragu bayan an yi amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da halayen fata.
A cikin ƙananan al'umma, mutane da yawa ba su da isashen sabulu, kuma suna amfani da toka ko ƙasa.
Ash ko ƙasa za su iya yin aiki fiye da ruwa kaɗai, amma ba za su iya yin aiki kamar sabulu ba.
Ƙari ga haka, idan ƙwayoyin cuta suka gurɓata ƙasa ko toka, hakan zai iya sa mutane su yi ciwo maimakon su hana su.
Kamar sabulu, toka ma tana kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da maganin alkaline.
WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu idan ba a samunsa.
Ƙungiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amirka ta ba da shawarar wanke hannu yadda ya kamata don hana kamuwa da cuta ta wajen bin waɗannan matakai:
Ka yi wanka da ruwan sanyi ko na dumi.
Ana ba da shawarar ruwan gudu saboda haɗarin gurɓata wuraren da ruwa ke tsayawa, yayin da zafin ruwan bai yi wani bambanci ba).
Ka zuba sabulu mai yawa a hannunka, ka shafa su a kan juna, ba tare da manta da bayan hannunka ba, tsakanin yatsanka da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna amfani da sabulu fiye da idan suna amfani da ruwa kawai.
Ka shafe akalla sakan 20 a cikin wannan takardar.
Yin shafa yana haifar da taɓawa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin taɓawa na dogon lokaci yana cire ƙwayoyin cuta da yawa.
Ka wanke da ruwa mai yawa.
Wanke hannu a cikin kwandon ruwa mai tsayawa zai iya sa hannu ya sake gurɓata.
Ka bushe da tawul mai tsabta ko kuma a waje.
Hannun da suke da danshi da kuma danshi suna da saukin sake kamuwa da cutar. Wuraren da aka fi mantawa da su su ne babban yatsan hannu, wuyan hannu, tsakanin yatsun hannu da kuma ƙusa.
Ƙwayoyin cuta suna iya zama a ƙusa da kuma ƙusa da aka yi da ƙusa.
Ana ba da shawarar yin amfani da man shafawa don hana hannuwan bushewa. Darin fata yana haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa cututtuka.
Akwai wasu hanyoyin wanke hannu masu tsada da yawa idan ba a samu ruwan famfo da sabulu ba. Misali, zubar da ruwa daga ramin da aka rataye da kuma bugawa da kuma/ko amfani da toka idan ya cancanta, a ƙasashe masu tasowa. A cikin yanayin da samar da ruwa ya iyakance (kamar a makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin da za a ceci ruwa, kamar su tippy-taps da sauran zaɓuɓɓukan tattalin arziki.
Tattalin ruwa fasaha ce mai sauƙi da ke amfani da tukunya da aka rataye ta da igiya, da kuma wani abin da ake amfani da shi don zuba ruwa a hannaye da kuma sabulu.
Yin bushewar hannu da kyau wani muhimmin bangare ne na tsaftace hannu, amma ana ta muhawara kan yadda za a bushe hannu a cikin gidan wanka na jama'a.
Bincike da yawa na nuna cewa tawul ɗin takarda sun fi na lantarki tsabtace hannu da ake samu a cikin gidajen wanka.
A shekara ta 2008, wani bincike da masana'antar wanke-wanke ta EU suka gudanar, wato European Tissue Symposium, an gudanar da shi a Jami'ar Westminster, Landan, domin kwatanta matakan tsabtace jiki da takarda-tufa, masu bushe-bushe-hannu masu zafi da masu bushe-bushe-hannu masu iska suke bayarwa.
Bayan an wanke hannu da kuma bushe shi a bushewar hannu, an gano cewa adadin ƙwayoyin cuta sun ƙaru da kashi 194 bisa ɗari a jikin yatsunsu da kuma kashi 254 bisa ɗari a hannun hannu.
Drying hannu da iska ya haifar da karuwar adadin kwayoyin cuta a kan yatsun hannu da kashi 42 cikin dari da kuma a kan dabino da kashi 15 cikin dari.
Bayan wanke hannu da bushewa da tawul ɗin takarda, an rage adadin ƙwayoyin cuta da kashi 76 cikin ɗari a matsakaita a kan yatsun hannu da kuma kashi 77 cikin ɗari a kan dabino. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko akwai yiwuwar gurɓata gurɓata tare da sauran masu amfani da gidan wanka da kuma yanayin gidan wanka dangane da kowace hanyar bushewa.
Mai bushe hannu mai iska, wanda ke hura iska daga na'urar a saurin da aka yi shelarsa na 180 m/s (650 km/h; 400 mph), yana iya fitar da kwayoyin cuta daga hannu da na'urar kuma yana iya gurɓata sauran masu amfani da banɗaki da kuma mahalli na banɗaki a cikin kewayon har zuwa mita 2.
Yin amfani da na'urar bushe hannu mai iska mai zafi yana ba da damar watsa kwayoyin cuta zuwa nisan mita 0.25 daga na'urar bushe hannu.
A shekara ta 2005, an yi nazarin hanyoyin bushe hannu dabam dabam a wani bincike da TÜV Produkt und Umwelt ya gudanar.
Bayan an bushe hannu, an lura da waɗannan bambance-bambance na ƙididdigar ƙwayoyin cuta:
Akwai masana'antun bushe hannu da yawa, kuma an gwada bushe hannu da bushewa ta amfani da tawul ɗin takarda.
Wanke hannu da kayan wankewa na iya zama mafita yayin tafiya, idan babu sabulu da ruwa.
Dole ne ruwan giya ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
An soma bukatar wanke hannu a asibitoci bayan da likita daga ƙasar Hungary mai suna Ignaz Semmelweis ya gano cewa wanke hannu yana da amfani sosai a asibitoci a shekara ta 1846.
Akwai na'urorin lantarki da suke ba da gargaɗi sa'ad da ma'aikatan asibiti suka manta da wanke hannu.
Wani bincike ya nuna cewa yin amfani da waɗannan abubuwa ya rage yawan kamuwa da cuta.
Wanke hannu na likita ya kamata ya ɗauki aƙalla dakika 15, ta yin amfani da sabulu da ruwa mai yawa ko kuma gel don kumfa da shafa kowane ɓangare na hannu.
Hannun ya kamata a shafa su a tsakanin yatsunsu.
Idan akwai ƙura a ƙarƙashin ƙusa, ana iya amfani da goga don cire su.
Tun da yake ƙwayoyin cuta da ke cikin ruwa suna iya zama a hannunka, yana da muhimmanci ka wanke hannunka sosai kuma ka goge shi da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don rufe famfo (da kuma buɗe ƙofar fita idan ya cancanta).
Hakan zai sa a guji sake gurɓata hannaye sa'ad da suka taɓa abubuwa.
Manufar wanke hannu a cibiyoyin kiwon lafiya ita ce cire ƙwayoyin cuta masu cutarwa ( ƙwayoyin cuta ) da kuma hana su watsawa.
Jaridar New England Journal of Medicine ta ba da rahoto cewa rashin tsabtace hannu ya ci gaba da zama abin ƙyama a yawancin cibiyoyin kiwon lafiya, da yawa daga cikin likitoci da ma'aikatan jinya suna mantawa da wanke hannu a kai a kai kafin su taɓa marasa lafiya, kuma hakan yana sa ƙwayoyin cuta su yaɗu.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi na iya rage kamuwa da cututtukan jini da ke tattare da yin amfani da katetare da kashi 66 cikin ɗari. Ƙungiyar Lafiya ta Duniya ta wallafa wata ƙasidar da ta bayyana yadda ake wanke hannu da kuma shafa hannu a fannin kiwon lafiya.
Ana iya samun shawarwari daga masu amfani da Intane a dandalin yanar gizon da ke ɗauke da takardar ja-gora na Hukumar kan tsabtace hannu.
Whitby et al. sun yi bincike mai kyau.
Ana iya samun na'urori a kasuwa da za su iya auna da kuma ba da tabbacin tsabtace hannu, idan an tabbatar da bin ƙa'idodi.
Kungiyar Lafiya ta Duniya ta bayyana  Bayani guda biyar  game da tsaftace hannu:
bayan an yi amfani da jini/ruwa mai rai;
kafin yin aikin aseptic; da kuma
Bayan sun sadu da mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta a sabulu (sabunan "magani" ko "anti-microbial") yana sa mai wanke hannu ya kashe ƙwayoyin cuta.
Ana so a kawar da waɗannan ƙwayoyin cuta kafin a yi aiki ko kuma a wurare da suke da kwayoyin da suka saba wa maganin rigakafi. Don a "sanya" hannu a kan aiki, ana bukatar famfo da za a iya buɗewa da rufewa ba tare da taɓa hannu ba, da kayan wanki na chlorhexidine ko iodine, da tawul da ba su da tsabta don bushe hannu bayan wanka, da goga mai tsabta don shafawa, da kuma wani kayan aiki mai tsabta don tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
A cikin wannan tsari, ana bukatar wanke hannu da gaban hannu har zuwa gwiwoyi, yawanci na tsawon minti 2 zuwa 6.
Ba lallai ba ne a shafe hannuwa na minti goma.
Ya kamata a guji ruwa daga gaban hannu zuwa hannaye yayin wankewa.
Bayan an wanke hannu, ya kamata a yi amfani da tawul mai tsabta don a bushe hannu kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko a yi amfani da maganin kashe ƙwayoyin cuta kafin a kula da mutum da kuma bayan an kula da shi.
Game da kula da kamuwa da cutar staphylococcus a asibitoci, an gano cewa an samu fa'idodi mafi girma na wanke hannu a kashi 20 na farko na wanke hannu, kuma akwai fa'idodi kaɗan na ƙara yawan wanke hannu fiye da kashi 35 cikin dari.
Idan aka gwada wanke hannu da sabulu na yau da kullum da wanke hannu da sabulu mai hana ƙwayoyin cuta, za a ga cewa adadin cututtukan da ke yaɗuwa daga abinci ya ninka sau uku. Hakazalika, idan aka gwada wanke hannu da ruwan giya da wanke hannu da sabulu mai hana ƙwayoyin cuta na tsawon dakika 30 kowannensu, za a ga cewa wanke hannu da sabulu na yau da kullum ya rage kamuwa da ƙwayoyin cuta da kashi 26 cikin dari idan aka kwatanta da na biyun.
Amma sabulu da ruwa sun fi giya tasiri wajen rage kwayar cutar mura A (H1N1) da kuma Clostridium difficile a hannu. Don inganta tsabtace hannu a wuraren kiwon lafiya, akwai iyawar koyar da ma'aikatan wanke hannu, samar da ƙarin kayan giya, da kuma rubuta da kuma tunatarwa game da wannan.
Ana bukatar ƙarin bincike don gano hanyoyin da suka fi tasiri a cibiyoyin kiwon lafiya dabam dabam.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu hanya ce mai arha da kuma muhimmiyar hanya ta kiyaye lafiya da kuma cin abinci mai gina jiki.
Amma, rashin ruwa mai kyau, sabulu, da kuma wuraren wanke hannu a gida, makaranta, da kuma wajen aiki, yana kawo ƙalubale wajen kafa ɗabi'a ta tsabtace hannu a dukan duniya.
Alal misali, a yawancin yankunan karkara na Afirka, ba a samun famfo don wanke hannu kusa da wuraren wanka na jama'a ko na masu zaman kansu, duk da akwai zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Duk da haka, rashin wanke hannu na iya zama saboda halaye na yau da kullum, maimakon rashin sabulu ko ruwa.
Tallafawa da kuma wayar da kan jama'a game da wanke hannu da sabulu na iya rinjayar yanke shawara a kan manufofi, ya sanar da amfanin wanke hannu, kuma ya kawo canji na dogon lokaci a cikin halayyar jama'a.
Don wannan ya zama nasara, ana bukatar gudanar da ayyukan sa ido da kuma kimantawa.
Binciken da aka yi a kan bincike 70 ya nuna cewa hanyoyin gida suna da tasiri wajen ƙara yawan wanke hannu a ƙasashe masu karancin kuɗi da matsakaitan kuɗi, kuma kamfen ɗin talla na zamantakewa ba shi da tasiri. Idan ya zo ga inganta wanke hannu a makarantu, misali na "Hanyar Taurari Uku" na UNICEF, wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi da araha don tabbatar da cewa ɗalibai suna wanke hannu da sabulu, yayin da suke bin wasu ƙa'idodin tsabta.
Da zarar an kai ga mafi ƙarancin ƙa'idodi, makarantu za su iya zuwa daga tauraro ɗaya zuwa uku na ƙarshe.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na inganta tsaftace hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke da'awar karfafa sauyin hali. Bayan annobar cutar korona ta 2019-2020, UNICEF ta karfafa karɓar emoji da ke nuna wanke hannu.
Ƙananan bincike sun bincika yawan kuɗin da ya rage na wanke hannu a ƙasashe masu tasowa dangane da yawan shekarun da aka samu na rayuwa mai kyau (watau DALY da aka kauce masa).
Amma, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftace-tsabta riba.
An fara gane muhimmancin wanke hannu ga lafiyar ɗan adam, musamman ga waɗanda suke cikin yanayi na rauni kamar uwaye masu haihuwa ko sojoji da suka ji rauni a asibitoci, a tsakiyar ƙarni na 19, ta hanyar manyan ma'aikatan tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis da ke aiki a Vienna, Austria, da Florence Nightingale, wadda ta kafa aikin jinya na zamani a Biritaniya.
A lokacin, mutane da yawa sun gaskata cewa ana samun cututtuka ne daga ƙamshi mai ƙamshi da ake kira miasm.
A shekarun 1980, annobar abinci da kuma cututtuka da ke faruwa a asibitoci sun sa Cibiyar Kula da Cututtuka da Rigakafi ta Amirka ta ƙara ƙarfafa tsabtace hannu a matsayin hanya mai muhimmanci na hana yaduwar cututtuka.
Farkon annobar mura ta aladu a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa a yi karin wayar da kan jama'a a kasashe da dama game da bukatar wanke hannu da sabulu don kare kai daga cututtuka masu yaduwa.
Alal misali, a Jamus, an saka alluna da ke nuna  hanyoyin wanke hannu da suka dace  kusa da banɗaki a gidajen wanka na jama'a da kuma na ofisoshin gwamnati da kuma na filayen jirgin sama.
Furucin nan "wanke hannuwanku" yana nufin cewa mutum ya ƙi ya ɗauki alhakin wani abu ko kuma ya ƙi ya yi wani abu.
An samo shi daga ayar Littafi Mai Tsarki na Matta inda Bilatus Babunti ya wanke hannuwansa domin ya yanke shawarar gicciye Yesu Kristi, amma wannan furcin ya zama ruwan dare a wasu yankunan Turanci.
A Shakespeare's Macbeth, Lady Macbeth ta yi wanka ta guje-guje don ta tsabtace wani tabo da ta yi tunanin cewa zai iya ɓata mata rai, wanda alama ce ta rashin lamirinta game da laifuffukan da ta aikata da kuma waɗanda ta sa mijinta ya yi.
An kuma gano cewa wasu mutane, bayan sun tuna ko kuma sun yi tunanin aikata ayyukan da suka saɓa wa ɗabi'a, suna yawan wanke hannayensu fiye da wasu kuma suna ba da muhimmanci ga na'urorin wanke hannu.
Ƙari ga haka, waɗanda aka ƙyale su su wanke hannuwansu bayan sun yi irin wannan tunanin ba sa son su yi wasu abubuwa da za su iya taimaka musu su tsarkake kansu, kamar aikin agaji.
Wasu addinai suna ba da umarnin wanke hannu don dalilai na tsabta da na alama. Wanke hannu na alama, wanda ya ƙunshi amfani da ruwa maimakon sabulu don wanke hannu, yana cikin al'adun wanke hannu da aka gabatar a cikin addinai da yawa, gami da Baha'i da Hindu, nutsuwa (tevilah) da wanke hannu na al'ada (Netilat Yadayim) a cikin addinin Yahudanci, lavabo a cikin Kiristanci, da wudhu a cikin Musulunci. Addinai kuma suna ba da umarnin wanke hannu don dalilai na tsabta, musamman bayan wasu ayyuka.
Bisa ga addinin Hindu, addinin Yahudanci da Musulunci, wanke hannu bayan wanka wajibi ne.
Hakazalika, addinin Hindu, Buddha, Sikh, addinin Yahudawa, da kuma Musulunci suna bukatar a wanke hannu kafin da kuma bayan kowane abinci.
Kula da cutar COVID-19 a wurin aiki
Kula da hadarin COVID-19 a wurin aiki na nufin aiwatar da hanyoyin lafiya da tsaro a wurin aiki don kula da hadarin don rigakafin cutar coronavirus 2019 (COVID-19).
Kulawa mai kyau na haɗarin aiki ya bambanta dangane da wurin aiki da ayyuka, bisa la'akari da ƙimar haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na mutum da ke iya zama mai saukin kamuwa da cutar COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aiki (OSHA) a Amurka, ayyuka da ke da ƙananan haɗarin kamuwa da cutar suna da ƙarancin hulɗa da jama'a da sauran ma'aikata. A wannan yanayin, ana ba da shawarar kawai matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya, da kuma kiyaye tsabtace aiki da kuma tsabtace yanayin aiki.
Ayyuka masu haɗarin matsakaici sun haɗa da waɗanda ke buƙatar yawan ko kusanci da mutanen da ba su da COVID-19 da ake zargi ko saninsu, amma waɗanda za su iya kamuwa da cutar saboda yaduwar al'umma ko kuma tafiya ta duniya.
Wannan ya haɗa da ma'aikata da suke hulɗa da jama'a musamman a makarantu, wuraren aiki masu yawan jama'a da kuma wasu wuraren sayar da kaya masu yawa.
Kula da haɗari a cikin wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska ta amfani da matattarar iska mai inganci, gilashin tsabta, da samar da kayan kariya na mutum idan aka haɗu da mutumin da ke da COVID-19.
LOSHA ta ɗauki ma'aikatan kiwon lafiya da na jana'iza da ke fuskantar mutane da ake zargi ko kuma aka san suna da cutar COVID-19 a matsayin masu haɗarin haɗari, zuwa haɗarin gaske idan suna yin hanyoyin samar da iska ko kuma ɗaukar ko sarrafa samfurori daga mutanen da ake zargi ko aka san suna da cutar COVID-19.
Kula da haɗarin da ya dace da waɗannan ma'aikata ya ƙunshi kulawar fasaha kamar su ɗakunan iska masu matsin lamba da kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata na iya kasancewa a waje domin sun yi rashin lafiya, suna bukatar su kula da wasu, ko kuma suna tsoron yiwuwar kamuwa da cutar.
Yanayin kasuwanci zai iya canjawa, a batun kayayyakin da ake nema da kuma hanyoyin samunsu (misali yin sayayya bayan lokutan da ake yawan cin kasuwa ko yin amfani da sabis na isarwa ko na tuki).
A ƙarshe, ana iya dakatar da jigilar kayayyaki daga yankunan da cutar COVID-19 ta shafa. Za a iya amfani da shirin shirye-shirye da amsa cututtuka masu yaduwa a matsayin jagora ga matakan kariya.
Shirye-shiryen suna la'akari da matakan haɗari da ke tattare da wurare da ayyuka daban-daban, ciki har da tushen haɗari, abubuwan haɗari da ke tattare da yanayin iyali da al'umma da kuma abubuwan haɗarin ma'aikata na mutum kamar tsufa ko cututtuka na kullum.
Sun kuma bayyana matakan da ake bukata don magance waɗannan haɗarin da kuma tsare-tsaren gaggawa don yanayin da zai iya tasowa bayan barkewar cutar.
Shirye-shiryen cututtuka da kuma amsawar cututtuka na iya zama batun shawarwari na kasa ko na yanki.
Manufofin amsa cutar sun haɗa da rage watsawa tsakanin ma'aikata, kare waɗanda ke da haɗarin haɗarin rikitarwa na kiwon lafiya, ci gaba da ayyukan kasuwanci da rage tasirin illa ga sauran ƙungiyoyi a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'ummar da kamfanin yake tasiri kan amsoshin da ake bayarwa.
Tsarin tsarin kula da haɗari ya samar da tsarin da ake amfani da shi a duniya a cikin lafiya da aminci a wurin aiki don rarraba kula da haɗari ta hanyar tasiri.
A inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun hanyoyin sarrafawa sune na fasaha, sannan na gudanarwa, kuma na ƙarshe kayan kariya na mutum.
Ana iya samun ƙarin bayani game da yadda ake yin amfani da kayan aiki da kuma yadda ake yin amfani da su a cikin kayan aiki.
Ana kiran gudanar da bincike canje-canje a manufofin aiki ko hanyoyin aiki da ke bukatar aiki daga ma'aikaci ko ma'aikaci.
An yi la'akari da cewa kayan kariya na mutum (PPE) ba su da tasiri fiye da na fasaha da na gwamnati, amma suna iya taimakawa wajen hana wasu kamuwa.
Dole ne a zaɓi kowane irin PPE bisa ga haɗarin da ke tattare da shi ga ma'aikaci, a daidaita shi yadda ya kamata (misali, abin rufe fuska), a saka shi yadda ya kamata kuma a kai a kai, a duba shi a kai a kai, a kula da shi kuma a maye gurbinsa yadda ya kamata, kuma a cire shi, a tsabtace shi, a adana shi ko a jefar da shi yadda ya kamata don kauce wa gurɓata shi.
Aikin da ke da ƙananan haɗarin kamuwa da cutar, bisa ga Hukumar Kula da Lafiya da Lafiya ta Aiki (OSHA) a Amurka, yana da ƙarancin hulɗa da jama'a da sauran ma'aikata.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar a duk wuraren aiki sun haɗa da wanke hannaye a kai a kai da kuma a hankali, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi, ciki har da rufe baki da hanci don tari da hanci, samar da tawul da kwandon shara, shirya don yin aiki daga nesa ko kuma sa'o'i masu yawa kamar yadda ake buƙata, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da kuma kiyaye tsabtace aiki na yau da kullun da kuma tsabtace yanayin aiki.
Ganowa da warewar mutane masu cutar da sauri mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauransu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) a Amurka sun bada shawara cewa ma'aikata da ke nuna alamun cutar numfashi mai tsanani su zauna a gida har sai sun daina samun zazzabi, alamun zazzabi, ko wasu alamun cutar a cikin awa 24 ba tare da amfani da maganin hana zazzabi ko wasu magungunan da ke magance alamun cutar ba. Sun kuma bada shawara cewa a yi amfani da manufofin hutu na rashin lafiya mai sassauci, a ba ma'aikata damar zama a gida don kula da wani memba na iyali da ke rashin lafiya, kuma a sanar da ma'aikata game da waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin matsakaicin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa da mutane sau da yawa ko kusa, a cikin nisan ƙafa shida (1.8 m), tare da mutanen da ba su da wanda ake zargi ko saninsa da COVID-19 amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma da ke gudana a kusa da hedkwatar kamfanin ko kuma saboda mutumin ya yi tafiya ta duniya kwanan nan zuwa yankin da yaduwar yaduwar COVID-19.
Wannan ya hada da ma'aikata da ke hulda da jama'a musamman a makarantu, muhallin aiki mai yawan jama'a da kuma wasu muhallin sayar da kaya masu yawa. Kulawar fasaha ga wannan rukuni da kuma wadanda ke da hadarin gaske sun hada da sanya masu tace iska masu inganci, kara yawan iska, sanya shingen jiki kamar su tsabtace filastik, da sanya taga mai hawa don sabis na abokin ciniki. Kulawar gwamnati ga wannan rukuni da wadanda ke da hadarin gaske sun hada da karfafawa ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurrukan abokan ciniki da na kamala, maimakon sanya wuraren aiki masu tasowa, dakatar da tafiye-tafiye zuwa wuraren da ba su da mahimmanci don taimakawa wajen kare ayyukan COVID-19, musamman samar da kayan aiki na yau da kullun, samar da kayan aiki na yau da kullun, samar da kayan aiki na yau da kullun, samar da kayan aiki na yau da kullun da kuma samar da kayan aiki na yau da kullun don kare ma'aikata daga cutar COVID-19, da kuma samar da wasu matakan kariya ga masu aiki da ke fuskantar hadarin COVID-19 da kuma samar da kayan aiki na yau da kullun, samar da kayan aiki na yau da kullun da kayan aiki na yau da kullun, samar da kayan aiki na yau da kullun da kuma samar da kayan aiki na yau da kullun.
Ma'aikata a cikin wannan rukunin haɗarin ba sa bukatar yin amfani da abin rufe fuska.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da: ware mai cutar daga sauran mutane ta hanyar nisan ƙafa 6, sanya wani ma'aikaci ya kula da mai cutar, kuma ya ba mai cutar abin rufe fuska, ko kuma ya nemi ya rufe bakinsa da hanci da tawul lokacin da yake tari ko kuma hancinsa.
Ma'aikatan jirgin ya kamata su sanya safofin hannu na likita na lokaci guda lokacin da suke kula da fasinjan da ke da rashin lafiya ko kuma idan suka taba ruwa mai guba ko kuma wuraren da ke da gurbatacce, kuma idan zai yiwu su sanya kayan kariya na mutum idan fasinjan yana da zazzabi, yana ciwon tari mai tsawo ko kuma yana da wahalar numfashi.
Dole ne a zubar da safofin hannu da sauran kayayyakin da za a iya zubar da su a cikin jakar da aka yi niyya don sharar da kwayoyin cuta masu haɗari, kuma a tsabtace da kuma tsabtace wuraren da suka kamu da cutar bayan haka. Don jiragen ruwa na kasuwanci, ciki har da jiragen ruwa masu yawon shakatawa da sauran jiragen fasinja, kula da haɗari sun haɗa da jinkirta tafiya idan akwai rashin lafiya da kuma keɓe kai da kuma sanar da cibiyar kiwon lafiya ta jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun cutar a cikin jirgin.
A mafi kyau, ana bukatar a yi bincike a cikin ɗakin da aka ware. A makarantun da kuma wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace da kuma kashe ƙwayoyin cuta idan mutum mai kamuwa ya ziyarci makarantar, ba tare da la'akari da yaduwar cutar a cikin al'umma ba.
Idan akwai ƙarancin yaduwar cutar a cikin al'umma, ana iya aiwatar da dabarun nisantar mutane, kamar soke tafiye-tafiye na ilimi, tarurruka da sauran manyan tarurruka kamar darussan motsa jiki ko na mawaƙa ko cin abinci a kantin, ƙara sarari tsakanin ofisoshi, daidaita lokutan isowa da fita, rage baƙi marasa mahimmanci da amfani da asibiti daban don yara masu alamun mura.
Idan akwai yaduwar cutar a cikin al'umma, ban da dabarun nisantar mutane, ana iya yin la'akari da tsawaita hutun makaranta. CDC ta ce ba shi da haɗarin lafiya na gaggawa ga jami'an tsaro da ke yin ayyuka na yau da kullum.
Jami'an tsaro da ke da alaƙa da waɗanda ake zargi ko kuma aka tabbatar da cewa suna da cutar COVID-19 dole ne su bi ka'idodi iri ɗaya da na ma'aikatan asibiti, ciki har da saka kayan kariya na sirri.
Idan aka yi kusa da mutum a lokacin da aka kama, ma'aikata su tsabtace da kuma kashe ƙwayoyin cuta a kayan aiki da kuma bel ɗin aiki kafin a sake amfani da su ta amfani da wanki ko kuma kayan tsabtace gida, kuma su bi ƙa'idodin tsare da kuma zubar da PPE da aka yi amfani da su da kuma tsare da kuma wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan jinya da na jana'iza a matsayin waɗanda ke da babban ko kuma haɗarin gaske na kamuwa da cutar.
Ayyuka masu haɗarin haɗari sun haɗa da ma'aikatan kiwon lafiya, masu ba da tallafi, ma'aikatan dakin gwaje-gwaje, da ma'aikatan sufuri na kiwon lafiya waɗanda ke fuskantar marasa lafiya da ake zargi ko kuma sanannun COVID-19.
Suna zama ma'aikata masu haɗarin kamuwa da cutar idan suna yin aikin samar da aerosols ko kuma ɗaukar ko sarrafa samfurori daga marasa lafiya da ake zargi ko kuma sanannun COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin jawo tari, bronchoscopies, wasu gwaje-gwaje da hanyoyin hakori ko kuma daukar samfurori na wucin gadi.
Ayyukan jana'iza masu haɗarin haɗari sun haɗa da ma'aikatan da ke shirya gawarwakin mutanen da ake zargi ko kuma aka san suna da COVID-19 a lokacin mutuwarsu; suna fuskantar haɗarin haɗari sosai idan suka yi bincike bayan mutuwa. Ƙarin ƙwarewar ƙwarewa ga waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da ake zargi ko kuma aka sani suna da COVID-19, ciki har da lokacin aiwatar da hanyoyin samar da iska.
Ana iya yin amfani da iska mai matsi mai ƙarfi a wasu wurare da ake yin jana'iza.
Za a yi amfani da samfurori a matakin matakin 3 na tsaro.
Ƙungiyar Lafiya ta Duniya (WHO) ta ba da shawarar a ware marasa lafiya da ke shigowa zuwa ɗakunan jira daban-daban bisa ga zargin COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar sanya abin rufe fuska ga mutanen da ke aiki a cikin nisan kafa 6 daga marasa lafiya da ake zargi ko kuma sanannun kamuwa da cutar SARS-CoV-2 da kuma waɗanda ke yin hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da mashin numfashi na N95 da NIOSH ta amince da shi ko kuma mafi girma a cikin tsarin cikakken shirin kariya na numfashi wanda ya hada da daidaitawa, horo da kuma duba likita.
Wasu nau'ikan abin rufe fuska na numfashi na iya ba da kariya mafi kyau da kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar hadawa ba, saboda COVID-19 cuta ce ta numfashi maimakon ta ruwa.
WHO ta ba da shawarar cewa ma'aikatan bincike ne kawai su sanya abin rufe fuska a wurin shiga.
WHO ta ba da shawarar cewa duk wanda ke tattara samfurin numfashi, kula da ko kuma kai marasa lafiya da ke fama da COVID-19 ba tare da yin aikin da ke samar da iska ba, ya sa a saka abin rufe fuska, tabarau ko abin rufe fuska, rigar rigar jiki da safofin hannu.
Idan ana yin aikin da ke samar da aerosol, sai a maye gurbin abin rufe fuska da abin rufe fuska na numfashi na N95 ko FFP2.
Saboda rashin wadatar PPE a duniya, WHO ta ba da shawarar rage bukatar PPE ta hanyar maganin jiyya ta nesa, da shinge na zahiri kamar su tagogi, da rage samun damar shiga dakin da mai cutar COVID-19 yake ciki ga mutanen da ke da hannu kai tsaye a kula da shi, da amfani da PPE da ake bukata don takamaiman aikin kawai, da ci gaba da amfani da abin rufe fuska guda ba tare da cire shi ba don kula da marasa lafiya da yawa da ke da irin wannan ganewar asali, da sa ido da daidaita sarkar samar da PPE, da kuma hana amfani da abin rufe fuska ga mutanen da ba su da alamun cutar.
DE: Katherine Maher, Shugabar Kamfanin Wikimedia
Ga: Dukan ma'aikatan Wikimedia Foundation
ABUBUWAR: [COVID-19] Sauƙaƙa nauyi da kuma shirya don nan gaba
RANAR KYAUTA: 14 ga watan Maris na shekarar 2020, 00:24 UTC
LISENCE: CC0: Babu haƙƙoƙi
A wannan watan muna cikin yanayi na musamman.
Cutar COVID-19 ta nuna sarai cewa dukanmu 'yan Adam muna da alaƙa da kuma hakkinmu ga juna.
Kalubalensa ba su da misali, amma mun san cewa amsarmu mafi kyau ta dogara ne akan irin tausayi, hadin kai da kuma ƙarfafa al'umma a duniya wanda yake a zuciyar wannan kungiya.
Yadda abokan aikinmu suke tattaunawa da juna da kuma yadda suke nuna ƙauna ta wajen aika mana saƙon imel da kuma yin hira da juna a lokaci ɗaya, ya nuna cewa muna da gatan yin aiki tare da mutane masu ban al'ajabi.
Ina godiya sosai kuma ina alfahari da ku duka a matsayin abokan aikina.
A makon da ya gabata, wani ya nuna godiya ga aikinmu.
Wannan mutumin ya tunatar da ni yadda yake da muhimmanci a duniya a samu damar duba Wikipedia a yanzu, da kuma yadda yake da alama cewa wannan muhimmin kayan aiki ya kasance a kan layi kuma yana samuwa ga kowa.
Wannan yana yiwuwa ne ta wurin aikinku, ko kun ci gaba da cibiyoyin aiki, ko kun biya abokan aikinmu ko kuma kun kiyaye al'ummominmu lafiya.
Duniya tana bukatar bayanin da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba, amma kuma yadda muke yi, zai yi tasiri mai muhimmanci a duniya.
Saboda muhimmancin wannan aiki da kuma matsayin da kuke takawa a cikinsa, za mu yi wasu gyare-gyare masu muhimmanci a yadda muke aiki tare daga mako mai zuwa.
Yin Gyara a Aikinmu da Kuma Tsarinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar ta taru a daren jiya don tattauna yadda za mu bi da al'amuranmu da kuma yadda za mu tsara lokacinmu a cikin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muke ganin zai zama amsar da ta dace da yanayin da muke fuskanta da kuma yadda za a tabbatar da dorewar ƙungiyar a wannan lokacin.
Mun yi iya ƙoƙarinmu don mu rage alhini kuma mu ci gaba da hidimarmu.
Idan kana bukatar ka yi gyara, kada ka damu.
Ga dukan ma'aikata, masu kwangila da kuma waɗanda aka ba su aiki:
Za mu yi aiki na awa 4 a rana, ko kuma awa 20 a mako har sai mun sake yin wani bayani.
Ba ma yin hutu: idan za ku iya samun ƙarin lokutan aiki, za ku iya zama da amfani ga aikin.
Duk da haka, duniya ba ta da tabbas a yanzu, kuma idan kana bukatar ka kula da ƙaunatattunka, ka je sayayya, ko kuma ka je asibiti, lafiyarka ce fifiko.
Ba ma lura da lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata mu ce ba, amma muna cewa.
Babu hutun rashin lafiya ko hutu da ake biya: kawai ka sanar da shugabanninka kuma ka taimaki ƙungiyarka ta duba jadawalin da kuma jadawalin lokaci don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano cewa kana da cutar COVID-19, ka sanar da Bryan na sashen T&amp;C Ops domin T&amp;C su taimake ka kuma su tabbatar da cewa an kula da yanayinka daga shugabanci.)
Za a biya ma'aikatan da suke aiki na ɗan lokaci cikakken albashi.
Mun riga mun sanar da haka, kuma mun sake maimaita alkawarinmu na cika hakkinmu ga masu aikin kwangila da kuma abokan aikinmu na lokaci.
Za a biya kowa daidai da yawan sa'o'in da ya saba aiki a yanayi na al'ada.
Wannan ya shafi idan kana rashin lafiya kuma ba ka iya aiki.
Idan kana son yin aiki, za mu tallafa maka.
Mutane da yawa suna amfani da aiki a matsayin hanyar kawar da matsin da ke tattare da duniya.
Abin da muke yi zai iya kawo albarka sosai, musamman a irin wannan lokacin.
A sake, manufar ita ce mu kāre ku.
Muna roƙonka ka tuntuɓi shugabanka ne kawai, domin mu san abin da za mu yi tsammani kuma mu yi tanadin da ya dace.
Ana ɗaukan wasu ayyuka da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Ƙungiyoyin SRE, HR Ops, Trust &amp; Safety da kuma Tattara Kuɗi (da sauransu) suna yin aiki mai muhimmanci da zai iya bukatar ƙarin taimako.
Za mu fara aiki tare da dukan sassan don mu tantance manufofinmu na yanzu kuma mu mai da hankali ga tallafa wa ayyuka na musamman da suke da muhimmanci a aikinmu.
Akwai aiki da yawa ga kowannenmu, za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Idan ka yi jinkiri yanzu, ba zai yi maka lahani ba.
Ba mu da niyyar yin aiki sau biyu don biyan lokacin da aka rasa lokacin da annobar ta wuce.
Ba za mu bukaci ku yi aiki na sa'o'i da yawa ba domin ku cika wasu takunkumi da ba za ku iya ba.
Mun fahimci cewa yanayi ya canja, kuma za mu yi ƙoƙari mu kafa sababbin manufofi da kuma jadawalin lokacin da ya dace.
Me game da APP?
Domin daidaitawa da sabon yanayinmu da kuma burinmu na lokutan aiki na yau da kullum, muna shirin daidaita lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Muna son mu ba da shawarar tsawaita shirinmu na 2019-2020 wanda zai ba da karin lokaci don tsara kasafin kuɗi domin ma'aikata su mai da hankali kan muhimman ayyuka, su kula da kansu da kuma waɗanda suke ƙauna yayin da kuma su daidaita da waɗanda suke bukatar ko kuma suke son rage lokacin aikinsu a cikin makonni masu zuwa.
Wannan tsawaitawar lokaci yana rage yawan aiki da matsin lamba na shirin da ake yi a yanzu a dukan ƙungiyar.
Za mu gabatar da shawararmu ga Majalisar a mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakai na gaba da zarar an tabbatar.
Na gode wa ƙungiyar APP don jagorancinku a wannan batun.
Yanayin ofishi, bayyanarsa da kuma tsabtace shi
A makon da ya gabata, mun samu labarin cewa wani abokin aikinmu da ke San Francisco ya kamu da cutar COVID-19.
Amma, don mu yi hankali, mun sa ƙungiyar masu tsabtace gidajenmu da ke San Francisco su tsabtace dukan wuraren da ke cikin ofishinmu.
Sun yi amfani da maganin rigakafin cutar da ake amfani da shi a asibiti don su tsabtace dukan wuraren da ke cikin ɗakin da kuma ɗakunan hawa da ke kai mu hawa.
Ginin yana amfani da tsarin kula da aikinsa wanda ke amfani da kayayyakin da ke tabbatar da lafiyar masu haya.
Muna da tabbacin cewa ofishin zai kasance a shirye idan muka yanke shawarar komawa.
Ofishinmu na Washington DC yana cikin wani wurin aiki na WeWork, wanda ya raba mana da dukkan ma'aikatan da ke Washington DC tsarinsa na COVID-19.
Tun makon da ya gabata, ofishinmu da ke Washington DC ya soma aiki a nesa bisa ga shawarar da aka bayar a San Francisco.
Kamar yadda wasu abokanmu da ke New York suka sani, mun kuma tattauna batun yin hayan wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka saba da aiki daga nesa sun fahimci cewa daidaitawa na iya zama da wahala kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa na awa ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, a yi amfani da kwanaki da yawa.
Ka bayyana taron a fili, ka kafa tsarin da za a bi, kuma ka aika da takardun da za a yi a gaba.
Yin bidiyo al'ada, ta hanyar kayan aiki kamar Google Docs da Zoom don karfafa haɗin kai da musayar kai tsaye.
Ka samu mai gudanarwa da zai yi wa kowane taro sauƙi, da wani da zai kula da tattaunawar nan take da kuma jerin masu magana, da kuma wani da zai taimaka wajen yin rubutu (ko kuma yin rubutu tare).
A aika imel zuwa ga masu goyon bayan fasaha idan kana bukatar kwalkwali mai dadi.
Ka yi amfani da kuɗin da ka karɓa don biyan kuɗin abincin da za ka ci.
Shiga tashar #remoties akan Slack don tattaunawa da abokan aikinka game da rarraba aiki
Ƙungiyar ayyukan HR tana nazarin jagororin ergonomics bisa ga shafuka don tallafawa ƙaruwar rarraba aiki a cikin Gidauniyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma su soke taron jama'a da Wikimedia ke tallafawa, kamar su shirya-a-thons, har sai WHO ta sanar da ƙarshen annobar.
Mun bayyana musu cewa mun fahimci cewa buƙatunmu na sokewa da sauran ƙuntatawa na iya sa ba zai yiwu ba su kammala ayyukan tallafi da aka amince da su kuma ba za a hukunta kowa ba idan aka jinkirta ko aka canza waɗannan manufofin.
A mako mai zuwa za mu wallafa ƙarin jagorori game da Wikimania da sauran taron al'umma da na yanki.
A bayyane yake cewa, al'ummar duniya suna baƙin ciki da wannan rikici, amma suna murna da wannan haske da kuma damar da suke da ita na mai da hankali ga al'ummarsu, Wikimedia da sauransu.
A gaba, CRT tana aiki kan kafa wani shafi a kan Meta-Wiki domin samar da sarari ga al'umma don lura da tasirin da kuma ci gaba da sadarwa da su.
Ku ci gaba da tuntuɓar juna duk da matsalolin COVID-19
Za mu aika muku da gayyatar taron ma'aikata na musamman da za a yi ranar Alhamis, 14:00 UTC zuwa 7:00 PT.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ciyar da lokaci tare.
Wannan yanayin ya shafe mu duka kuma muna nan don mu taimake ku a kowace hanya.
Kafin wannan lokacin, za ka iya samun bayanan da ke cikin wannan imel ɗin, da kuma duk wasu muhimman bayanai game da COVID-19, a Office Wiki.
Hukumar tana ɗaukaka waɗannan shafuka kuma tana tattara dukan bayanai a wuri ɗaya.
Muna kuma ƙoƙari mu ci gaba da sadarwa a kai a kai da ma'aikatan da suke ƙasashen da aka yi wa illa sosai.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, aiki mai yawa, ko kuma matsalar samun bayanai, ko kuma idan kana bukatar taimako game da wani abu, ka gaya wa CRT.
Muna nan don mu tallafa muku kuma mu ba ku hanyar sadarwa idan kuna bukatar hakan.
Idan kana da wata tambaya mai muhimmanci ko kuma mai muhimmanci, ka aika imel zuwa Bryan Judan, Daraktan Ayyuka na Human Resources na Ƙasashen Duniya.
Babu wani cikin waɗannan canje-canjen da ya kamata a ɗauka cewa ya rage aikinmu da kuma hakkinmu.
Maimakon haka, ya kamata mu fahimci cewa a yanzu aikinmu da kuma wajibai za su yi daidai da yadda muke yi a dā.
Waɗannan su ne matakan da muke ganin ya zama dole domin mu tallafa wa juna kuma mu ci gaba da aikinmu, mu ba wa motsinmu taimakon da yake bukata, kuma mu ba duniya sabis da kowa zai iya dogara da shi.
Aikin da muka shirya zai kasance a nan yana jiranmu.
Yanzu ne lokacin da za mu taimaki juna mu shirya don aiki mai muhimmanci da zai faru a makonni da wata masu zuwa.
Muna bukatar kowannenku ya samu, don haka dole ne ku kula da kanku da kuma iyalinku domin ku iya ba da mafi kyawun lokacinku.
A ƙarshe, ku wanke hannuwanku kuma kada ku taɓa fuskarku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S), da sauran ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
bLenzyme mai sauya angiotensin 2 (ACE2) wani enzyme ne wanda ke da nasaba da waje (mambran sel) na ƙwayoyin huhu, jijiyoyi, zuciya, koda da kuma hanji.
LACE2 tana yaki da aikin enzyme mai sauya jini (ACE) ta hanyar rage yawan dangiotensin II da kuma kara lAng (1-7) wanda hakan ya sa ta zama wata babbar hanyar magani wajen maganin cututtukan zuciya da jijiyoyin jini. LACE2 kuma ita ce hanyar shigar wasu kwayoyin coronaviruses cikin kwayoyin.
An kira kwayar halitta ta mutum hACE2.
Langiotensin 2 mai sauya enzyme shine zinc-containing metallolenzime wanda yake a farfajiyar endothelial da sauran ƙwayoyin.
Kwayar ACE2 tana dauke da wani yanki na peptidase na M2 mai ƙare N da kuma wani yanki na collectrin mai ɗaukar amino acid na ƙwayoyin cuta mai ƙare C.
LACE2 shine mai wucewa guda ɗaya mai ɗaukar hoto mai nau'in I, wanda yankin aikinsa na enzymatic yana kan farfajiyar ƙwayoyin huhu da sauran kayan.
An cire yankin waje na ACE2 daga yankin transmembrane ta wani enzyme da ake kira sheddase; an saki furotin mai narkewa a cikin jini kuma a ƙarshe an cire shi cikin fitsari.
LACE2 tana cikin yawancin gabobin jiki: LACE2 tana haɗe da membrane na ƙwayoyin jiki, musamman na ƙwayoyin alveoli na huhu na nau'in II, ƙwayoyin enterocytes na ƙananan hanji, ƙwayoyin endothelial na arterial da na vein, da ƙwayoyin jini na tsokoki masu santsi na yawancin gabobin jiki.
Ana kuma bayyana mRNA na ACE2 a cikin cortex na kwakwalwa, striatum, hypothalamus da kuma ƙwaƙwalwar kwakwalwa.
Babban aikin ACE2 shi ne ya biya ACE.
ACE tana rarraba angiotensin I zuwa angiotensin II mai hana jini.
LACE2 kuma yana rarraba amino acid phenyllamine tare da ƙarshen carboxyl na angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da kuma hydrolysis zuwa angiotensin mai yaduwa (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
LACE2 na iya kuma tsage wasu peptides da dama ciki har da [des-Arg9]-bradykinin, lapelin, neurotensin, dynorphine A, da ghrelin.
LACE2 kuma tana daidaita yaduwar membrane na mai ɗaukar amino acid mai tsaka tsaki SLC6A19 kuma tana da hannu a cutar Hartnup.
A matsayin furotin mai wucewa ta membrane, ACE2 shine babban hanyar shiga cikin ƙwayoyin wasu ƙwayoyin cuta na coronavirus, ciki har da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman ma, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 a farfajiyar ƙwayoyin halitta yana haifar da ƙwayoyin cuta da kuma sauya wuri na ƙwayoyin cuta da ƙwayoyin cuta a cikin ƙwayoyin cuta.
Wannan tsarin shiga kuma yana buƙatar ƙaddamar da furotin S ta hanyar mai masaukin baki mai suna TMPRSS2, wanda aka fara binciken hana shi a matsayin magani mai yuwuwa. Wannan ya sa wasu suka yi tunanin cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙi da kamuwa da cuta.
Duk da haka, ƙwararrun ƙungiyoyi da hukumomi da yawa sun ba da shawarar ci gaba da maganin daidaitattun tare da taimakon ACE inhibitor da ARB.
Wani bita na yau da kullun da kuma wani bincike na meta da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa  amfani da masu hana ACE yana da alaƙa da raguwar 34% na haɗarin ciwon huhu idan aka kwatanta da masu kula. 
Bugu da ƙari, an rage haɗarin kamuwa da ciwon huhu a cikin marasa lafiya da aka yi wa maganin ACE inhibitor waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman waɗanda suka kamu da bugun jini da kuma rashin ƙarfi na zuciya.
Amfani da masu hana ACE an kuma danganta shi da rage mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon bai nuna cewa wannan cutar ba ce mai tsanani ba. 
An yi hasashen cewa maganin mai sauya kwayar halittar mutum mai suna recombinant angiotensin 2 (rhACE2) zai zama magani na farko na cutar huhu mai tsanani kuma yana nuna inganta haemodynamics na huhu da kuma oxygen saturation a cikin aladu da ke fama da cutar lipopolysaccharide-induced acute respiratory distress syndrome.
Rabin rayuwar rhACE2 a cikin mutum ya kai awa 10 kuma tsawon lokacin aikinsa minti 30 ne, ƙari ga tsawon lokacin aikinsa (tsawon) awa 24.
An yi la'akari da cewa rhACE2 na iya zama magani mai kyau ga mutanen da ba su iya jurewa da maganin rigakafin tsarin renin-angiotensin (RAI) na gargajiya ko kuma cututtuka da ke da yawan jini na angiotensin II. An yi nazarin rhACE2 a matsayin maganin maganin rigakafi don maganin cututtukan numfashi.
Aikace-aikacen COVID-19 aikace-aikacen wayar hannu ne da aka tsara don sauƙaƙe bin diddigin lambobin sadarwa a cikin yanayin annobar cutar coronavirus ta 2019-20, wato, gano mutanen ( lambobin sadarwa ) waɗanda za su iya haɗuwa da mutumin da ke da cutar.
An tsara ko kuma gabatar da aikace-aikace iri-iri, tare da goyon bayan gwamnati a wasu yankuna da kuma wasu hukumomi.
An tsara wasu kayayyakin more rayuwa don tsara aikace-aikacen bin diddigin tuntuba.
Waɗannan tsarin, musamman waɗanda suka dogara da bin diddigin wurin da masu amfani da aikace-aikacen suke, suna haifar da tambayoyi game da mutunta sirrin mutum.
Akwai wasu zaɓuɓɓuka masu sauƙi, kamar yin amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da haɗin kai tsaye a cikin tsarin aiki na Android da iOS na fasalin da ke ba da damar tallafawa waɗannan aikace-aikacen Bluetooth.
Gwamnatin Sin, tare da Alipay, ta tura wani manhaja a China wanda ke ba wa 'yan ƙasa damar bincika ko sun taɓa hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a birane fiye da 200 a China, kuma Singapore ta yi amfani da wani app mai suna TraceTogether.
An samar da shi ta hanyar al'umma na masu ilimin kwamfuta, kuma an samar da shi a cikin tushen budewa kuma za a ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da  StopKorona! , wani aikace-aikacen Bluetooth wanda ke sa ido kan haɗuwa da mutanen da ke da cutar kuma yana sadarwa da sauri tare da hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da manhajar.
Tun daga ranar 14 ga Afrilu, 2020, ana jiran amincewar aikace-aikacen daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce ana ci gaba da inganta manhajar bin diddigin mutane kuma za a iya tura ta cikin makonni masu zuwa. An shirya irin wannan manhajar a Ireland da Faransa ( StopCovid ).
Australia da New Zealand suna shirin kafa aikace-aikace irin na TraceTogether a Singapore da kuma bisa tsarin BlueTrace. Rasha na son gabatar da aikace-aikacen gano wuri ga marasa lafiya da aka gano suna da cutar COVID-19 da ke zaune a Moscow, don tabbatar da cewa ba sa fita daga gida.
Ross Anderson, Farfesa a fannin aikin tsaro a Jami'ar Cambridge, ya yi magana game da matsaloli masu yawa da za a iya fuskanta a aikace-aikacen da aka kafa, kamar su, rashin inganci da rashin inganci idan ƙananan mutane ne kawai ke amfani da aikace-aikacen.
Dangane da damuwar da ake da ita game da yaduwar aikace-aikacen cutar coronavirus na karya ko na cutarwa, Apple ya ba da izinin kawai hukumomi ko kuma masu amintacce su ƙara aikace-aikacen da suka shafi cutar coronavirus a cikin App Store.
Google da Amazon sun kafa irin wannan takunkumi.
Masu fafutukar kare sirrin mutane sun nuna damuwarsu game da tasirin aikace-aikacen coronavirus kan sa ido kan jama'a, musamman yiwuwar rushe tsarin sa ido da aka kafa don magance annobar coronavirus da zarar an kawar da barazanar.
Kungiyar Amnesty International da kuma wasu kungiyoyi fiye da 100 sun fitar da wata sanarwa da ke kira ga a rage irin wannan sa ido.
Waɗannan ƙungiyoyi sun ba da takunkumi takwas da za a bi a cikin tsarin ayyukan gwamnati:
Ya kamata a yi  bin doka, wajibi da kuma daidaitacce ;
tsawaita iko da sa ido ya kamata ya kunshi sharuddan kashewa;
Ya kamata a ƙuntata amfani da bayanai don manufar yaƙi da COVID-19.
Tsaron bayanai da kuma rashin sani ya kamata a kiyaye su ta hanyar da za a iya tabbatar da ita;
Ya kamata a lura da sa ido na dijital don kauce wa ƙaruwar nuna bambanci da kuma warewa;
duk wani raba bayanai tare da wasu ya kamata a ayyana a cikin doka;
Ya kamata a samar da kariya daga cin zarafi da kuma hanyoyin da 'yan ƙasa za su iya bi idan aka yi amfani da su;
 muhimmiyar sa hannu  na duk masu ruwa da tsaki  zai zama tilas, musamman na masana kiwon lafiyar jama'a da kuma na kungiyoyin da ba su da 'yanci. Ƙungiyar Kwamfuta ta Chaos (CCC) da kuma Reporters Without Borders (RSF) a Jamus sun wallafa jerin abubuwan bincike.
Shirin da Google/Apple suka gabatar yana nufin magance matsalar ci gaba da sa ido ta hanyar cire tsarin bin diddigin tsarin aiki daga na'urorin su da zarar ba a bukatarsa.
Wasu ƙasashe sun yi amfani da tsarin gano wuri na hanyar sadarwa maimakon aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikace da kuma ikon kaucewa bin diddigin.
A Isra'ila, an amince da yin amfani da hanyar sadarwa.
Hanyoyin sadarwa da ke da damar zuwa bayanan wuri na asali suna da manyan matsaloli na sirri.
Duk da haka, ba dukan tsarin da ke da cibiya mai cibiya ba ne ke bukatar samun damar yin amfani da bayanan wurin mutum; an tsara wasu tsarin domin yin amfani da cibiya mai cibiya kawai don sadarwa, wanda ke ba da damar kiyaye sirrin mutum (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin bin diddigin mutane ba tare da yin amfani da manhajar ba.
Maimakon yin amfani da aikace-aikacen da aka keɓe, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban, ciki har da bayanan bin diddigin na'urorin hannu da kuma bayanan ma'amala ta katin, wanda suka haɗa don aika gargadi ta hanyar SMS ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu son tuntuɓar, gwamnati ta kuma ba da damar samun bayanin wurin da mutane suke, wanda ya biyo bayan manyan canje-canje a dokokin kare bayanan bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da dama.Kasashe kamar Jamus sun yi la'akari da amfani da tsarin tsare sirri na tsakiya.
Ba a bayyana cikakken bayani ba a ranar 6 ga Afrilu 2020.
Binciken sirri na tuntuɓar mutum ya zama sanannen ra'ayi, wanda ke da goyon bayan babban adadin bayanan bincike tun daga 2013. A ranar 7 ga Afrilu, 2020, sama da gungun masana goma sha biyu suna aiki kan hanyoyin kiyaye sirri, ciki har da amfani da fasahar Bluetooth Low Energy (BLE) don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
Duk da haka, aikin PEPP-PT wani shiri ne na daidaitawa wanda ya hada da hanyoyin da aka maida hankali da kuma rarraba su, ba yarjejeniya guda ba. Tsarin da aka rarraba ya hada da Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambobin Saduwa na Wucin gadi (TCN, a baya sun kira Lambobin Taron Saduwa (CEN), Ka'idojin Tsaro na Tsaro da kuma Tsarin Saduwa na Saduwa da Wayar Hannu (PACT), da sauransu.
Waɗannan hanyoyin suna tabbatar da cewa bayanan mutum da za a iya ganewa ba sa barin na'urar kuma duk wani aiki da aka yi da su yana faruwa a kan na'urar.
Kungiyar Sirri a MIT Media Lab tana ci gaba da samar da SafePaths, wani dandamali na amfani da fasahohin tsare sirri wajen tattarawa da amfani da bayanan wuri ko na lamba don bin sawun yaduwar COVID-19.
Wannan dabarar ta dogara ne akan sakamakon farar takarda  Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic  da aka fitar a watan Maris na 2020. Tsarin SafeTrace na Enigma MPC, wani kamfani da ke haɓaka fasahar tsare sirri da aka kafa a MIT Media Lab, wani irin wannan ƙoƙari ne.
SafeTrace tana amfani da fasahohin kayan aiki masu tsaro don ba masu amfani damar raba bayanai masu ma'ana na wuri da kuma kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da yin watsi da sirrinsu ba.
A ranar 5 ga Afrilu, 2020, an kafa Ƙungiyar TCN ta Duniya ta ƙungiyoyi da suka haɗu a kan hanyar da aka saba da ita da kuma yarjejeniyoyi masu kama da juna, don rage rarrabuwa da kuma tabbatar da haɗin kai na duniya na aikace-aikacen sa ido da faɗakarwa, wanda ke da muhimmanci wajen samun karɓuwa daga jama'a.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da sakin lambar tushe na yarjejeniyar BlueTrace da aka yi amfani da ita a aikace-aikacen ta na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, waɗanda ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da shirin bin diddigin lambobin sadarwa, suna cewa zai ba da damar kiyaye sirrin mutum kuma zai haɗa da fasahar Bluetooth Low Energy da kuma ɓoye ɓoye na sirri.
Sun kuma wallafa takamaiman fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, tsarin zai kasance a matakai uku:
tura kayan aiki da zai baiwa gwamnatoci damar samar da aikace-aikacen bin diddigin cutar korona masu mutunta sirrin mutane
Google da Apple suna shirin magance matsalolin tallafi da ci gaba da sa ido ta hanyar rarraba tsarin farko ta hanyar sabunta tsarin aiki da kuma cire shi a baya ta hanyar wannan hanyar da zarar barazanar ta tafi.
Sake sanya magani (wanda ake kira sake turawa, sake tsarawa, sake sanyawa ko canza yanayin maganin magani) yana nufin sake canza magani da aka amince dashi don cuta ko yanayin likita daban da wanda aka fara kirkirar sa.
Wannan wani yanki ne na bincike na kimiyya da ake gudanarwa yanzu don samar da ingantacciyar hanyar magani na COVID-19.
Sauran fannonin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma karban jini daga mutanen da suka warke. SARS-CoV-2 yana da kimanin sunadarai 66 da ake iya amfani da su wajen warkarwa, kowannensu yana da wurare da yawa da ke ɗaure ligand.
Binciken waɗannan wuraren haɗin yana ba da kyakkyawan tsari na haɓaka maganin rigakafin cutar da ke da tasiri a kan sunadarai na COVID-19.
A cikin manyan sunadarai da SARS-CoV-2 ke amfani da su sun hada da protease irin papain, RNA polymerase, RNA helicase, S protein, da kuma ADP ribose phosphatase.
Hussein A A, et al. sun yi nazarin wasu magungunan da suka yi niyya, sannan suka inganta su kuma suka bincika su don gano kamanceceniya da magungunan da aka amince da su don hanzarta samar da wani magani mai ƙarfi na SARS-CoV-2 a cikin binciken su na farko da za a ba da shawarar a cikin ƙirar gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro kuma ana amfani da shi wajen magance wasu cututtuka na rigakafin jiki.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da nasaba da shi za su kasance cikin magunguna huɗu da ake nazari a gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin chloroquine da hydroxychloroquine a jihar New York a ranar 24 ga watan Maris. A ranar 28 ga watan Maris, FDA ta ba da izinin amfani da sulfate na hydroxychloroquine da chlororoquine phosphate a ƙarƙashin izinin gaggawa (US).
Ba a amince da maganin ta hanyar gwajin asibiti na FDA ba kuma an ba da izini ne kawai a ƙarƙashin Amurka a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da ke asibiti amma ba za su iya karɓar magani a gwajin asibiti ba.
CDC ta ce ba a riga an kafa amfani, sashi ko tsawon lokacin da za a yi amfani da Lhydroxychloroquine ba don rigakafi ko maganin cutar SARS-COV-2 .
Likitoci sun ce a yi amfani da wannan magani  idan babu wani zaɓi .
Wata ƙungiyar bincike ta Turkiya a Istanbul tana gudanar da karamin bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
NYU Langone Medical School tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine a matsayin maganin rigakafi.
Gwaje-gwajen asibiti na kasar Sin da aka gudanar a Wuhan da Shenzhen sun tabbatar da cewa favipiravir  ya kasance mai tasiri .
35 daga cikin marasa lafiya a Shenzhen sun nuna cewa ba su da cutar cikin matsakaicin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su samu maganin ba.
A wani bincike da aka yi a Wuhan a kan marasa lafiya 240 da ke fama da ciwon huhu, rabin sun sha favipiravir, sauran rabin sun sha lumifenovir.
Hukumar magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke kan wannan magani kadan ne kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyarta kuma za ta yi amfani da sojojin kasar wajen isar da maganin zuwa asibitocin jami'o'i inda za a yi amfani da maganin wajen kula da marasa lafiya da ke fama da COVID-19.
A cewar South China Morning Post, Shinzo Abe ya bude hanyoyin da gwamnatin Trump za ta iya samun maganin. Maganin na iya zama mai rauni a cikin manyan cututtukan cutar inda cutar ta riga ta yadu.
Wataƙila ba zai kasance da lafiya ba ga mata masu juna biyu ko waɗanda suke ƙoƙarin su haifi yara.
Wani bincike na lopinavir/ritonavir (Kaletra), haɗin maganin rigakafin cutar lopinavir da ritonavir, ya kammala cewa babu wani amfani da aka samu.
An tsara waɗannan magungunan don su hana ƙwayar cuta ta HIV yin kwafi ta wajen ɗaure ta da sinadarin protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara waɗannan magungunan don gano wani fili da zai haɗa da protease na SARS-CoV-2. Akwai sukar a cikin masana kimiyya game da amfani da albarkatu don sake sanya magungunan da aka tsara musamman don cutar HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir cikin gwajin Solidarity na duniya.
Gilead Sciences ce ta kirkiro da kuma samar da Remdesivir don maganin cutar Ebola da kuma cututtukan Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafin cutar a cikin in vitro akan filovirus, pneumovirus, paramyxovirus da coronavirus.
Wata matsala da ke tattare da maganin rigakafin ƙwayoyin cuta ita ce, ƙwayoyin cuta suna iya zama masu tsayayya ta hanyar canji, wanda hakan zai iya sa a kamu da cuta da kuma yaduwa.
Wasu bincike na farko kafin gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin halitta akan juriya. Gwaje-gwaje da dama na ci gaba, ciki har da biyu da asibitocin jami'a na Cleveland ke gudanarwa; daya a kan mutanen da ke fama da rashin lafiya mai matsakaici, ɗayan kuma a kan waɗanda ke fama da nau'ikan rashin lafiya masu tsanani.
Akwai gwaje-gwaje uku na asibiti da ake yi a kan bitamin C a cikin jijiya ga mutanen da ke asibiti da ke da cutar COVID-19 mai tsanani; biyu da aka yi wa magani (China da Kanada) da kuma guda ɗaya da ba a yi wa magani ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Lafiya da Magunguna ta Kasa ta Japan (NCGM) ta shirya gwajin asibiti na Teijin's alvesco (cyclesonide), wani maganin corticosteroid da ake sha don shan iska mai guba, don maganin marasa lafiya da ke da alamun cutar coronavirus.
Wani nau'i na enzyme mai sauya jini na 2 na kashi na biyu yana gudana tare da karbar marasa lafiya 200 daga cikin marasa lafiya masu tsanani da ke asibiti a Denmark, Jamus da Austria domin sanin ingancin maganin.
Masu bincike a Cibiyar Kula da Zuciya ta Montreal a Kanada suna nazarin matsayin colchicine wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke da alamun cutar COVID-19 na matsakaici.
Binciken da ake kira COLCORONA ya kunshi manya 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da cutar COVID-19 kuma suna da alamun cutar da ba su bukatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da hanyar hana haihuwa mai inganci ba ba za su iya shiga ba.
Ana gwada wasu magungunan hana jini a ƙasar Italiya.
Ana amfani da ƙananan ƙwayar heparin a yawancin marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da wani bincike mai cibiya guda 300 a Italiya a ranar 14 ga Afrilu, wanda ke nazarin amfani da enoxaparin sodium a matsayin maganin rigakafi da magani.
Saboda SARS-CoV-2 kwayar cuta ce, masu bincike da yawa sun mai da hankali kan sake sanya magungunan rigakafin cutar da aka amince da su waɗanda aka samar don barkewar cutar kamar MERS, SARS da West Nile virus.
Ribavirin: an bada shawarar ribavirin don maganin COVID-19 bisa ga fitowar ta 7 na ka'idojin kasar Sin
Umifenovir: an bada shawarar amfani da umifenovir don maganin COVID-19 bisa ga fitowar ta 7 na dokokin kasar Sin
An gano wasu maganin rigakafi da za a iya sake sanya su a matsayin maganin COVID-19:
Tocilizumab (mai hana IL-6): an amince da shi daga kasar Sin.
Ana kuma yin gwaji a Italiya da China.
Rigakafin COVID-19 rigakafin da ake tsammani ne na cutar coronavirus 2019 (COVID-19).
Ko da yake babu rigakafin da ya wuce gwajin asibiti, ana ci gaba da yin gwaje-gwaje da yawa.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a sa ran samun allurar rigakafin cutar SARS-CoV-2, kwayar cutar da ke haifar da cutar, har sai aƙalla watanni 18.
A watan Afrilu, an gudanar da gwajin lafiya na kashi na 1 na allurar rigakafi guda biyar.
An gano COVID-19 a watan Disamba na shekarar 2019.
An samu wata babbar annoba a duniya a shekarar 2020, wanda ya haifar da zuba jari da bincike mai yawa domin samar da rigakafi.
Ƙungiyoyi da yawa suna amfani da kwayoyin halittar da aka buga don samar da allurar rigakafin cutar SARS-CoV-2.
An bayyana shi a watan Afrilu, abubuwan da ake bukata a shirin CEPI na samar da rigakafi su ne saurin, iyawar samarwa, yaduwar yaduwa, da kuma samun damar yin amfani da shi a dukan duniya.
A watan Afrilu masana kimiyya na CEPI sun bayyana cewa dandamali daban-daban na fasaha guda 10 suna gudanar da ayyukan bincike da ci gaba a farkon shekarar 2020 da nufin samar da ingantaccen rigakafin COVID-19.
Manufofin babban dandamali da aka ƙaddamar a cikin binciken tsaro na Phase I sun haɗa da:
nucleic acid (DNA da RNA) (matakin farko mai samarwa da kuma dan takarar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai ɗaukar hoto na lokaci na farko da mai ɗaukar hoto): CanSino Biologics, mai ɗaukar hoto na adenoviral nau'in 5)
Kamar yadda masana kimiyyar CEPI suka bayyana a watan Afrilu, jimillar masu neman rigakafi 115 suna cikin farkon matakan ci gaba, 78 daga cikinsu (79 bisa ga Cibiyar Milken) an tabbatar da cewa suna aiki, kuma an sanar da wasu 37 amma ba a samu cikakken bayani ba (wanda ake zaton ana shirinsa ko kuma tsara shi).
Gwajin Phase I-II yana gudanar da gwajin farko na lafiya da kuma na rigakafi, yawanci ana yin sa ne a bazuwar, ana gwada shi da placebo, kuma ana gudanar da shi a wurare da yawa, ana ƙayyade ƙarin ƙwayoyin da suka dace.
Gwaje-gwaje na Phase III yawanci suna da mahalarta da yawa, sun haɗa da rukunin kulawa, kuma suna gwada ingancin allurar rigakafin a rigakafin cutar, yayin da suke lura da sakamako mara kyau a mafi kyawun sashi.
Daga cikin allurar rigakafi 79 da ake ci gaba da samarwa (wanda aka tabbatar a farkon watan Afrilu 2020), 74 ba su riga sun shiga matakin kimantawa a kan mutane ba (har yanzu ana gudanar da bincike  na farko ).
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar cewa tana nazarin yiwuwar yin allurar rigakafin kwayar halitta da za ta iya canza kwayoyin kwayar cutar don motsa amsawar garkuwar jiki.
A ranar 24 ga Janairu, 2020, Cibiyar Alurar Rigakafin Duniya (VIDO-InterVac) a Jami'ar Saskatchewan a Kanada ta sanar da cewa ta fara aiki kan allurar rigakafin da ake sa ran za a fara gwajin ta a kan mutane a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ke jagoranta, ya sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen tana samar da maganin rigakafin da za a iya sha a baki tare da abokin aikinta a fannin kimiyyar halittu, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda kan ƙirar allurar rigakafi da ke da irin fasahar da ake amfani da ita wajen yin allurar rigakafin cutar kansa.
A ranar 25 ga Maris, darektan cibiyar bincike ya sanar da cewa sun kammala samar da allurar rigakafin kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immuno-Oncology ya sanar da cewa ya fara aikin rigakafi da nufin samar da maganin rigakafin cutar COVID-19 da ke dauke da maganin peptides Ii-Key.
Suna son su samar da wani rigakafi da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St Louis ta sanar da shirin samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Bincike da Kayan Aikin Sojojin Amurka a Fort Detrick da Cibiyar Bincike ta Sojoji ta Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun sanar da cewa suna kan aikin samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta haɗu da Novavax Inc.
a cikin ci gaba da kuma samar da rigakafi.
Abokan hulɗa sun kuma sanar da shirin gwajin rigakafin cutar da gwajin asibiti na kashi na 1 a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna kan aikin gano mutane 11 kuma ko da a cikin hanzarta aiki, zai ɗauki kimanin shekara daya da rabi zuwa shekara biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfani na kimiyyar halittu da ke Quebec, Quebec, ya ce yana samar da kwayar cutar coronavirus ta hanyar samun wani bangare na tallafin daga cibiyoyin bincike na kiwon lafiya na Kanada.
Ana gudanar da bincike kan allurar rigakafin a dakin gwaje-gwaje, kuma an shirya yin gwajin a kan mutane a watan Yuli ko Agusta na 2020.
A farkon wannan makon jaridar Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac  kudade masu yawa domin samun damar yin allurar rigakafin COVID-19 , wanda hakan ya jawo zanga-zangar gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɗin gwiwar haɓaka allurar rigakafin mRNA.
A halin yanzu ana gudanar da gwajin rigakafin BNT162 na mRNA tare da fara gwajin asibiti a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, a Italiya, Takis Biotech, wani kamfanin kere-kere na Italiya, ya sanar da cewa zai samu sakamakon gwajin rigakafin a watan Afrilu na shekarar 2020 kuma zai iya fara gwajin rigakafinsa na ƙarshe a kan mutane a cikin kaka.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Innovations in Epidemic Preparedness (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin wata ƙungiyar bincike kan allurar rigakafin COVID-19 da ta hada da Pasteur Institute, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda hakan ya kawo jimillar saka hannun jari na CEPI a cikin samar da allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan zuba jari na CEPI don samar da allurar rigakafin COVID-19 su ne Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da kuma Jami'ar Queensland.
A ranar 20 ga Maris, 2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin alluran rigakafi guda shida a kan dabbobi.
Masu bincike a Kwalejin Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa suna kan samar da rigakafin RNA mai kara kuzari da kansa don COVID-19.
An samar da maganin rigakafin ne cikin kwanaki 14 bayan da kasar Sin ta aika da jerin kwayoyin.
A ƙarshen Maris, gwamnatin Kanada ta sanar da bayar da tallafin dala miliyan 275 na C don gudanar da ayyukan bincike 96 kan maganin COVID-19, ciki har da wasu masu neman allurar rigakafi a jami'o'i da cibiyoyin kiwon lafiya na Kanada kamar Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da ware dala miliyan 192 don samar da allurar rigakafin COVID-19 tare da shirye-shiryen kafa bankin allurar rigakafin ƙasa wanda ke ɗauke da sabbin alluran rigakafi da za a iya amfani da su idan har sake barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, wata allurar rigakafin COVID-19 a cikin beraye, suna mai cewa SARS-CoV-2 S1 subunits na allurar rigakafin da aka yi amfani da su ta hanyar micro-nail sun haifar da babban amsawar takamaiman antibody na antigen [a cikin beraye] da aka lura makonni 2 bayan rigakafin.
A Kanada, a ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo ta sanar da cewa an tsara wani takardar rigakafin da ke bisa DNA a cikin wani nau'i na fesa hanci.
Ta amfani da kwayoyin cuta masu cin nama, za a tsara DNA don yin kwafi a cikin kwayoyin halittar mutum don samar da kwayoyin cutar da ba su da lahani kamar kwayoyin cutar da za su iya motsa tsarin garkuwar jiki wajen samar da kwayoyin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun hada kan albarkatunsu don samun damar manyan kwamfutocin IBM, tare da albarkatun kwamfuta da ke cikin girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako dabam dabam, wanda ake kira sakamako marar takamaimai.
Wannan yana nufin cewa suna iya ba da fa'idodi fiye da cutar da suke hanawa.
Wani gwaji na bazuwar a Australia yana shirin haɗa da ma'aikatan kiwon lafiya 4,170.
Wataƙila alluran rigakafin da ake ci gaba da samarwa ba su da lafiya ko kuma ba su da tasiri.
Bincike na farko don kimanta ingancin rigakafi ta amfani da samfuran dabbobi na musamman na COVID-19, kamar su mice ACE-2 da aka canza kwayoyin halitta, sauran dabbobi masu gwajin gwaji, da kuma dabbobi masu kama da dabbobi, ya nuna bukatar aiwatar da matakan tsare-tsaren tsaro na matakin 3 don sarrafa ƙwayoyin cuta masu rai, da kuma daidaitawa tsakanin ƙasashe don tabbatar da daidaitattun hanyoyin tsaro.
An gwada allurar rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekarar 2020, babu maganin rigakafin cutar SARS da aka tabbatar da cewa yana da lafiya da kuma inganci a cikin mutane.
A cewar takardun bincike da aka wallafa a shekara ta 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna don maganin SARS ya kasance babban fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya. Babu wani rigakafin da aka gwada na cutar MERS.
Lokacin da cutar MERS ta bazu, an yi tunanin cewa binciken SARS na iya zama abin koyi wajen samar da allurar rigakafi da magunguna don kamuwa da cutar MERS-CoV.
A watan Maris na shekarar 2020, allurar rigakafin MERS guda ɗaya (da ke bisa DNA) ta kammala gwajin asibiti na kashi na I a cikin mutane, kuma an ci gaba da gwaji uku; duk alluran rigakafin masu ɗaukar hoto ne na kwayar cuta, biyu masu ɗaukar hoto na adenoviral (ChAdOx1-MERS, BVRS-GamVac) da ɗaya mai ɗaukar hoto na MVA (MVA-MERS-S).
Shafukan sada zumunta sun yada ra'ayin cewa an san kwayar cutar COVID-19 kuma an riga an samar da maganin rigakafin cutar.
Takardun mallakar da aka ambata a shafukan sada zumunta daban-daban suna nuni ne ga takardun mallakar da aka riga aka samu na samar da kwayoyin halitta da kuma allurar rigakafi ga wasu nau'in cutar korona kamar SARS-CoV-2.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar coronavirus 2 da ke da nasaba da cutar SARS-CoV-2.
Alamun da ake yawan samu sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Sauran alamun na iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin daɗin ci da ciwon ciki.
Lokaci tsakanin bayyanar da bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma yana iya zama tsakanin kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin mutane ba sa nuna irin wannan ciwon, wasu suna iya kamuwa da cutar huhu da kuma ciwon gabobin jiki.
A ranar 17 ga Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a ƙasashe 210 da yankuna, wanda ya yi sanadin mutuwar mutane fiye da 153,000.
An warkar da mutane fiye da 568,000, kuma cutar tana yaɗuwa ne ta wurin haɗuwa da mutane, sau da yawa ta hanyar tari da kuma magana.
Tun da yake ana samar da waɗannan ɗigon a lokacin numfashi, yawanci suna faɗuwa ƙasa ko kuma a kan wasu wurare maimakon su zama masu haɗarin kamuwa da cuta a nesa mai nisa.
Mutane kuma za su iya kamuwa da cutar ta wurin taɓa wani abu da ke da cutar, sai su taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cuta za ta iya rayuwa a kan wani abu har tsawon sa'o'i 72.
Yana da yafi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suke zaton cewa suna da cutar da kuma masu kula da su.
Shawarwari game da sanya abin rufe fuska ga jama'a sun bambanta, wasu hukumomi sun ba da shawarar kada a yi amfani da shi, wasu sun bada shawarar yin amfani da shi, wasu kuma sun bukaci a yi amfani da shi.
A halin yanzu babu takamaiman maganin rigakafi ko maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a mafi yawan ƙasashe na yankuna shida na WHO.
Mutane da suka kamu da cutar na iya zama marasa alamun cutar ko kuma su iya samun alamun cutar mura kamar zazzabi, tari, gajiya, rashin numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, wahalar tafiya, fuska ko lebe mai shuɗi; idan akwai waɗannan alamun, ya kamata a nemi likita nan da nan.
A wasu lokatai, ana iya samun ciwon hanci da ciwon hanci.
An lura da alamun ciwon ciki kamar su ciwon ciwon ciki, amai, da kuma zawo a wurare dabam dabam.
Wasu mutane a China sun fara da matsin zuciya da kuma bugun zuciya.
A wasu, wannan cuta tana iya sa huhu ya kumbura, gabobin jiki da yawa su kasa aiki, kuma mutum ya mutu.
Wannan shi ne abin da ake kira lokacin da ake yin ɓoye-ɓoye.
Lokacin da cutar COVID-19 ke ɓuɓɓugowa yawanci kwanaki biyar zuwa shida ne, amma yana iya kaiwa kwanaki 14.
Kashi 97.5 na mutanen da suka samu alamun cutar za su samu a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duka mutanen da suka kamu da cutar ba ne za su samu alamun cutar.
Ba a san cikakken matsayin waɗannan masu dauke da cutar ba a watsa cutar, amma akwai wasu bayanai na farko da ke nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san yawan mutanen da suka kamu da cutar ba tare da nuna alamun cutar ba kuma ana ci gaba da bincike. Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) sun ruwaito cewa kashi 20 cikin dari na dukkan wadanda aka tabbatar da su sun kasance ba su da alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta Sin ta fara hada wadanda ba su da alamun cutar a cikin adadin masu cutar ta yau da kullum a ranar 1 ga Afrilu; daga cikin mutane 166 da aka samu a wannan rana, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Duka hawan jini da kuma haushi suna iya ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana sa mutane su ji daɗin magana fiye da yin magana a kai a kai.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi tari ba tare da ya kāre kansa ba, zai iya zubar da ɗigon ruwa daga nesa na mita 4.5 (mita 15).
Ko da yake ba a yawanci ana yada kwayar cutar ta iska, National Academy of Sciences ta ba da shawarar cewa ana iya yada ta ta hanyar iska mai rai kuma masu tara iska da ke cikin hanyar wucewa a waje da ɗakunan marasa lafiya sun samar da samfurori masu kyau na RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar su intubation da kuma cardiopulmonary resuscitation (CPR) na iya watsa ɓarnar numfashi kuma hakan na iya kai ga yaduwar iska.
Ko da yake akwai damuwa game da yaduwar cutar ta hanyar kwance, ana ganin cewa wannan hadarin ba shi da yawa. Kwayar cutar tana yaduwa sosai lokacin da mutane ke da alamun cutar; ko da yake yaduwa na iya yiwuwa kafin bayyanar cututtuka, amma wannan hadarin ba shi da yawa.
Cibiyar Kula da Cututtuka da Tsaro ta Turai (ECDC) ta ce idan ba a san yadda cutar take yaɗuwa ba, mutum ɗaya yakan yaɗa cutar zuwa mutane biyu ko uku, kuma ƙwayoyin cuta suna iya rayuwa a kan mutane na tsawon sa'o'i ko kwanaki.
An gano cutar bayan kwana ɗaya a kan kwali, bayan kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304) kuma bayan awa huɗu a kan jan ƙarfe kashi 99 cikin ɗari.
Amma, wannan yana bambanta dangane da zafi da kuma zafin jiki.
Sabulu da kayan wanke-wanke ma suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna lalata fatar da ke kare kwayar cutar, ta haka ne ta kashe ta kuma kawar da ita daga fata da sauran wurare.
A wani bincike da aka yi a Hong Kong, an ɗauki samfurori na hawaye a matsakaici kwana biyu bayan an fara asibiti.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna yawan kwayar cutar, yayin da na shida ya nuna yawan kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus 2 mai nasaba da cutar numfashi mai tsanani (SARS-CoV-2) sabuwar kwayar cutar korona ce mai nasaba da cutar numfashi mai tsanani, wadda aka fara ganowa a cikin mutane uku da ke da ciwon huhu da ke da nasaba da cutar numfashi mai tsanani ta Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna cikin kwayar cutar korona da ke da nasaba da ita a yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu, wanda ke karya murfin kariya. SARS-CoV-2 dangi ne na kusa da SARS-CoV na asali.
COVID-19 ya fi shafar huhu saboda kwayar cutar tana shiga cikin ƙwayoyin da ke cikin jikinta ta hanyar enzyme mai sauya jini na 2 (ACE2) wanda ya fi yawa a cikin ƙwayoyin alveolar na nau'in II na huhu.
Kwayar cutar tana amfani da wani takamaiman glycoprotein da ake kira  spicule  (peplomer) don ɗaure zuwa ACE 2 kuma ta shiga cikin kwayar mai masaukin.
An samu raunin zuciya mai tsanani a kashi 12 cikin 100 na waɗanda aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a lokacin da cutar ta fi tsanani.
Yawan cututtukan zuciya suna da yawa, saboda amsawar kumburi na tsarin cuta da kuma rashin lafiyar tsarin garkuwar jiki yayin ci gaban cutar, duk da haka lalacewar myocardial mai tsanani na iya kasancewa da alaƙa da masu karɓar ACE 2 a cikin zuciya.
Ana nuna masu karɓa na ACE 2 sosai a cikin zuciya da kuma ayyukan zuciya da ke ciki.
An samu yawan kamuwa da cutar jini (31%) da cutar jini mai saurin narkewa (25%) a cikin marasa lafiya a sashen kula da gaggawa da ke fama da cutar COVID-19 kuma ana iya danganta su da rashin ciwon. Binciken gawa na mutanen da suka mutu daga COVID-19 ya nuna lalacewar alveolar diffuse (DAD) da kuma kumburi mai dauke da kwayar cutar lymphocyte a cikin huhu.
Ko da yake SARS-COV-2 yana nuna ƙarancin ƙwayoyin epithelial na hanyar numfashi waɗanda ke nuna ACE-2, marasa lafiya da ke da COVID-19 mai tsanani suna nuna alamun cutar mai saurin kumburi.
Musamman, kwayoyin T masu ɓoye GM-CSF ne aka danganta su da samun ƙwayoyin cuta masu ɓoye IL6 da kuma cutar huhu mai tsanani a cikin marasa lafiya da ke da COVID-19.
An kuma samu wasu ƙwayoyin lymphocyte a lokacin da aka yi wa mutum jinya.
Hukumar lafiya ta duniya ta wallafa wasu hanyoyin gwaji na cutar.
A cikin tsarin gwajin da aka saba amfani da shi ana amfani da juyin juya halin polymerase chain reaction real-time (rRT-PCR).
Ana yin gwajin ne a kan samfurorin numfashi da aka samu ta hanyar ƙwayar rhinopharyngeal; duk da haka, ana iya yin amfani da ƙwayar hanci ko kuma ƙwayar ɓuɓɓugar hanci.
Sau da yawa ana samun sakamako cikin sa'o'i kaɗan ko kuma kwanaki biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini sau biyu a tsakanin makonni biyu kuma sakamakon ba shi da amfani nan take.
Masana kimiyya na kasar Sin sun iya ware wani nau'in cutar korona kuma sun fitar da tsarin kwayoyinta, don haka dakunan gwaje-gwaje a duk duniya sun iya samar da gwajin polymerization chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta da kuma kamuwa da cutar da mutum ya riga ya kamu da ita) amma ba a yi amfani da shi sosai ba.
Gwajin gwajin na kasar Sin ya nuna cewa daidaici na kashi 60-70 ne kawai.
Hukumar FDA a Amurka ta amince da gwajin farko na kusa da mai haƙuri a ranar 21 ga Maris, 2020, wanda za a yi amfani da shi a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga yanayin asibiti da kuma hadarin annobar.
Alamar farko na kamuwa da cuta ita ce, akwai gilashin da ke da yawa da ke da bambanci da kuma rarraba a gefen, a baya da kuma a baya.
Ƙarfin da ke ƙarƙashin bakin ciki, da kuma haɗuwa da ke tsakanin ɓangarorin jikin mutum da kuma ƙarar ƙurar ƙurar ƙurar ƙurar ƙurar ƙurar ƙurar ƙurar ƙurar ƙwarya, za su iya bayyana yayin da cutar take ci gaba.
Ba a samu bayanai masu yawa game da lalacewar da ke faruwa ta hanyar gani da kuma yadda cutar COVID-19 take.
Babban binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Binciken da aka yi: ciwon zuciya, ciwon zuciya, ƙullawar huhu, da kuma kumburin huhu
Za a iya lura da nau'ikan nau'ikan cutar huhu na kwayar cuta guda huɗu:
ciwon huhu mai saurin tashi: kumburi na huhu, hawan jini, ƙwayoyin cuta masu yawa, kumburi na ciki da ke saurin shiga cikin ƙwayoyin cuta da kuma ƙwayoyin jini masu girma da yawa
ciwon huhu mai tsanani: lalacewar alveolar (DAD) tare da ɓarnar alveolar.
DAD tana haddasa matsanancin ciwon numfashi (AFS) da kuma matsanancin rashin isashshen jini.
ciwon huhu da ke warkewa: haɗuwa da ƙwayoyin cuta a cikin alveolar cavities da kuma ciwon huhu na interstitial
Jinin: yaduwar jini cikin jini (CIVD); halayen leuko-erythroblastic
Matakan kariya na rage haɗarin kamuwa da cuta sun haɗa da zama a gida, guje wa wuraren da mutane suke da yawa, wanke hannaye da sabulu da ruwa a kai a kai na akalla sakan 20, kiyaye tsaftace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da takunkumi lokacin da kake tari ko kuma hancinka da kuma amfani da ciki na wuyan hannu idan babu takunkumi.
Ana ba da shawarar a tsabtace hannaye bayan an yi tari ko kuma tari.
CDC ta ba da shawarar rufe fuska da takarda a wuraren jama'a don rage yaduwar cutar a cikin mutanen da ba su da alamun cutar. Dabaru na nisantar da jama'a na nufin rage hulɗa tsakanin mutane masu kamuwa da cutar da manyan rukuni ta hanyar rufe makarantu da wuraren aiki, rage tafiye-tafiye, da kuma soke manyan tarurrukan mutane.
Ƙa'idodin nisantar mutane sun haɗa da kiyaye tazarar ƙafa 6 (1.8 m) tsakanin mutane.
Babu wani magani da aka sani da zai iya taimakawa wajen hana COVID-19. Tun da ba a sa ran samun rigakafin cutar ba sai 2021 da wuri, wani muhimmin bangare na kula da COVID-19 shi ne ƙoƙarin rage yawan annobar, wanda kuma ake kira da "yarfafa ƙirar".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan 20, musamman bayan sun je bayan gida ko kuma idan hannayensu suna da datti sosai; kafin cin abinci; da kuma bayan sun yi hanci, tari, ko kuma hancin.
Ya kuma bada shawarar a yi amfani da maganin kashe wuka na hannu da aka yi da barasa wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa, amma idan ba a samun ruwa da sabulu. Ga yankunan da ba a samun maganin kashe wuka na hannu na kasuwanci, WHO ta ba da shawarwari biyu don samarwa a gida.
A cikin waɗannan magungunan, aikin rigakafin ƙwayoyin cuta ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin giya, ba abu ne mai aiki na maganin kashe wuka ba.
Ana ƙara glycerol a matsayin mai ƙosar da ruwa.
Ana kula da mutane ta hanyar kulawar tallafi wanda zai iya haɗa da maganin ruwa, maganin oxygen da kuma goyon bayan sauran gabobin rayuwa da suka kamu.
Hukumar ta CDC ta ba da shawarar cewa mutanen da ake zargi da dauke da cutar su sanya abin rufe fuska.
An yi amfani da maganin oxygenation na membrane na waje da jiki (ECMO) wajen magance matsalar numfashi, amma ana ci gaba da nazarin amfaninsa.
An ba da shawarar tsaftace kai, salon rayuwa mai kyau da abinci mai gina jiki don inganta rigakafi.
Maganin tallafi na iya zama da amfani ga waɗanda ke da alamun rashin lafiya a farkon kamuwa da cutar. WHO da Hukumar Lafiya ta China sun ba da shawarwari game da kula da mutanen da ke asibiti don COVID-19.
Likitocin da ke kula da masu warkarwa da kuma masu nazarin huhu a Amirka sun tattara shawarwari na magani daga hukumomi dabam dabam a cikin wani kayan aiki na kyauta, wato, IBCC.
A watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Game da bayyanar cututtuka, wasu ma'aikatan kiwon lafiya suna ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen a matsayin magani na farko.
Dole ne a ɗauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a yanayin kulawa inda aiwatar da hanyoyin zai iya haifar da aerosols, kamar intubation ko iska mai hannu.
CDC ta ba da shawarar cewa masu kula da lafiyar da ke kula da mutane da ke da COVID-19 su sanya mutum a cikin wani ɗaki na keɓewa wanda ya dace da kamuwa da cutar ta iska (AIIR) ban da yin amfani da daidaitattun matakan kariya, hanyoyin tuntuɓar mutane da kuma hanyoyin kariya na yaduwar cutar ta iska. CDC ta nanata jagororin da suka shafi amfani da kayan kariya na mutum (PPE) a lokacin annobar.
Kayan da ake bada shawara su ne: rigar PPE, abin rufe fuska ko na numfashi, kariya ga idanu da safofin hannu.Idan akwai, ana ba da fifiko ga abin rufe fuska (a kan abin rufe fuska).
An amince da abin rufe fuska na numfashi na N95 a ƙarƙashin yanayin masana'antu, amma FDA ta ba da izinin amfani da waɗannan abin rufe fuska a ƙarƙashin izinin amfani na gaggawa (Amurka).
An tsara su ne don kare ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancin su a kan takamaiman masu amfani da kwayoyin halitta ba don amfani da ba a nuna ba.
Idan ba a samu abin rufe fuska ba, CDC ta ba da shawarar yin amfani da abin rufe fuska, ko kuma a matsayin mafita, abin rufe fuska da aka yi da hannu.
Yawancin cututtukan COVID-19 ba su da tsanani da za su bukaci yin amfani da iska ko wasu hanyoyin, amma akwai wasu kashi na masu cutar.
Ana ci gaba da bincike kan irin taimakon numfashi da za a yi wa mutanen da ke fama da cutar COVID-19 a asibitoci. Akwai wasu shaidu da ke nuna cewa ana iya guje wa yin numfashi ta hanyar yin amfani da na'urar hanci mai saurin gudu ko kuma matsin numfashi mai saurin gudu biyu.
Ba a san ko ko ɗaya ko duka suna kawo riba iri ɗaya ga waɗanda suke cikin yanayi mai tsanani ba.
Wasu likitoci sun fi son yin amfani da na'ura mai kwantar da hanci idan ana iya samunsa domin wannan fasaha tana rage yaduwar aerosol fiye da na'urar hanci mai gudu.
Kasashe da yawa masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya na kula da karuwar adadin masu cutar COVID-19 da ke da tsanani sosai da ke bukatar a kwantar da su a asibiti.
Wani bincike a China ya nuna cewa kashi 5 cikin 100 na waɗanda suka kamu da cutar sun shiga sashen kula da masu ciwo, kashi 2.3 cikin 100 sun bukaci taimakon numfashi, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30 cikin ɗari na waɗanda aka kwantar da su a asibiti da COVID-19 a ƙarshe ana shigar da su cikin sashen kula da masu ciwo mai tsanani.
Yin iska ta hanyar inji ya zama da wuya yayin da cutar ta COVID-19 ta haifar da ciwon numfashi mai tsanani (Acute Respiratory Stress Syndrome - ARDS) kuma samun iskar oxygen ya zama da wuya.
Ana bukatar na'urorin iska masu kula da matsin lamba da kuma PEEP mai yawa domin inganta isar da iskar oxygen da rage hadarin lalacewar huhu da ke tattare da iska da kuma pneumothorax.
Ana iya samun ƙarancin PEEP a tsofaffin na'urorin iska.
Bincike kan yiwuwar maganin ya fara a watan Janairun 2020 kuma ana gwajin magungunan rigakafin ƙwayoyin cuta da dama a asibiti.
Remdesivir ne ke da kyau sosai.
Ko da yake ba za a iya samar da sabbin magunguna ba har zuwa 2021, an riga an amince da magunguna da dama da ake gwadawa a wasu alamomi kuma an riga an ci gaba da gwaji.
Ana iya gwada maganin rigakafin cutar a kan mutane da ke fama da ciwo mai tsanani.
WHO ta ba da shawarar masu sa kai su shiga gwaji kan inganci da amincin magunguna. FDA ta ba da izini na ɗan lokaci don plasma na mutanen da suka warke a matsayin magani na gwaji a lokuta da rayuwar mutumin ke cikin haɗari mai tsanani ko nan take.
Ba a yi gwajin asibiti da ya dace don tabbatar da amincinsa da ingancinsa ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da manhajar wayar salula don magance cutar.
Ana tambayar masu amfani su shigar da sunansu da kuma lambar shaidar.
Aikace-aikacen na iya gano  kusanci  ta amfani da bayanan sa ido kuma saboda haka yana iya gano yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano wata barazana, app ɗin ba kawai yana ba da shawarar keɓe kai ba, amma kuma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanai mai yawa daga bayanan wayar hannu, fasahar gane fuska, wurin wayar hannu da kuma ilimin kere kere don gano mutanen da ke da cutar da kuma waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba wa hukumomin tsaro damar gano bayanan wayar hannu na mutanen da ake zargin suna da cutar korona.
An yi wannan ne domin a kiyaye dokar killace mutane da kuma kare mutanen da suka iya kasancewa tare da mutanen da suka kamu da cutar.
Har ila yau, a watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan gano inda wayar take da hukumar gwamnatin tarayya ta Jamus, cibiyar Robert Koch, domin bincika da kuma hana yaduwar cutar.
Rasha ta tura fasahar gane fuska don gano mutanen da ba sa bin dokar keɓewar kai.
A Italiya, Ministan Lafiya na yankin Giulio Gallera ya ce masu sadarwar wayar salula sun sanar da shi cewa  40% na mutane suna ci gaba da tafiya .
Gwamnatin Jamus ta gudanar da wani karshen mako na hackathon na sa'o'i 48 da sama da mutane 42,000 suka halarta.
Shugaban kasar Estonia, Kersti Kaljulaid, ta yi kira ga duniya da ta nemi hanyoyin da za su hana yaduwar cutar korona.
Mutane na iya shan wahala daga keɓewar kansu, ƙuntatawa na tafiya, sakamakon magani ko kuma tsoron kamuwa da cutar kanta.
BBC ta nakalto Rory O'Connor yana cewa,  Ƙara warewar jama'a, kadaici, damuwar lafiya, damuwa da koma bayan tattalin arziki su ne cikakkun abubuwan da ke cutar da lafiyar kwakwalwa da lafiyar mutane .
Cutar na iya zama mai saurin ci gaba da rashin alamun cutar ko kuma ba ta nuna alamun cutar, kamar sauran cututtukan numfashi na yau da kullum kamar su mura.
Masu cutar masu saurin kamuwa da cutar sukan warke cikin makonni biyu, yayin da masu cutar masu tsanani sukan yi makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanan da aka samu daga irin wannan ƙwayoyin cuta, kamar SARS da MERS, duk da haka, babu bayanai game da COVID-19. A wasu lokuta, COVID-19 na iya shafar huhu kuma ya haifar da ciwon huhu.
A cikin waɗanda suka kamu da cutar sosai, COVID-19 na iya saurin ci gaba zuwa matsanancin ciwon numfashi (Acute Respiratory Stress Syndrome - ARS) wanda ke haifar da rashin numfashi, tashin hankali ko kuma rashin aiki da yawa.
Matsalar da ke tattare da COVID-19 sun haɗa da cutar sankarar jini, rashin jini, da kuma lalacewar zuciya, koda da hanta.
An bayyana rikicewar jini, musamman a cikin yawan prothrombin, a cikin kashi 6 cikin ɗari na waɗanda ke asibiti da COVID-19, tare da rashin aikin koda a cikin kashi 4 cikin ɗari na mutanen da ke wannan rukunin.
Kimanin kashi 20 zuwa 30 cikin ɗari na mutanen da ke da cutar COVID-19 suna da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Wannan rahoton ya nuna cewa matsakaicin lokacin da mutum ya mutu daga lokacin da ya soma nuna alamun cutar kwanaki goma ne, kuma kwanaki biyar ne aka kwantar da shi a asibiti.
Duk da haka, marasa lafiya da aka kai su ICU sun yi matsakaicin kwana bakwai tsakanin shiga asibiti da mutuwa.
A cikin binciken da aka yi na farkon kamuwa da cutar, matsakaicin lokacin da aka yi tsakanin bayyanar cututtuka da mutuwa kwanaki 14 ne, tare da jimlar kwanaki daga shida zuwa 41.
A wani bincike da hukumar kiwon lafiya ta kasar Sin (NHC) ta yi, an gano cewa maza suna mutuwa da kashi 2.8 cikin dari, yayin da mata suke mutuwa da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
An lura da canje-canje na kwayar cutar a cikin ƙwayoyin huhu.
Wannan hoton na huhu yana kama da ciwon numfashi mai tsanani (ADRS).
A cikin kashi 11.8 na mutuwar da Hukumar Lafiya ta Ƙasa ta Sin ta ruwaito, an ga raunin zuciya da ya faru ne saboda yawan troponin ko kuma rashin ciwon zuciya.
Bayanai na watan Maris daga Amurka sun nuna cewa kashi 89% na waɗanda aka kwantar a asibiti suna da cututtuka da suka riga sun wanzu.
Ƙididdigar yawan mutuwar cutar ta bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda ƙalubalen da ake fuskanta a hanyoyin da ake bi.
Rashin ƙididdigar ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin.
Amma, mutuwar da aka yi a baya na iya nuna cewa ba a kimanta yawan mutuwar a yanzu ba.
Masu shan sigari sun fi sau 1.4 na samun munanan alamun cutar COVID-19 kuma sun fi sau 2.4 na shiga asibiti na gaggawa ko mutuwa idan aka kwatanta da marasa shan sigari. An kuma nuna damuwa game da tasirin cutar na dogon lokaci.
Hukumar asibiti ta Hong Kong ta lura da raguwar kashi 20 zuwa 30 cikin 100 na ikon numfashi a wasu mutane da suka warke daga cutar, kuma binciken da aka yi a cikin huhu ya nuna cewa akwai lalacewar jiki.
Wannan kuma zai iya kai ga ciwon da ake kira post-intensive care syndrome bayan an warke.
A watan Maris na shekarar 2020, ba a san ko kamuwa da cutar da aka yi a baya tana ba da gagarumar rigakafin cutar ba a cikin mutanen da suka warke daga cutar.
Ana ganin cewa ana iya samun rigakafi, bisa ga halayyar sauran ƙwayoyin cuta, amma an samu rahoton mutane da suka warke daga COVID-19 kuma suka gwada tabbatacciyar cutar a wani lokaci.
Ana ɗaukan waɗannan a matsayin ƙarin kamuwa da cuta maimakon sake kamuwa da cuta.
An yi imanin cewa kwayar cutar ta halitta ce kuma ta samo asali ne daga dabbobi, ta hanyar yaduwar kamuwa da cuta.
Ba a san ainihin asalin cutar ba, amma a watan Disambar 2019 yaduwar cutar ta kusan ta hanyar yaduwa daga mutum zuwa mutum.
Binciken da aka yi na mutane 41 da aka fara tabbatar da su da cutar COVID-19 da aka buga a cikin Janairu 2020 a cikin jaridar The Lancet ya gano cewa farkon lokacin da aka fara nuna alamun cutar ya kasance ranar 1 ga Disamba, 2019.
Bayanan hukuma na WHO sun nuna bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa wajen kimanta yawan mutuwa.
Waɗannan adadi sun bambanta a yankuna da kuma lokaci, kuma suna da nasaba da yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma al'amuran alƙaluma kamar su shekaru, jinsi, da kuma yanayin kiwon lafiya.
A karshen shekarar 2019, WHO ta sanya lambobin gaggawa na CIM-10 U07.1 don mutuwar da aka tabbatar a dakin gwaje-gwaje na kamuwa da cutar SARS-CoV-2 da U07.2 don mutuwar waɗanda aka gano a asibiti ko kuma a fannin cututtukan cutar COVID-19 ba tare da tabbatar da kamuwa da cutar SARS-CoV-2 a dakin gwaje-gwaje ba.
A cewar kididdigar Jami'ar Johns-Hopkins, adadin mutuwar da cutar a duniya ya kai kashi 6.9 (153,822/2 240,191) a ranar 17 ga Afrilu, 2020.
Wannan adadi ya bambanta a yanki. Sauran ma'auni sun haɗa da yawan mutuwar mutane (CFR) wanda ke nuna yawan mutanen da aka gano cewa suna mutuwa daga cutar, da kuma yawan mutane da suka kamu da cutar (IRF) wanda ke nuna yawan mutanen da suka kamu da cutar (ko an gano su ko ba a gano su ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a lokaci kuma suna bin takamaiman yawan mutane da suka kamu da cutar a ƙarshen cutar.
Ko da yake ba dukan mutane da suka kamu da cutar ba ne suke samun rigakafin cutar, amma idan akwai rigakafin cutar, hakan zai iya nuna yawan mutanen da suka kamu da cutar.
A cikin cibiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin ƙauye na mutane 4,600, 80 daga cikinsu (1.7%) sun riga sun mutu.
A Gangelt, cutar ta bazu ta hanyar bukukuwa, kuma ga matasa, wanda ya haifar da ƙananan adadin mutuwa, kuma ba a iya rarraba duk mutuwar da ke da nasaba da COVID-19 a matsayin irin wannan ba.
Ƙari ga haka, ba a cika tsarin kiwon lafiya na Jamus ba.
A ƙasar Netherlands, kusan kashi 3 cikin 100 na mutane suna iya samun ƙwayoyin cuta, bisa ga ƙididdigar masu ba da jini.
An tabbatar da mutuwar mutane 69 (0.004% na yawan jama'a) da ke da nasaba da COVID-19.
Tasirin cutar da yawan mace-mace sun bambanta tsakanin maza da mata.
A cikin binciken da aka yi a China da Italiya, an ga cewa mutane sun fi mutuwa.
Maza masu shekara 50 ne suke da haɗarin kamuwa da cutar, kuma bambancin tsakanin maza da mata ya ragu ne kawai sa'ad da suka kai shekara 90.
A ƙasar Sin, adadin mutuwar mutane ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin da ya sa mata da maza suke da bambanci ba, amma ana iya ganin cewa wasu abubuwa da suka sa sun bambanta sun shafi hali da kuma kwayoyin halitta.
Bambance-bambance na rigakafi bisa ga jinsi, ƙarancin shan sigari a cikin mata, da kuma ci gaban cututtuka na ciki kamar hawan jini a cikin maza a wani lokaci fiye da mata na iya taimakawa wajen mutuwar maza.
A Turai, kashi 57 cikin ɗari na waɗanda suka kamu da cutar maza ne kuma kashi 72 cikin ɗari na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta tattara bayanan da suka shafi nau'in kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura, da kuma SARS suna shafan maza da mata dabam dabam.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne kuma suna cikin haɗarin kamuwa da cutar.
Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar a hukumance zai zama  COVID-19 .
Darakta Janar na WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na nufin kwayar cuta kuma D na nufin cuta, 19 ne farkon gano cutar: 31 ga Disamba, 2019.
An zaɓi wannan sunan ne don kaucewa ambaton takamaiman wuri (misali China), nau'in dabba, ko kuma rukuni na mutane, bisa ga shawarwarin ƙasashen duniya na sunayen da ake so a hana ƙyama. Ana kiran kwayar cutar da ke haifar da COVID-19 da coronavirus 2 da ke da alaƙa da matsanancin cutar numfashi (SARS-CoV-2).
WHO ta kuma yi amfani da  kwayar cutar COVID-19  da  kwayar cutar da ke haifar da COVID-19  a cikin sanarwar ta ga jama'a.
An fi kiran cutar da kwayar cutar  coronavirus .
A lokacin da cutar ta fara bulla a Wuhan, China, an fi kiran cutar da cutar  coronavirus  da  Wuhan coronavirus .
A watan Janairun 2020, WHO ta ba da shawarar yin amfani da sunayen cutar na wucin gadi 2019-nCov da kuma cutar numfashi mai tsanani 2019-nCoV don cutar da cutar, daidai da umarnin 2015 game da amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Domin iyakar iyawar da ke cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan kula da lafiya kamar su tasoshin ruwa da kuma kayan numfashi.
Alal misali, sa'ad da asibiti na Italiya ya bukaci bawul din numfashi na gaggawa kuma mai ba da sabis bai iya kawo shi a kan lokaci ba, wani sabon abu na gida ya sake tsarawa kuma ya buga bawul 100 da ake bukata cikin dare ɗaya.
Bayan barkewar cutar COVID-19, ra'ayoyin makirci, da bayanan karya da kuma bayanan da ba daidai ba sun fito game da asalin cutar, yaduwarta, rigakafinta, magani da sauran fannoni kuma nan da nan suka bazu a Intanet.
Kamar dai mutane suna iya yaɗa cutar zuwa wasu dabbobi.
Bincike bai sami tabbacin kwayar cutar ba a aladu, da ducks da kaji.
Babu magani ko allurar rigakafi da aka amince da shi don magance cutar.
Ana gudanar da bincike na duniya kan alluran rigakafi da magunguna na COVID-19 a yanzu ta kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da gwajin SOLIDARITY don kimanta tasirin maganin ƙwayoyin cuta huɗu da ke da ƙarfin gaske.
Babu allurar rigakafi, amma hukumomi da dama suna aiki tukuru wajen samar da masu neman allurar rigakafi.
Ana amfani da aikin SARS-CoV na baya saboda SARS-CoV da SARS-CoV-2 dukansu suna amfani da mai karɓar ACE 2 don shiga cikin ƙwayoyin ɗan adam.
Ana bincike kan dabarun yin allurar rigakafi guda uku.
Na farko, masu bincike suna ƙoƙarin yin allurar rigakafin cutar gaba ɗaya.
Amfani da irin wannan kwayar cutar, ko ta mutu ko ta mutu, na nufin haifar da amsawar garkuwar jiki cikin sauri idan mutum ya sake kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi ta ƙananan ƙwayoyin cuta, tana nufin samar da allurar da za ta sa tsarin garkuwar jiki ya gane wasu ƙananan ƙwayoyin cuta.
A cikin SARS-CoV-2, wannan bincike ya mayar da hankali ne a kan furotin S mai ƙwayoyin cuta wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE 2.
Dabara ta uku ita ce rigakafin nucleic acid (DNA ko RNA, sabuwar hanyar samar da rigakafi).
A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar rigakafi tare da masu ba da kai huɗu a Seattle.
Rigakafin yana ɗauke da lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An nuna cewa kunna kwayar cutar ta dogara da kwayar cutar a matsayin ƙalubale a cikin haɓaka rigakafin SARS-CoV-2, amma yana da rikici.
A watan Afrilu na 2020, sama da gwaji na asibiti 300 na gudana.
Gwaje-gwaje bakwai sun gwada maganin zazzabin cizon sauro da aka riga aka amince da shi, ciki har da gwaje-gwaje huɗu da suka yi amfani da hydroxychloroquine ko chloroquine.
Magungunan rigakafin ƙwayoyin cuta da aka sake juyawa sun zama mafiya yawan bincike na kasar Sin, tare da gwajin asibiti na kashi na uku na remdesivir tara a kasashe da dama da ake sa ran bayar da rahotannin su a ƙarshen watan Afrilu.
An kuma gudanar da bincike mai ƙarfi na ci gaban asibiti na allurar rigakafin COVID-19 da magunguna a watan Afrilu na 2020. Ana gwada magungunan rigakafin cutar da ke akwai a cikin maganin COVID-19, ciki har da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir, da lopinavir/ritonavir tare da interferon beta.
Bayanai na farko sun nuna cewa remdesivir yana da tasiri a watan Maris na 2020.
An ga ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir a cikin jiyya.
Ana gudanar da gwajin asibiti na mataki na III a Amurka, China da Italiya. An yi nazarin maganin chloroquine a China a watan Fabrairu na 2020, tare da sakamakon farko.
Amma, wasu suna son a yi bincike na kansu.
Hukumomin kiwon lafiya na kasar Sin da Koriya sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kiwon Lafiyar Kwayar cuta ta Wuhan, duk da cewa tana ba da shawarar a sha gram ɗaya a kowace rana, ta ce ninka wannan adadin yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da hydroxychloroquine da chloroquine a ƙarƙashin izinin amfani da gaggawa a cikin ikon likitocin da ke kula da marasa lafiya na COVID-19. bugu na 7 na jagororin na kasar Sin ya hada da interferon, ribavirin ko lumifenovir don COVID-19.
Bayanai na farko sun nuna cewa ana bukatar manyan allurai na ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar nitazoxanide don ci gaba da nazarin in vivo bayan nuna ƙarancin ƙwayar cutar SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na farko wanda ke farawa ta hanyar amfani da sinadarin sirrin 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE 2.
Nazarin da aka yi kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana al'ummar likitanci karɓar waɗannan jiyya ba tare da ƙarin nazarin ba. Loseltamivir baya hana SARS-CoV-2 in vitro kuma ba shi da wani muhimmin matsayi a cikin maganin COVID-19.
Cutocin shock na iya zama matsala a cikin matakan COVID-19 mai tsanani.
Akwai shaidar da ke nuna cewa Lhydroxychloroquine na iya samun kaddarorin anti-cytokine. An saka tocilizumab a cikin jagororin magani ta Hukumar Lafiya ta Kasa ta Sin bayan an gudanar da karamin bincike.
Ana gudanar da gwajin kashi na 2 a Italiya bayan da aka nuna cewa yana da kyau a cikin mutane da ke da cutar mai tsanani.
Idan aka haɗa shi da gwajin jini na ƙwayar jini don gano ciwon cytokine, dole ne ya magance irin waɗannan canje-canje da ake zargin cewa suna haifar da mutuwar wasu mutane da ke fama da cutar.
FDA ta amince da maganin mai karɓar mai karɓar interleukin-6 bisa nazarin yanayin baya don maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A yau, babu wani gwaji da aka yi a hankali da aka yi a hankali da ya nuna cewa tocilizumab yana da tasiri wajen maganin CFS.
Ana nazarin canja wurin ƙwayoyin cuta da aka tsabtace da aka samar ta tsarin garkuwar jiki na mutanen da suka warke daga COVID-19 zuwa mutanen da suke bukatarsu a matsayin hanyar da ba rigakafi ba na rigakafin da ba na aiki.
An gwada wannan dabarar don SARS da sakamako kaɗan.
Rashin cutar kwayar cuta ita ce hanyar da ake tsammani maganin rigakafi na iya samar da kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin kamar su cytotoxicity na kwayar cutar da ke dogara da kwayoyin cuta da/ ko phagocytosis na iya yiwuwa.
Ana ci gaba da samar da wasu nau'o'in maganin rigakafi, kamar yin amfani da ƙwayoyin cuta na monoclonal da aka ƙera.
Za a iya ƙara samar da maganin rigakafi daga waɗanda suka warke, wanda ya ƙunshi ruwan jini na marasa lafiya da suka warke da ke ɗauke da ƙwayoyin cuta na musamman da ke yaƙi da wannan cuta, don a iya saurin tura shi.
Cutar Coronavirus, Ƙungiya ce ta cututtuka da ke da alaƙa da juna
Li Wenliang, likita a asibitin Wuhan wanda daga baya ya kamu da COVID-19 kuma ya mutu bayan ya jawo hankali kan yaduwar cutar.
